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9Abstract
Solid state NMR is a powerful method to obtain information on structure
and dynamics of proteins, protein complexes, and other biomolecular
assemblies, that due to solubility and size limitations cannot be achieved
by other methods. This thesis is dedicated to the use of proton detected
solid state NMR experiments at fast (60-100 kHz) magic angle spinning
speeds to probe biomolecular structure, dynamics and intermolecular
interactions. We used solvent paramagnetic relaxation enhancements to
(i) speed up experiments and (ii) measure solvent accesibililty to map
protein – protein interfaces. Further we use nuclear spin relaxation
measurements to obtain information on protein dynamics in a small
protein in two different ensembles; crystalline and precipitated in a >
300 kDa complex. We also apply a combined solution and solid state
NMR approach to investigate the interactions between possibly the most
promising antibiotic lead in modern time, teixobactin, and arguably the
most exciting bacterial target, lipid II. Our most important results include
a new method for probing protein-protein interactions using solvent
paramagnetic relaxation enhancements, the first site specific dynamics
measurements spanning a wide range of time scales obtained in a large
protein complex using as little as 8 nanomoles of isotopically labelled
material, the use of solvent paramagnetic relaxation enhancements to
enable measurements of conformational exchange in a large protein
complex and finally we have identified important conformational changes
involved in the binding of teixobactin to cell wall precursor lipid II.
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1. Introduction
The following chapter provides theoretical basis for understanding the
experimental chapters 2-5. Chapter 2 discusses characterisation of
protein – protein interfaces using solvent paramagnetic relaxation
enhancements. Chapters 3-4 concern protein dynamics in large protein
complexes and chapter 5 interactions between an antibiotic and a
bacterial cell wall precursor. The common theme in all the experimental
chapters is that they include the use of solid state NMR to obtain vital
information about interactions in biomolecular complexes. In chapters 2-
4 the complex studied is a > 300 kDa protein – antibody complex formed
between the B1 domain of bacterial Protein G (GB1) and human
immunoglobulin G (IgG), in chapter 5 it is the complex formed between
an antibiotic, teixobactin, and a cell wall precursor, lipid II. This
introduction includes information regarding bacterial cell walls, solid state
NMR of biomolecules and structure determination by NMR in solution and
in solid state. More specific information related to the experimental work
conducted is provided in each experimental chapter. The introduction
gives more general descriptions of important information that is not
included in the experimental chapters, i.e. information that is vital to
understand how the results were obtained but not suitable for inclusion in
publications. The original aim of my PhD project was to obtain structural
information on bacterial cell walls or on cell wall fragments involved in
the cell wall synthesis and how antibiotics can inhibit the synthesis of cell
walls. In order to achieve this I worked a lot on methods development for
solid state NMR approaches on large complexes, e.g. the GB1:IgG
complex.
1.1 GB1:IgG complex
The B1 domain of Protein G (GB1) has been used as a model protein in
solution and solid state NMR method developments for decades due to its
stable fold and large yields in protein production. The solution NMR
structure of GB1 was solved already in 19911. For solid state NMR
applications it is also beneficial that it is easy and straight-forward to
obtain microcrystals of GB1 yielding NMR spectra with high resolution,
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leading to that it was one of the first protein structures solved by solid
state NMR2–4. However, there is also a biological interest for GB1; the
binding to IgG antibodies. Protein G is produced by group G and C
streptococci as a part of the bacterial defence strategy against antibodies
that enables bacteria to escape detection by the host immune system.5
The high affinity between GB1 and IgG is commonly exploited in
numerous biotechnological applications such as immunosorbent assays or
affinity purification of antibodies. IgG antibodies are used in a range of
therapeutic applications such as cancer treatment and treatments of
infectious diseases. Antibody-based drugs are one of the fastest growing
classes of protein therapeutics and of these unmodified IgG antibodies
are the most common.6 Solution NMR and X-Ray crystallography has
been used to study interactions between domains of Protein G and
fragments of IgG but only with solid state NMR is it possible to
investigate interactions with full length IgG. See chapter 2 for more
details on interactions between GB1 and IgG and chapters 3-4 for details
on the dynamics of GB1 in complex with IgG.
1.2 Antimicrobial resistance
Antimicrobial resistance (AMR) is a global threat resulting in hundreds of
thousands of deaths each year. At the same time the development of
new antibiotics has been slow and there is an urgent need for new
antibiotics that can tackle bacteria that have acquired resistance against
current last resort antibiotics. If these issues are not tackled the
estimated deaths caused by AMR are expected to overtake cancer and
according to the O’Neill report7 10 million people will die each year from
AMR in 2050. Strategies for obtaining new antimicrobial agents include
identifying good targets, which are conserved between different strains of
bacteria and not present in human cells. Such a target is the cell wall
building block lipid II, which is considered in the work presented here.
1.2.1 Peptidoglycan
Bacterial cell wall consists of peptidoglycan, which as the name suggests
is made up of peptides and sugars. Peptidoglycan is an essential part of
bacterial cells. Its main task is to maintain the integrity of the cell by
12
withstanding turgor pressure. If the peptidoglycan is damaged or if the
synthesis of peptidoglycan is interrupted the cell will be destroyed. This
has of course been widely utilized in antibiotics design. In fact penicillin,
which was discovered by Alexander Fleming in the famous accidental
growth of mould incident8, is inhibiting the synthesis of peptidoglycan in
bacteria. Although it took around 35 years from the initial discovery until
it was discovered that penicillin works by inhibiting transpeptidation (see
Fig.1.2) in the peptidoglycan synthesis9,10. Peptidoglycan is also
responsible for keeping a certain cell shape and functions as a scaffold
for anchoring other cell envelope components such as proteins and
teichoic acids. It is closely involved in cell division and cell growth.11
Figure 1.1 shows a schematic drawing of peptidoglycan.
Figure 1.1. Schematic drawing of peptidoglycan. Red lines indicate peptide links connecting glycan
strands.
Peptidoglycan is composed of linear glycan strands that are connected
through peptide links (red lines in Fig. 1.1). The glycan strands consist of
alternating N-acetylglucosamine (NAG, green in Fig. 1.1) and N-
acetylmuramic acid (NAM, orange in Fig. 1.1) connected through β-1-4 
bonds.11 The glycan strands can be modified in different ways; N-
deacetylation, N-glycolylation, O-acetylation, δ-lactam formation, 
attachment of surface polymers and formation of 1-6 anhydro ring.12
There are no bacteria known to have completely unmodified glycan
strands. Modifications affect how the host cells recognize pathogenic
bacteria and it can also result in resistance against host defence
mechanisms. An example is that N-deacetylation has been shown to
increase resistance against lysozyme by making the peptidoglycan a
much worse substrate for the enzyme. The actual effect of the different
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modifications is not very well understood, even though some enzymes
responsible for modifications have been identified.12
The peptide links are formed between peptide stems situated on the
NAM residue of each disaccharide. The peptide stem varies between
different species but the most common is L-Ala-D-Glu-
DAP(diaminopimelic acid)/L-Lys-D-Ala-D-Ala. Variations in this peptide
sequence can result in resistance against antibiotics, which is the case for
bacteria that have obtained resistance against vancomycin (discussed
below in section 1.1.2). The peptide link is usually established between
the carboxyl group in the amino acid at position 4 and the amino group
in the diamino acid at position 3.11 In most gram negative bacteria it is a
direct cross-link and in most gram positive bacteria it has an interpeptide
bridge. Two of the most studied bacteria when it comes to peptidoglycan
are the gram negative Escherichia coli and the gram positive
Staphylococcus aureus. These two differ in peptide cross links as E. coli
has a direct 3-4 cross link while S. aureus has a 3-4 pentaglycine bridge.
The length of the interpeptide bridge can vary between 1 and 7 amino
acids and there are many different amino acids present in different
bacteria. Also the degree of cross-linkage varies. In E. coli approximately
20% of the peptide stems are involved in cross-linkage whereas in S.
aureus it is more than 90%.11 All these different variations in
peptidoglycan structure may be important for how bacteria respond to
antimicrobial agents and more understanding of peptidoglycan and the
synthesis of peptidoglycan is important for the development of new
antibiotics.
Figure 1.2 shows a schematic drawing of the peptidoglycan
biosynthesis pathway adapted from a recent review by Teo and Roper13.
The potential of disturbing the synthesis of peptidoglycan by attacking
this biosynthesis pathway makes it interesting to study and many of the
enzymes involved have been identified as potential targets for antibiotics.
However, perhaps the most interesting target is not an enzyme but the
cell wall precursor lipid II since it is highly conserved between different
bacteria and difficult to modify.
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Figure 1.2. Peptidoglycan synthesis pathway13
Lipid II consists of the general building blocks of peptidoglycan (shown
in figure 1.1), linked through a pyrophosphate group and a carrier lipid
(undecaprenyl pyrophosphate) attached to the membrane (the chemical
structure of lipid II is shown in figure 1.3).
1.2.2 Antibiotics binding to Lipid II
Antibiotics that inhibit the cell wall synthesis are the most popular type of
antibiotics and, as mentioned before, lipid II is an excellent target to
focus on. There are many different types of lipid II binders including;
glycopeptides, defensins, lantibiotics and nonribosomally synthesised
peptides (e.g depsipeptides), recently reviewed by Oppedisjk et al14.
Glycopeptides are peptides that contain residues with glycans attached to
the side chains. The only lipid II binding antibiotic currently in clinical use
is the glycopeptide vancomycin. Vancomycin binds the D-Ala – D-Ala at
the C-terminus of the peptide stem of lipid II by the formation of five
hydrogen bonds. Vancomycin was in clinical use for more than 30 years
before resistance was detected, which highlights the importance of lipid
II binding antibiotics. The resistance towards vancomycin was obtained
from the change of the D-Ala – D-Ala to D-Ala – D-Lac or D-Ala – D-Ser
in the peptide stem of lipid II, resulting in only four hydrogen bonds
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being formed leading to almost a 1000 fold decrease in affinity15. This
substitution has been seen in Lactobacillus casei naturally and in
Enterococci with acquired resistance to vancomycin11. Since vancomycin
binds the peptide stem it can also bind mature peptidoglycan, which
vancomycin intermediate Staphylococcus aureus (VISA) has taken
advantage of by making a thicker peptidoglycan layer leading to that
most vancomycin will bind to the mature peptidoglycan rather than lipid
II. Other parts of lipid II such as the sugars and pyrophosphate are more
conserved between bacteria. Especially the carrier lipid, undecaprenyl
pyrophosphate is very important in the peptidoglycan synthesis pathway
and is not present in mature peptidoglycan. Hence, antibiotics that bind
to the sugars and/or undecaprenyl pyrophosphate of lipid II have the
potential, if they become commercially available, to be used for a long
time before (if ever) antimicrobial resistance will emerge. For this reason
many of the antibiotics that have been studied more carefully recently
are those that are believed to interact with that part. In fact, the
lantibiotic nisin, which interacts with the pyrophosphate group and
possibly parts of the lipid tail has been used for more than 40 years in
the food industry without any resistance being detected. Figure 1.3a
shows suggested binding sites for different interesting lipid II binding
antibiotics. The chemical structure of lipid II is shown in figure 1.3b.
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Figure 1.3. (a) Schematic model of lipid II with binding sites for different types of antibiotics indicated.
(b) chemical structure of lipid II. The lipid tail is represented by C55 as it contains 55 carbons.
A novel lipid II binding mode was identified for nisin from solution NMR
measurements of a nisin – lipid II complex16. In this binding mode a
pyrophosphate cage is formed by intermolecular hydrogen bonds
between backbone amides of nisin in the N-terminus lanthionine ring and
the pyrophosphate group of lipid II. The N-terminal lanthionine ring is
conserved in many lantibiotics and it is likely that the same binding mode
occurs in other lantibiotics. A lanthionine ring is formed by bonds
between side-chains of modified alanines where the β-carbons are cross-
linked with a sulfur atom in between. Nisin belongs to the class A
lantibiotics which are characterized by an elongated structure. They
actually have two killing modes, where the binding of lipid II through the
pyrophosphate cage mode represents the first step, the second step is a
pore formation resulting from insertion of the elongated peptide into the
membrane. Each of those modes would be sufficient to kill bacteria but
the combined mode makes the class A lantibiotics even more efficient.
Class B lantibotics, like mersacidin, works by binding lipid II leading to
the accumulation of cell wall precursors and inhibition of
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transglycosylation. Class B lantibiotics undergo substantial
conformational changes in different environments and when binding lipid
II. This behaviour was shown in an NMR study where conformational
changes were detected when the sample solution was changed from a
methanol/water solution to a membrane environment
(dodecylphophocholine (DPC) micelles) and then again when Lipid II was
present17. Such conformational changes could be important for how the
antibiotic enters the cell and reaches the membrane where lipid II is
located.
An example of an interesting depsipeptide is ramoplanin, which is a cyclic
lipoglycodepsipeptide. Ramoplanin inhibits peptidoglycan synthesis by
blocking transglycosylation upon binding to Lipid II. The mode of action
of ramoplanin seems to be similar as mersacidine, in both cases they
accumulate cell wall precursors inhibiting the formation of peptidoglycan,
and even though the chemical structure is very different between the two
antibiotics their 3D structures are very similar and they both undergo
conformational changes upon binding to lipid II18.
Defensins are found in mammals, invertebrates and plants where they
function as host defence peptides. A very interesting defensin is
plectasin19, which was shown by NMR to form hydrogen bonds with the
pyrophosphate of lipid II and blocking synthesis of peptidoglycan in a
similar way as mersacidine and ramoplanin. In that study several other
defensins binding lipid II were isolated from fungi, maggots and mussels
20.
In many structural studies of antibiotics NMR has been an indispensable
technique. However, in some studies it was noted that antibiotics – lipid
II complexes form large soluble aggregates, making solution NMR
unusable. In the case of ramoplanin it formed fibrillar structures18 that
resulted in severe broadening of the spectra. To prevent fibrillation non-
physiological solvents, such as DMSO, had to be used. In our approach to
study the teixobactin – lipid II complex, which also formed large soluble
aggregates, we took advantage of the fact that in solid state NMR the
18
size dependent tumbling of molecules is not present. This study is
presented in chapter 5.
1.3 NMR
The main technique used in the work presented in this thesis is NMR.
Depending on the sample investigated the experiments were performed
in solution or in solid state. Most of the samples were not suitable for
solution NMR due to size implications but in the cases where applicable,
solution NMR gave important information: It was used to obtain solvent
accessibility for isolated GB1 in chapter 2 and to solve the 3D structure of
teixobactin in membrane mimics in chapter 5. This section is mostly
focused on solid state NMR, but the information is valid for solution NMR
as well and important aspects where the techniques differ are pointed
out.
1.3.1 Basic theory
In this section a few important theoretical aspects of NMR will be briefly
discussed. The NMR interactions are described by quantum mechanics
and it is beyond the scope of this thesis to go into a full description of the
physics required to explain it properly. Some important theoretical
aspects will be introduced but the explanations will be left out. This
section is based on information that can be found in the NMR text books
written by Malcolm H. Levitt21, James Keeler22, Melinda J. Duer23, Gordon
S. Rule and Kevin T. Hitchens24.
First of all, it is important that the nuclei investigated are NMR active,
that is they have a spin angular momentum. All nuclei that have an odd
mass number have spin angular momentum since they have an unpaired
proton. The nuclei commonly occurring in proteins are hydrogen, carbon,
nitrogen and oxygen. All of these have isotopes that are NMR active
(table 1.1). As can be seen in the table also nuclei with even mass
number can have a spin angular momentum, that is if they have an odd
charge. Nuclei that have spin angular momentum have a non-zero spin
number. Nuclei with even number of protons and neutrons have spin
number 0, and hence no spin angular momentum.
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Table 1.1. Properties important for NMR of different isotopes of the most common nuclei in proteins.
Nucleus Spin Abundance (%) γ (MHz / T)
1H ½ 99.98 42.57697
2H 1 0.0015 6.535857
3H ½ 0 45.41486
13C ½ 1.108 10.70842
14N 1 99.63 3.077738
15N ½ 0.37 -4.31628
17O ⁵⁄₂ 0.037 -5.77398
For hydrogen the most abundant isotope is 1H, which also has the largest
gyromagnetic ratio (γ) of all nuclei used for NMR. 3H has a larger γ, but it
is radioactive and not naturally abundant so it is not often used in NMR.
For carbon, where the most abundant isotope is 12C, which is a spin 0
isotope, typically it is necessary to introduce 13C (natural abundance 13C
can be used for smaller compounds) and 15N is introduced instead of 14N
(which is quadrupolar and can be measured but is generally not used in
proteins) for NMR applications. Oxygen would be very useful but since
16O is spin 0 and the NMR active 17O is spin 5/2 and hence has a
quadrupolar moment it is not often used in protein NMR (though it is still
an active area of method development).
The first interaction in NMR that needs to be considered when a sample is
put in a static magnetic field (B0) is called the Zeeman interaction, which
describes how spins are split into quantum states with different energy
levels (Figure 1.4a). For nuclei with spin I the number of energy levels is
2I+1. Spin ½ nuclei have then two energy levels, generally called Eα and
Eβ, where the difference in energy between the two states is defined as
the Larmor frequency:
    =        =   ×        (1.1)
in Hz, γ is the gyromagnetic ratio (rad s-1 T-1) and B0 the static magnetic
field (T). The 2π is used to convert from rad s-1 to Hz. The spins are said
to precess around the B0 field at the Larmor frequency (figure 1.4b).
NMR magnets are often referred to by their 1H Larmor frequency in MHz.
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The population ratio between the energy levels is described by Boltzmann
distribution:
   
   
=       ħ        (1.2)
where ħ is Plancks constant divided by 2π, k is the Boltzmann constant
and T is the temperature.
Figure 1.4. (a) Zeeman splitting for a spin ½ nuclei. The difference between the energy levels is the
Larmor frequency. (b) Larmor precession around the B0 field.
The Boltzmann distribution is important since the NMR signal partly
depends on that the populations of the energy levels are different and
the quantity of the difference can be changed by changing the
gyromagnetic ratio, the B0 field and the temperature. Higher magnetic
field gives higher signal, higher gyromagnetic ratio gives higher signal
and lower temperature gives higher signal, although for proteins there is
normally not much room for changing the temperature to make any
difference.
In a one pulse experiment a π/2 radiofrequency pulse is applied at the 
Larmor frequency of the nuclei of interest with a certain nutation
frequency
    =   ×     (1.3)
creating a local magnetic field B1. The spins will be rotated from the z-
axis and precess at the Larmor frequency in the xy plane. The precession
results in an oscillating magnetic field, which, in accordance to Faradays
law, induces a current in a coil in the NMR probe recorded as the free
21
induction decay (FID). The FID is then Fourier transformed into a time
domain axis and plotted as intensity versus frequency.
Before moving on to experiments correlating different nuclei a few more
interactions need to be introduced. So far the interactions (described by
Hamiltonians in quantum mechanics) have been external; interactions
between the magnetic field and the spins and interactions between
radiofrequency pulses and the spins, but there are also internal
interactions. The internal Hamiltonians are interactions of spins with the
local electronic environment (chemical shift), with each other (dipolar
and scalar couplings) and with electric field gradients (quadrupolar
couplings). For spin ½ nuclei, which are considered in all experiments
here, no quadrupolar interactions are present. The internal interactions
can have parts that are isotropic (independent of orientation with respect
to B0) and anisotropic (dependent of orientation with respect to B0).
Dipolar couplings are anisotropic and consist of both homonuclear and
heteronuclear couplings in a sample with more than one nucleus. To fully
describe the dipolar couplings it would be necessary to involve quantum
mechanics, but for the purpose of this thesis it is sufficient to present the
dipolar couplings as:
  ∝          
    (3 cos     − 1) (1.4)
where r is the distance between the coupled spins and θ is the angle
formed between the spins and the B0 field. The chemical shift depends on
the Larmor frequency and chemical shielding based on the electronic
environment around the spin. The chemical shift can be described as:
  =       (1 −   ) (1.5)
where σ is the chemical shielding. The isotropic chemical shift (i.e. the
component of chemical shift that is independent of the orientation with
respect to B0) is simply the Larmor frequency determined from the local
magnetic field that each spin feels as a combination between the static
field and the field produced by surrounding electrons. The magnetic field
created by the electrons around a nucleus is not uniform so there will be
an anisotropic part to the chemical shift, which just as for the dipolar
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couplings is proportional to the second Legendre polynomial ½(3cos2θ –
1). Scalar couplings, or J-couplings as they are normally referred to, are
isotropic and give rise to J-splittings in NMR spectra. Since they are much
weaker than dipolar couplings and chemical shift anisotropy the line
widths reachable in solid state NMR typically are broader than the J-
splittings so they are often ignored. However, with recent methodological
advances and improvements in resolution J-couplings receive more
attention in the solid state.
Line broadening is caused by the effect of anisotropic interactions on the
T2 relaxation time, which represents the loss of coherence in the
transverse plane due to spin-spin interactions. Further information on
relaxation is given in section 1.3.3. There are two main ways of removing
unwanted broadening caused by the interactions described above;
rotating the sample and decoupling. In solution NMR the molecules
tumble freely and sample all orientations leading to that anisotropic
interactions are averaged to 0. J-couplings, which are isotropic, are still
present but can be removed by decoupling. Heteronuclear J-couplings
are weak and easily removed by applying a weak radio frequency field
on, for example, the 13C channel during 1H detection. Homonuclear J-
couplings, however, are more complicated to remove and lead to J-
splitting normally seen in solution NMR experiments. As mentioned
above, in solid state NMR the lines are often not sufficiently narrow to
observe J-splittings. To remove anisotropic interactions in solid state
NMR the sample is mechanically rotated at the magic angle (θ = 54.74°),
where ½(3cos2θ – 1) = 0. For the magic angle spinning (MAS)25,26 to
efficiently average out the anisotropic interaction the spinning speed
needs to be much faster than the strength of the interaction (in Hz).
As mentioned above the Boltzmann distribution is important for the
sensitivity of an NMR experiment, the increase in γ to increase the
sensitivity is taken advantage of in the cross–polarization (CP)27
experiment, in solid state NMR, where magnetization from the higher γ 
nuclei, often 1H, can be transferred to lower γ nuclei (13C or 15N in
proteins) to increase the signal. Figure 1.5 shows the pulse sequence of a
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CP experiment and what happens to the magnetization during the
experiment.
Figure 1.5. Cross polarization experiment. Left, block diagram of the pulse sequence. Right,
magnetization transfer showed on xyz coordinates.
First a π/2 pulse is applied to the 1H channel, which causes the
magnetization to go into the xy plane. In this example the pulse was
applied about the y axis leading to magnetization along x. The CP
transfer is made up of spin-lock pulses at both channels simultaneously
causing the magnetization to precess around x at the same nutation
frequency for both nuclei as long as the pulse is on. Now the strong
heteronuclear dipolar couplings will cause magnetization to transfer
between the excited 1H spins and the 13C spins. Once the pulse is turned
off the spins will precess around the x-axis at the Larmor frequency and
the FID can be recorded on the 13C channel, while heteronuclear
decoupling is applied to the 1H channel. For the transfer to work the
nutation frequencies need to be equal for both channels so that the
Hartmann – Hahn condition is fulfilled:
      =       (1.6)
This is valid in static samples, but when MAS is employed making the
dipolar couplings time dependent the Hartmann-Hahn matching condition
becomes:
      ±       =           ,   = 1,2 (1.7)
If the magnetization transfer would be 100% efficient the signal could be
increased by a factor of γ1/γ2, compared to an experiment with direct
excitation of the lower γ nuclei, which is approximately 4 if γ1 is 1H, γ2 is
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13C and 10 if γ1 is 1H, γ2 is 15N. CP experiments can also be repeated
quicker since the repetition delay depends on the T1 relaxation time (see
section 1.3.3) of the excited nuclei and the spins need to return to
equilibrium before the next experiment can be started. T1s for protons
are much shorter than T1s for lower gamma nuclei (e.g 13C and 15N)
leading to higher signal to noise ratio in the same time (signal to noise
ratio increases by √n, where n = number of repetitions).  
In most NMR experiments it is desirable to obtain as narrow lines as
possible, especially in protein NMR since the spectra typically contain
many signals and if the peaks are too broad it is difficult to assign which
peaks belong to which atom in the protein. To achieve narrow lines when
using MAS it is important that the rotor angle is set properly. There are
several options for what type of sample is used to set the angle
depending on the spinning speed. The probes that were used in this work
were 1.3 mm probes that have operational MAS speeds up to 60 kHz and
0.81 mm probes with operational MAS speeds up to 100 kHz. The probe
sizes refer to the outer diameter of the rotors used in the specific probe.
In this fast spinning regime the magic angle can be set using a [13C’]
labelled alanine sample since the spinning speeds are much higher than
the strengths of the anisotropic interactions in this sample. Figure 1.6a
shows a schematic drawing of MAS and 1.6b shows CP spectra of
[13C’]alanine obtained at 60 kHz MAS with the magic angle slightly off,
anisotropic interactions causing line broadening (red) and the magic
angle set correctly, anisotropic interactions sufficiently averaged out
(blue). Not only is the peak narrower when the magic angle is set
properly, the maximum intensity is also higher. Overall, the line width
also depends on inhomogenous broadening, which depends on how well
the sample is recrystallised. In our laboratory, for a well-crystallised
[13C’]alanine sample the 13C line width in the case where the magic angle
is properly adjusted is < 20 Hz.
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Figure 1.6. Magic angle spinning. (a) NMR rotor with the angle towards the static magnetic field
indicated. (b) 1H – 13C CP spectra of [13C’]alanine with the magic angle set correctly (blue line) and the
magic angle set incorrectly (red line).
It can be noted in the spectra in Figure 1.6b that the chemical shift (δ) is 
presented in ppm, parts per million. This is the general convention of
how chemical shifts are presented as spectra can then easily be
compared between experiments acquired at different B0 fields. The
chemical shifts in ppm are calculated as:
  =                            
   
      × 10   (1.8)
where    
      is the chemical shift of a reference material. In protein NMR
the reference used is often DSS (2,2-dimethyl-2-silapentane-5-sulfonic
acid) as it is soluble in aqueous solutions and does not interact with
biological samples. It can be put into the rotor in solid state NMR or the
sample tube in solution NMR together with the protein sample. The 1H
chemical shift of DSS is only very slightly affected by the temperature in
the sample (at least in the range of temperatures suitable in protein
NMR) further making it suitable as a reference. Referencing is then easily
done by recording a 1 pulse 1H experiment and setting the peak
originating from the DSS sample to 0 ppm. References for 13C and 15N
can then be calculated indirectly from the 1H reference by using IUPAC
recommended ratios28,29.
1.3.2 Biological assemblies in NMR
A main benefit of solid state NMR towards other techniques such as
solution NMR and X-Ray crystallography is what type of samples can be
used. Solution NMR requires soluble stable proteins that tumble free in
the solution fast enough to average out the anisotropic interactions.
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However, large molecules tumble slowly, which results in efficient
transverse relaxation causing severe broadening of the lines so that no or
little information can be extracted from the spectra. Solution NMR
therefore suffers from strong size limitations for larger molecules (>40
kDa). The size of molecules accessible to solution NMR can be sometimes
extended by using a number of methodological tricks such as deuteration
and TROSY type techniques but it is difficult in general. X-ray
crystallography requires good quality diffracting crystals and membrane
proteins or molecules with large internal motions or highly flexible
domains are notoriously difficult to crystallize. With solid state NMR it is
in principle possible to study any kind of biological molecules and
assemblies independent of the size and there are several different ways
of preparing the samples before they are put into the NMR rotors. Very
good resolution is achieved from microcrystalline proteins, without the
need for the same kind of quality crystals as in X-ray crystallography. No
long-range order is required, however the sample needs to be
homogenous since inhomogeneous broadening can severely limit the
possibility of obtaining good quality spectra. Samples can also be
precipitated, sedimented by ultracentrifugation, freeze dried, or analysed
in the form of fibrils. In many cases proteins packed into NMR rotors can
be stable for months and even years.
Solid state NMR has become an important technique for studying protein
assemblies30–39. The main areas of interest for large complexes or
assemblies are fibrils, virus capsids and membrane proteins. Recent
developments in solid state NMR of membrane proteins have been
reviewed by Ladizhansky40. Quinn and Polenova41 have reviewed
developments in solid state NMR on structure and dynamics of protein
complexes and other biomolecular assemblies (e.g. virus capsids). Of
specific interest to this thesis is the use of proton detection to study
protein complexes and biomolecular assemblies. Regarding membrane
proteins and fibrils it was first shown by Linser et al. that high quality
spectra could be obtained using proton detection of Alzheimer’s disease
β-amyloid peptide (fibrils) and membrane proteins.42 Further work in
method developments lead to fast experiments to achieve assignments
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and structural information using proton detection on these types of
complicated samples as shown for example in ref. 43. Recent
developments of fast spinning MAS probes and high field NMR magnets
enable high resolution site specific information requiring only a few
nanomoles of labelled material (e.g. as demonstrated for GB1 in complex
with IgG36).
In the work presented in this thesis three different types of sample
preparations were used; microcrystalline protein, precipitated protein –
protein complex and a sedimented sample of cell wall bound antibiotic.
Figure 1.7 shows 1H-15N correlation spectra of samples prepared using
these different methods, including both perdeuterated crystalline [U-
13C,15N]GB1 with 100% of exchangeable protons back-exchanged (a) and
fully protonated crystalline [U-13C,15N]GB1 (b). Figure 1.7c shows a
spectrum of 100% back-exchanged perdeuterated [U-13C,15N]GB1 in a
precipitated complex with full length natural abundance human
Immunoglobulin G (IgG) antibody and (d) shows a sedimented complex
of [U-13C,15N]teixobactin with natural abundance lipid II in deuterated
dodecylphosphocholine (DPC) micelles. All solid state experiments
considered in this thesis are acquired with proton detection. For proton
detected experiments it is important to use fast MAS as strong 1H-1H
dipolar couplings will otherwise lead to broad lines, just like in solution
NMR if a protein tumbles too slowly. How fast the spinning needs to be
depends mainly on how dense the proton network is. In most
experiments considered here samples with only protons on exchangeable
sites are considered (i.e mostly amide protons). For 100% back-
exchanged perdeuterated samples 60 kHz MAS is sufficient to obtain high
quality spectra suitable for structure determinations and dynamics
measurements, but for the samples that are fully protonated 90-100 kHz
MAS is used to get high quality spectra. For large protein complexes or
other biological assemblies only containing small amounts of labelled
material it is often useful to add a solvent paramagnetic relaxation
enhancement agent to the sample44. As mentioned previously regarding
CP experiments the T1 relaxation time of the excited nuclei determines
how fast an experiment can be repeated (recycle delay). The addition of
28
a paramagnetic agent to the sample will shorten the T1 relaxation time
and hence speed up the acquisition. As an example the spectrum of GB1
in complex with IgG (fig 1.7c) was recorded with 288 scans and a recycle
delay of 2 s, which took around 14 h, but the addition of 2 mM
gadolinium diethylenetriaminepentaacetic acid bismethylamide
(Gd(DTPA-BMA)) as paramagnetic relaxation enhancement agent allowed
for a recycle delay of 0.6 s and a spectrum with similar signal to noise
ratio could then be acquired in 3.5 h. Solvent paramagnetic relaxation
enhancements were used to speed up experiments in chapters 4 and 5
and to probe intermolecular interfaces in chapter 2. For a more detailed
explanation of this phenomenon, see chapter 2.
Figure 1.7. 2D 1H-15N correlation spectra for 4 different samples, with 1D slices showing examples of
average 1H linewidths included. (a) Crystalline [U-2H,13C,15N] GB1, back-exchanged in 100% H2O.
Spectrum acquired at 700 MHz 1H Larmor frequency with 60 kHz MAS. (b) Crystalline [U-13C,15N] GB1.
Spectrum acquired at 600 MHz 1H Larmor frequency with 100 kHz MAS (c) Precipitated complex
consisting of [U-2H,13C,15N] GB1, back-exchanged in 100% H2O, and natural abundance full length
human antibody IgG. Spectrum acquired at 700 MHz 1H Larmor frequency with 60 kHz MAS. (d)
Sedimented complex consisting of [U-13C,15N]teixobactin and natural abundance lipid II in deuterated
DPC micelles. Spectrum acquired at 600 MHz 1H Larmor frequency with 90 kHz MAS.
A comparison between fully protonated GB1 (fig. 1.7b) and GB1 with
only exchangeable protons (fig. 1.7a) illustrates the effect on proton line
widths of diluting the proton network with deuterium. Even at 100 kHz
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MAS the proton lines are broader in the fully protonated GB1 sample
(1.7b) compared to the 100 % back-exchanged deuterated GB1 sample
at 60 kHz MAS in 1.7a. According to simulations by Böckmann et al.
spinning speeds of up to 250 kHz would be required to obtain the same
line widths in a fully protonated sample as in a 100% back-exchanged
perdeuterated sample at 100 kHz MAS45. There are currently probes that
can spin at 100 kHz and above available from the 3 main probe
developers (reported operational MAS speeds in brackets); Bruker 0.7
mm (111 kHz), JEOL 0.75 mm (100 kHz), Samoson 0.81 mm (100 kHz),
Samoson 0.6 mm (130 kHz) and Samoson 0.5 mm (150 kHz).
1.3.3 Protein dynamics
Proteins are not static but move around constantly and are involved in
motions spanning several magnitudes of time scales. NMR is a versatile
tool for accessing information on motion at atomic resolution. Relaxation
measurements in solution can be used for motions on picosecond to
nanosecond time scales, limited by the tumbling of the molecules, which
generally occur on nanoseconds timescale. It is also possible to access
information on the nanosecond – millisecond motions in solution using
alternative methods such as residual dipolar couplings or exchange
methods. Figure 1.8 shows examples of dynamic processes occurring in
proteins and which timescales relaxation measurements in solution and
solid state NMR can pick up.
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Figure 1.8. Examples of time scales of dynamic processes in proteins and relaxation measurements to
obtain information on them.
In solid state NMR where molecules generally don’t tumble, relaxation
measurements can be used to characterize time scales and amplitude of
motion spanning from picoseconds – milliseconds. In this work three
types of relaxation measurements were used; R1, R1ρ and R1ρ relaxation
dispersion.
To understand how these measurements relate to protein dynamics it is
useful to first introduce the longitudinal (R1=1/T1) and transverse
(R2=1/T2) relaxation rates. Excited nuclear spins will return to equilibrium
through these relaxation processes. Longitudinal relaxation refers to the
loss of z magnetization and transverse relaxation refers to the loss of
coherence of xy magnetization. Generally, relaxation processes occur
through anisotropic interactions; chemical shift anisotropy (CSA) and
dipolar couplings (also quadrupolar interactions but they are not
considered here). CSA results in local magnetic fields that depend on
bond vector orientations relative to the static magnetic field. When a
protein rotates relative to the B0 field and/or the bond vector rotates
relative to the protein backbone, the local magnetic field will change with
time, which produces an oscillating field that can stimulate relaxation.
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Through space dipolar couplings between pairs of nuclear spins depend
on both distance between the spins and orientation towards the B0 field
(see equation 1.4). The distance and the orientation may change with
time and thus leads to local magnetic field oscillations , which just as the
CSA stimulates nuclear relaxation. In solution NMR, information on
protein motion can then indirectly be obtained from measuring R1 and R2
relaxation rates. In order to quantify the ps-ns dynamics of a protein in
solution heteronuclear NOEs (Nuclear Overhauser Effects) are generally
also measured. The heteronuclear NOEs occur due to dipolar interactions
between 1H and a hetero atom (15N or 13C), and as mentioned above
dipolar interactions stimulate nuclear relaxation due to protein motions at
ps-ns timescales. Site specific measurements of these three parameters
can give a full characterization of ps-ns motions in a protein in solution.46
In the solid state however, to extract information on dynamics from
relaxation rates, coherent effects also need to be considered. The
discussion below about effects of coherent contributions to R1, R2 and R1ρ
relaxation are based on a review by Lewandowski47. Spin diffusion is a
coherent effect, originating from the incomplete averaging of a strong
network of dipolar couplings, i.e. it is difficult to extract information on
protein dynamics from relaxation measurements unless spin diffusion is
properly suppressed. For site specific measurements of R1 relaxation
rates, which are measured by following the magnetization aligned with
the static magnetic field as a function of relaxation delay, spin diffusion
will cause magnetization transfer between different sites leading to
average relaxation rates over several sites and no site specific
information. Since spin diffusion is caused by anisotropic dipolar
couplings it can be suppressed. In proteins the strongest dipolar
couplings are caused by protons, so diluting the proton network is an
efficient way of suppressing spin diffusion. Fast MAS will also suppress
spin diffusion as it depends on the term ½(3cos2θ – 1). Generally, a
combination of diluting the proton network with deuterium and using fast
MAS is used to measure site specific R1 relaxation rates in proteins.
Applying strong radio frequency pulses can also suppress spin diffusion
but is generally not helpful as in order to achieve sufficient suppression
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very strong radio frequency pulses would have to be used, which could
heat up the sample and damage the equipment. For 15N R1 relaxation
measurements, which are studied in chapters 2 and 3, the variant of spin
diffusion one needs to worry about is proton-driven spin diffusion (PDSD)
and it is assisted by 1H-15N dipolar couplings. It has been shown that
even in fully protonated proteins PDSD is sufficiently suppressed to allow
site specific 15N R1 measurements already at 20 kHz MAS48–50. The
strength of the dipolar couplings depend on the gyromagnetic ratios of
the coupled nuclei leading to that it is more difficult to suppress spin
diffusion for 13C than for 15N and even more difficult for 1H. We
investigate the use of 1H R1 measurements with 100 kHz MAS, not to
measure dynamics, but to study protein – protein interfaces in chapter 2.
While R1 relaxation rates report on dynamics at picosecond – nanosecond
time scales R2 report on dynamics on nanoseconds – millisecond motions.
R2 relaxation is called spin – spin relaxation or transverse relaxation and
occur due to decay of magnetization in the xy-plane, perpendicular to the
static magnetic field. An important challenge when measuring R2
relaxation rates is that coherent effects dominate the decay rates, in
particular dipolar dephasing, which originates from strong 1H-1H dipolar
couplings. As mentioned earlier 1H-1H dipolar couplings are the most
difficult to suppress and even if fast MAS (> 60 kHz) and a high degree
of deuteration (10% back-exchange of exchangeable protons) is applied
it is very challenging to measure R2 relaxation rates in proteins. It is
though possible to measure R1ρ relaxation to get information on
nanosecond – millisecond motion. R1ρ relaxation rates are measured by
following the decay of magnetization under a spin-lock field. For 15N R1ρ
measurement the coherent contributions can be sufficiently suppressed
by a > 10 kHz spin-lock pulse and > 45 kHz MAS even in fully protonated
proteins47. In chapter 3, R1 and R1ρ relaxation are investigated and
related to protein motion for the protein GB1 in crystals and in a
precipitated complex with IgG.
Relaxation dispersion is a method used to study conformational exchange
and provide information on short lived conformational states and thereby
report on local structure. These motions occur on microsecond –
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millisecond timescales and are measured by quantifying R2 or R1ρ
relaxation rates at varying spin-lock frequencies. However as the spin-
lock field strength needs to be varied and one cannot rely on the spin-
lock to help suppressing dipolar dephasing, higher levels of deuteration
and/or faster MAS speed needs to be applied compared to standard R1ρ
relaxation measurements. Ma et al. showed that dipolar dephasing was
sufficiently suppressed with 39.5 kHz MAS in a 50% back-exchanged
perdeuterated crystalline sample of the small protein ubiquitin.51 In
chapter 4 we show that we can access microsecond motion in the small
protein GB1 in a > 300 kDa complex with full length human IgG.
1.4 NMR structure calculations
NMR, both in solution and in solid state, is a powerful tool for solving
structures of biomolecules. Traditionally this is a very time consuming
process but recent developments in NMR instrumentation and automation
of structure calculation software have significantly shortened the time it
takes from the first NMR experiments until a final structure can be
determined. In order to determine a structure using NMR it is required to
assign resonances relating to the atoms of the protein and to obtain
distance restraints. In solution NMR the distance restraints are typically
obtained from 2D and/or 3D NOESY (Nuclear Overhauser Effect
SpectroscopY) experiments. This is often supplemented with torsion
angle restraints, that for example can be calculated from the chemical
shifts using the software TALOS+52. It is also possible to add restraints
obtained from other types of NMR experiments and if there is information
available from other sources that would aid the calculation it can also be
added. There are several different software packages available for
structure calculations as compared in the Critical Assessment of
Automated Structure Determination of Proteins from NMR Data (CASD
NMR)53, some of which use the traditional method described here and
some of which calculate the structure based on chemical shifts.
Before the fast MAS frequencies that are currently available could be
achieved, structure calculations in solid state NMR were often relying on
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13C-13C distances rather than the 1H-1H distances commonly used in
solution NMR. However with MAS speeds of 100 kHz and above it is now
possible to use a similar approach as in solution NMR which has been
demonstrated with fully protonated proteins54 and a combination of
100% back exchanged perdeuterated protein for 1HN-1HN distance
restraints and partly labelled protein for distance restraints between
methyl groups55. In the work presented here UNIO ATNOS-CANDID, with
CYANA as molecular dynamics software was used for the structure
calculation of teixobactin presented in chapter 5.
1.4.1 Resonance assignments in solution and solid state
There are several different approaches to obtain full chemical shift
assignments of proteins and peptides. For smaller peptides (up to around
20-30 residues), it might be sufficient to use 2D experiments with
unlabelled material in solution. Figure 1.9 shows the approach for
assignments using 2D spectra. The 1H-1H COrrelation SpectroscopY
(COSY) experiment gives a walk through each residue, where the cross -
peaks that show up are coupled. The diagonal shows peaks of the
protons with itself. The example in the figure is alanine, where the first
diagonal peak from the top is Hβ-Hβ, following the dotted line leads to 
Hβ-Hα, horizontally to the diagonal is Hα-Hα, following the dotted line 
vertically leads to Hα-HN and finally vertical to the diagonal shows HN-HN.
The same information can be obtained from the 1H-1H Total COrrelation
SpectrosopY (TOCSY) experiment, but in a TOCSY all correlations
between spins in a spin system is shown for each proton. This approach
doesn’t give any interresidue information, which has to be obtained from
interresidual HN-HN peaks in 1H-1H NOESY spectra. If a peptide chain
contains many residues of the same amino acid unambiguous sequential
assignments becomes difficult.
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Figure 1.9. Schematic drawing of 2D assignment spectra used in solution NMR. Peaks resulting from
alanine are highlighted in the figure.
If labelling is possible the assignment becomes easier, as 3D experiments
can be recorded. Figure 1.10 shows an approach based on a combination
of two 3D experiments. CBCANH gives the correlations between the NH
group of residue n and the Cα (positive peaks, red-yellow in fig1.10) and 
Cβ (negative peaks, green-blue in fig 1.10) from residues n and n-1, 
while CACB(CO)NH only gives the peaks between an NH group of residue
n and the Cα and Cβ from residue n-1. With these two experiments a 
backbone walk through the peptide chain to achieve assignments for all
N, HN, Cα and Cβ can be performed. It is often required, in larger 
systems or if the peptide chain contains many similar residues, to acquire
additional spectra connecting the C’ to HN as the chemical shift dispersion
of C’ is often larger than that of Cα. In this respect it should also be 
mentioned that it is useful to assign atoms that are not directly needed
for the structure calculation (e.g. C’) since chemical shifts also contain
structural information in itself (which is discussed in chapter 5). If a 3D
hCCH TOCSY is acquired as well, the Hα, Hβ and side chain carbons and 
protons can also be assigned.
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Figure 1.10. Example strips from solution NMR 3D assignment spectra for [U-13C,15N]teixobactin in
DPC micelles. Spectra acquired at 700 MHz 1H Larmor frequency. DGN = D-Glutamine, DAI = D-allo-
Isoleucine. The colour gradient from red to yellow represents the intensities of positive peaks. The
colour gradient from green to blue represents the intensities of negative peaks.
In proton detected experiments in the solid state similar 3D experiments
can be recorded. In figure 1.11 example strips of the assignment spectra
for [U-13C,15N]teixobacin in complex with natural abundance lipid II are
shown. The experiments hCANH and hCONH are purely based on CP
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transfers whereas the hCOCAHA uses dipolar recoupling enhanced by
amplitude modulation (DREAM)56 transfer between C’ and Cα. The 
DREAM also transfers to the Cβ from the C’ (however the spectrum was 
folded and therefore only Cα was considered in this case), and hence also 
gives the assignments for Cβ and Hβ. 
Figure 1.11. Example strips from assignment spectra of [U-13C,15N]teixobactin in a sedimented
complex with natural abundance lipid II in deuterated DPC micelles. Spectra acquired at 600 MHz 1H
Larmor frequency with 90 kHz MAS. DGN = D-glutamine, DAI = D-allo-isoleucine.
DREAM is a type of dipolar recoupling sequence. In contrast to the CP
transfer that recouples heteronuclear dipolar couplings, DREAM recouples
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homonuclear dipolar couplings by fulfilling the double quantum
HOmonucleaR ROtary Resonance (HORROR) condition:
    =          (1.9)
where ω1 is the nutation frequency of the adiabatic pulse in the DREAM
experiment. Another homonuclear recoupling technique called radio
frequency driven recoupling (RFDR)57 is used to obtain 1H – 1H distance
restraints, similar to NOESY in solution NMR. In an RFDR experiment a
train of rotor synchronized π pulses is applied on the 1H channel to
recouple the homonuclear dipolar couplings, the longer the train of
pulses is the further the magnetization is transferred.
1.4.2 CYANA libraries
When calculating a 3D structure based on NMR data it is necessary to use
a molecular dynamics software. CYANA performs molecular dynamics
calculations using torsion angle dynamics58. The degrees of freedom are
based on the number of torsion angles, which are much smaller than the
Carthesian coordinates and hence CYANA is much faster than molecular
dynamics software that uses Carthesian space dynamics.
Many lipid II binders contain peptides with non-standard amino acid
residues and in order to perform structure calculations on these kinds of
molecules library entries for a molecular dynamics software need to be
produced. In order to produce library entries for non-standard residues it
is necessary to understand how CYANA libraries work. Torsion angles are
defined in CYANA library files following a tree structure with a base rigid
body that is fixed in space and n rigid bodies that are connected by n
rotatable bonds. The rigid base is the amino acid backbone starting at
the N-terminus, it then branches out and terminates at the end of the
side-chains and C-terminus58. The CYANA library files are built as shown
in figure 1.12a. The first line contains the short name of the residue, in
this example ALA (alanine), followed by the number of torsion angles (4),
the number of atoms (14), the first atom included in the residue (3)
which means that atom 1 and 2 belong to the previous residue in the
polypeptide chain. The last number of the first line represents the last
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atom included in the residue (13), which means that atom number 14
belongs to the next residue in the chain. The peptide bonds are defined
like this, so that each entry in the library representing a standard amino
acid starts with C and O of the previous residue and ends with N of the
following residue. The second line in the library entry defines the first
torsion angle, which for all standard amino acids is ω (OMEGA). Each 
angle is defined by exactly 4 atoms and for side chain angles also a fifth
atom is included which represents the last atom being affected by
changing the angle. For ω the 4 atoms defining it are Cn-1 (2), On-1 (1), Nn
(3) and Hn (4), since it is a backbone torsion angle the fifth number is 0.
Continuing down the library entry we see the other three torsion angles
of alanine φ (PHI), χ1(CHI1) and ψ (PSI), where χ1 is the only side chain 
torsion angle and hence has a non-zero entry as the fifth number (11)
representing HB3 of the methyl group. Any of the HB atoms could be
used here or QB, the pseudo atom which is positioned at the centre of
the HB1, HB2 and HB3 atoms. Pseudo atoms are used to represent
groups of protons that are connected to the same heavy atom or
symmetrical protons in aromatic rings. Pseudo atoms can also be used
for methyl groups that are connected to the same carbon, such as in
valine or leucine. After the angles are defined all the atoms are defined,
first the number of the atom, then name, then the atom type, the
coordinates, which other atoms it is bonded to and the last number
indicates the corresponding pseudo atom (0 for atoms where there is no
corresponding pseudo atom).58
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Figure 1.12. Structure of CYANA library entry58. (a) example of library entry for the amino acid alanine.
(b) Definition of atom types used in Cyana. (c) Tree structure of alanine.
The different atom types used in CYANA are shown in figure 1.12b. As
CYANA doesn’t use a complete physical force field the atom type only
specifies the repulsion radius, whether or not an atom can be involved in
a hydrogen bond (0 for no, 1 for protons that can form hydrogen bonds
and -1 for hydrogen bond acceptors). The last column in figure 1.12b is
for which chemical element the atom is (1 for hydrogen, 6 for carbon
etc.). Figure 1.12c shows a schematic view of how the torsion angles are
defined for alanine. Each angle is defined by two atoms before the angle
and two atoms after, as described in the example of the OMEGA angle
above.58
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The standard CYANA library includes all standard amino acid residues,
RNA bases and DNA bases but if structure calculations with non-standard
residues are to be performed, library entries for these have to be
produced. Recently a software called Cylib59 was released. Cylib can
convert any molecular topology description from the PDB Chemical
Component Dictionary (CCD) into CYANA library entries. This makes it
much easier to perform structure calculations of peptides containing non-
standard residues as it is tedious process to produce library entries
manually. There are however cases where Cylib doesn’t work; (i) if there
is no entry in the PDB CCD or (ii) if the connection between residues is
not a standard peptide bond. In these cases an entry has to be created
manually. Figure 1.13 shows the steps needed to prepare a new library
entry. Here L-allo-enduracidine was used as example, which is an
unusual amino acid present in teixobactin. The first step is to obtain
starting coordinates and connections for all the atoms in the new residue.
This can be done by drawing it in any molecule drawing software and
convert it into a 3D drawing. Then it needs to be saved in a format that
UCSF Chimera60 can read, for example as a mol file. If there is an
available 3D structure of the residue or a similar residue this first step
can be skipped and one can download the 3D structure and add the
overlapping atoms to the connecting residues (in dotted circles at the top
of Figure 2), which can be done in UCSF Chimera. The file should then be
saved as a PDB file, which can be read by MOLMOL61 and a file containing
coordinates and connections can be created. The final step is to manually
rearrange and rename the atoms, add angles, pseudo atoms and add
atom types. It is important that the atoms and angles are arranged
according to the tree structure of CYANA library files.
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Figure 1.13. Stepwise explanation for how to create Cyana library entries for non-standard amino
acids. Here with L-allo-enduracidine as example.
1.4.3 Structure calculations using UNIO-ATNOS CANDID
With (almost) complete chemical shift assignments and functioning
molecular dynamics software the final consideration for structure
calculations is distance restraints. Generally, NOESY spectra are used for
this since NOE transfer is based on dipolar couplings, which are distance
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dependent and the intensity of the cross-peaks in NOESY spectra will be
proportional to the distance between two protons.
To obtain distance restraints from NOE spectra in solution NMR the
chemical shifts of the two protons involved in the cross peak needs to be
unambiguously assigned. As the chemical shift range of protons in
proteins is fairly small < 15 ppm and the accuracy of which NOE cross
peaks can be measured is limited it is very difficult to unambiguously
assign the peaks. By using 3D HSQC-NOESY spectra, which are resolved
through an additional 13C or 15N chemical shift, it becomes easier than for
2D 1H – 1H NOESY experiments but is still very challenging. NOESY
spectra can also be quite noisy and contain artefacts making the process
even more challenging. Traditionally picking and assigning NOE cross
peaks was an iterative process where a preliminary 3D structure was
calculated from a limited amount of unambiguously assigned peaks. The
preliminary 3D structure was then used to identify more peaks. Luckily,
due to a lot of effort into software development it is now much easier and
faster to perform NMR structure calculations. There are several software
packages that can achieve high quality 3D structures of proteins with
unassigned peak lists from NOESY spectra compared in the CASD-NMR53.
Of the software packages tested in that study only two submitted results
based on raw spectra as input, UNIO and Ponderosa. Using raw spectra
as input is very appealing as it eliminates time consuming and error
prone peak picking. As previously mentioned UNIO ATNOS-CANDID was
used for the structure calculation of teixobactin presented chapter 5.
UNIO includes different algorithms for backbone assignments (MATCH)62,
side-chain assignments (ATNOS-ASCAN)63,64 and NOE assignments and
structure calculations (ATNOS-CANDID)63,65. In a structure calculation
with UNIO ATNOS-CANDID in combination with a molecular dynamics
software (CYANA or other) the traditional method is performed
automatically in a much less error prone fashion. The software performs
the calculation in a way so that in the first cycle ATNOS picks peaks
based only on the chemical shift list containing resonance assignments
supplied by the user, similar to how a manual peak picking would be
attempted. The validated peaks are sent to CANDID which assigns them
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and transforms them into distance restraints for CYANA and a preliminary
structure is calculated. This structure is then used by ATNOS to identify
more peaks and by CANDID to assign them and add more distance
restraints for the next structure calculation, the structure based criteria
for peak validation in ATNOS is loosened up, while the acceptance for
NOE assignment and distance restraints by CANDID is tightened.
Generally 7 cycles are performed in a standard structure calculation
using UNIO ATNOS-CANDID.
Two important elements that were incorporated in CANDID are network
anchoring and constraint-combination. In network anchoring the
assignment for each NOE cross-peak is weighted by how well it fits in a
network including all other NOE assignments. This works because any
network of correct NOE cross-peak assignments can be seen as a self-
consistent set. Constraint combination is used to combine several
distance restraints into one in order to reduce the risk of artefacts
influencing the structure calculation. This is especially important for long-
distance restraints that have a larger impact on the structure
calculation.65
The same procedure works in solid state NMR, but RFDR spectra are
normally used instead of NOESY. There are however not yet any
published structures calculated from solid state NMR data where raw
spectra have been used as input. A few structures have recently been
published using the “solution NMR” approach in UNIO with unassigned
peak lists from spectra of fully protonated proteins in solid state NMR54.
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2 Characterization of protein-protein interfaces in
large complexes by solid state NMR solvent
paramagnetic relaxation enhancements
This chapter was accepted for publication as:
Characterization of protein-protein interfaces in large complexes by solid
state NMR solvent paramagnetic relaxation enhancements, Öster, C.;
Kosol, S.; Hartlmüller, C.; Lamley, J. M.; Iuga, D.; Oss, A.; Org, M.-L.;
Vanatalu, K.; Samoson, A.; Madl, T.; Lewandowski, J. R. J. Am. Chem.
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2.1 Abstract
Solid-state NMR is becoming a viable alternative for obtaining
information about structures and dynamics of large biomolecular
complexes including ones that are not accessible to other high resolution
biophysical techniques. In this context, methods for probing protein-
protein interfaces at atomic resolution are highly desirable. Solvent
paramagnetic relaxation enhancements (sPREs) proved to be a powerful
method for probing protein-protein interfaces in large complexes in
solution but have not been employed towards this goal in the solid state.
We demonstrate that 1H and 15N relaxation-based sPREs provide a
powerful tool for characterizing intermolecular interactions in large
assemblies in the solid state. We present approaches for measuring
sPREs in practically the entire range of magic angle spinning frequencies
used for biomolecular studies and discuss their benefits and limitations.
We validate the approach on crystalline GB1 with our experimental
results in good agreement with theoretical predictions. Finally, we use
sPREs to characterize protein-protein interfaces in the GB1 complex with
immunoglobulin (IgG). Our results suggest the potential existence of an
additional binding site and provide new insights into GB1:IgG complex
structure that amend and revise the current model available from studies
with IgG fragments. We demonstrate sPREs as a practical, widely
applicable, robust and very sensitive technique for determining
52
intermolecular interaction interfaces in large biomolecular complexes in
the solid state.
2.2 Introduction
Knowledge of protein-protein interactions is essential for the
understanding of many biological processes. However, atomic-resolution
structural characterization of many important biomolecular complexes is
impeded by their size, solubility or ability to form crystals, preventing the
application of standard methods such as solution NMR and X-ray
crystallography. Solid state NMR is an emerging alternative for studies of
large protein assemblies,1–10 with new technologies and methods leading
to continuously improved sensitivity and signal resolution for atomic level
structural information of large protein complexes.
Paramagnetic relaxation enhancement (PRE) occurs when an unpaired
electron increases nuclear relaxation rates through dipolar interactions,
which depend on the distance between the nucleus and the paramagnetic
center. Strategies that make use of paramagnetic molecules help to
alleviate the challenge of low sensitivity by enabling fast repetition of
experiments and also provide a source of information about structures
and dynamics.7,11–21 PREs have been used successfully in the solid state
with the PREs obtained from paramagnetic tags attached to the
proteins22 or by replacing non-paramagnetic ions with paramagnetic ions
in metalloproteins.11,16,23,24 One potential disadvantage of such
approaches is that introducing a non-native moiety into the protein can
influence its structural integrity and/or dynamics and such effects have to
be considered carefully. In this context, employing an inert paramagnetic
molecule dissolved in the solvent and which does not bind to the protein
is less invasive and can provide long range structural information with
less potential for influencing the structure and dynamics of the studied
system.25,26 If a paramagnetic compound, such as gadolinium
diethylenetriaminepentaacetic acid bismethylamide (Gd(DTPA-BMA)), is
added to the buffer surrounding the protein, the paramagnetic effects
from such an agent, often called solvent PREs (sPREs), can be used to
quantify solvent accessibility.27–30 sPREs have been used in solution NMR
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to gain additional restraints for structure calculation, prediction, and
validation,31–33 to probe domain architecture34 and analyze protein-
protein interactions.35
While paramagnetic agents are often used to speed up acquisition in
solid state NMR,36 there are few examples where sPREs have been used
to study solvent accessibility in solid state NMR and, to our knowledge,
they have not yet been employed for characterization of protein-protein
interfaces in biomolecular complexes. However, sPREs have been used,
e.g. to identify crystal contacts in a heavily deuterated crystalline sample
of the α-spectrin domain of SH3.17 In that work, irregularly high 1H sPREs
for residues in close proximity to exchangeable hydroxyl protons (< 3.5
Å) were observed leading to major challenges in the interpretation of
distances between nuclei and protein surface.17 In another study, 13C R1
based sPREs were used to identify regions with increased solvent
accessibility in A1-40 fibrils.37 Because of still active spin diffusion, which
leads to the partial averaging of 13C R1 rates over several sites,38 the
obtained sPREs were only qualitative in nature.37 Overall, elimination of
spin diffusion is a prerequisite for obtaining quantitative site-specific
sPREs. Suppression of spin diffusion can be achieved through either
dilution of the strong dipolar proton-proton network through
deuteration17 or fast magic angle spinning or a combination of the two
approaches.39
Here, we explored sPREs derived from 1H R1, 15N R1 and 15N R1
measurements in order to develop a practical approach for applying
sPREs to characterize protein-protein interfaces in large complexes in the
solid state. We considered several factors that can influence applicability
of the approach including signal to noise, site-specific nature of
measurements, sensitivity and dynamic range of the employed probe and
accessibility of specialized equipment.
To test the suitability of solid state sPREs to map solvent accessibility
we have performed measurements on the B1 domain of immunoglobulin-
binding protein G (GB1) in three different environments: isolated GB1 in
solution (GB1free), GB1 in a crystal on its own (GB1cryst) and, finally, GB1
in a precipitated complex with full length IgG (GB1IgG). Protein G is part
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of the bacterial defense strategy against antibodies that enables bacteria
to escape detection by the host immune system. The high affinity
between GB1 and IgG is commonly exploited in numerous
biotechnological applications such as immunosorbent assays or affinity
purification of antibodies. Insights into molecular aspects of the complex
can guide and support therapeutic strategies as well as bio-engineering
efforts. Differences in the solvent accessibility from sPREs revealed
details of binding of GB1 to IgG and evidence for previously not observed
additional interactions.
2.3 Results and Discussion
2.3.1 Overview of the different sPRE approaches
In solution NMR sPREs can be obtained by measuring relaxation rates in
a sample with increasing concentration of a paramagnetic dopant. The
slope of the line obtained from fitting the relaxation rates as a function of
dopant concentration yields the sPREs. The same approach can be used
in the solid state, but with an individually prepared sample for each
dopant concentration. The most popular paramagnetic dopant used in
solid state NMR applications is CuEDTA. However, complexes using EDTA
as a chelator were shown to bind preferentially to some proteins due to
their overall negative charge and thus introduce undesired bias in sPRE
applications.40,41 Even though CuEDTA does not bind to either GB1 or
GB1:IgG complex, in order to increase general applicability of the
approach, we have decided to use a neutral probe for most of our
measurements. Towards this aim, we employed Gd(DTPA-BMA), which is
one of the most popular stable neutral paramagnetic probe for sPRE
applications in solution NMR and a popular intravenous MRI contrast
agent. An additional benefit of using this dopant instead of CuEDTA is
that Gd3+ is much more efficient in inducing PREs compared to Cu2+,
which means that much smaller concentrations of the dopant can be used
to obtain similar effect.42 In the solid state, Gd3+ complexes were shown
to lead to improved SNR per unit time compared to CuEDTA in
applications on a membrane protein.42 In addition, reducing the required
dopant concentration aids to minimize the rf induced heating.
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We found that Gd(DTPA-BMA) can be added to hydrated protein
samples in solid state NMR after they were prepared in the required solid
form, e.g. crystal, sediment or precipitate, without need for co-
crystallization of the proteins with the paramagnetic agent as it has been
suggested previously.15 We did not observe any significant deviations
from a linear relationship between relaxation rates and dopant
concentrations under the conditions and concentrations explored in this
study. The advantage in measuring sPREs with this approach lies in that
the sPREs do not need to be modelled explicitly (e.g. fitting correlation
times etc.), consequently allowing a more straightforward comparison
between sPREs derived from different types of measurements in solution
and solid state. However, global scaling of the data is required to allow
comparison of two data sets (see below).
1H relaxation for sPRE in the solid state is one of the most sensitive
probes to paramagnetic effects. For 1H relaxation measurements, to
maximize sensitivity, one would like to maximize concentration of the
protons in the sample.7,43,44,37,38 On the other hand, to suppress the rate
averaging spin diffusion one needs to minimize the concentration of
protons or average out the 1H-1H dipolar couplings by fast magic angle
spinning. For different levels of protonation different spinning frequencies
are optimal. For example, deuterated 100% back-exchanged samples at
60 kHz spinning provide the best compromise between resolution and
sensitivity.43 However, the 1H-1H spin diffusion is not sufficiently
suppressed under these conditions to enable site-specific
measurements.45 Due to both cost and practical considerations we
decided to use deuterated GB1 with 100% back-exchanged protons and
fully protonated natural abundance IgG. The presence of more protons in
the system required very fast spinning to sufficiently suppress 1H-1H spin
diffusion for site-specific measurements of 1H sPREs (Figure 2.4a). We
have previously demonstrated that high quality spectra can be obtained
for 100% back-exchanged [U-2H,13C,15N]GB1 in complex with natural
abundance IgG using as little as 15 g of labelled protein in a 0.81 mm
rotor with ~100 kHz MAS.7 Furthermore, recent studies report that at
>100 kHz spinning frequencies 1H-1H spin diffusion is significantly slowed
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down even in fully protonated samples, especially for protons with large
differences in their chemical shifts.45,46 This is in accordance with the
observation of large differences in site-specific 1H R1 (Fig. 2.4a) in our
experiments, suggesting that at 100 kHz spinning 1H-1H spin diffusion is
sufficiently slowed down – if not completely suppressed - to at least allow
characterization of the protein-protein interfaces from sPREs (e.g. T18H
and E19H are separated by about 1 ppm and their sPREs differ by a
factor of ~2). The sufficient suppression of the proton spin diffusion is
corroborated by the absence of the unusually high 1H sPREs for amide
protons in the proximity of hydroxyl sites that were observed in the
presence of residual spin diffusion17 (e.g. T18H, which one might expect
to be influenced in this way has a rather low sPRE).
Employing 1Hs for sPRE measurements will therefore require specialized
and still not widely available ultrafast MAS probes. In addition,
experiments at > 100 kHz spinning frequencies necessitate use of rotors
with very small volumes. The decrease of signal-to-noise ratio due to the
small sample volume can be, to a large extent, offset by detecting signal
on protons.44 However, 100% back-exchanged perdeuterated samples
can be used effectively for 1H detected experiments already at 60 kHz in
which case larger volume rotors can be used.43 Finally, for systems with
extensive slow dynamics sometimes adequate 1H resolution is difficult to
achieve even at the highest spinning frequencies, requiring use of 13C or
15N detected experiments, in which case larger volume rotors are
desirable. For the above reasons, it is worth to explore other probes for
sPREs that can be utilized at slower spinning frequencies in larger volume
rotors.
In the case of 15N, at spinning frequencies > 20 kHz proton driven spin
diffusion is sufficiently slowed down to enable site-specific measurements
of 15N R1 even in fully protonated systems.47–49,56 In the solid state,
protein 15N T1s are very long (20-40 s) so, in spite of lower sensitivity of
15N to paramagnetic effects compared to 1H, a high dynamic range of the
relaxation rates is available and relatively small changes can be detected.
Consequently, large variations in 15N sPREs can be observed just as in the
case of 1H but the measurements can be performed even at moderate
57
spinning frequencies (as low as 10 kHz47–49 if minimal rate averaging can
be tolerated). A disadvantage of using 15N R1 for sPREs is that the long
relaxation times require long (i.e. many seconds) relaxation delays for
adequate sampling of the relaxation rates resulting in long overall
experimental times. Alternatively, we examined the applicability of the
typically much shorter 15N T1 times (on the order of dozens to hundreds
of milliseconds9,10,50–53) as basis for sPREs. Below we demonstrate that
15N R1 sPREs are sufficiently sensitive to characterize protein-protein
interfaces with the emerging picture virtually identical to the one
obtained from 15N R1. The much shorter required relaxation delays in 15N
R1 experiments permit considerably faster performance compared to 15N
R1 sPRE, acquisition, further allowing higher signal to noise ratios in the
available experimental time. For example, measurements for one
concentration of paramagnetic dopant for GB1IgG took 3-4 days in the
case of 15N R1 (estimation of 15N R1 from only two points, which took 5
days, was practically possible for the diamagnetic variant with the
measurement of full curve being prohibitively long8) and 18-24 hours in
the case of 15N R1. As a side note, 1H T1 typically are too short to
provide a reliable quantitative sPRE probe (or at least not in a range
where no significant line broadening is observed).
2.3.2 sPREs: solution vs. crystal
First, we set out to explore the applicability of sPREs by investigating
reduced solvent accessibility in GB1 crystals. To that end, we used
experimental 15N R1-based sPREs of free GB1 in solution (GB1free) to
provide a baseline for observing changes in solvent accessibility due to
protein-protein interactions and crystal contacts. The 15N R1-based sPREs
shown in Fig. 2.1a inform on the solvent accessibility of the protein in the
absence of intermolecular interactions and regions that are well protected
from solvent access in isolated GB1 can be identified as most of1, parts
of the -helix and parts of 4. In contrast, the most accessible regions
are the outer beta strands 2 and 3. This is in good agreement with
scaled theoretical sPREs calculated from an available structure of isolated
GB1 using a previously described grid-based approach30,33,54 (see
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experimental section). The predicted values reproduce the experimental
sPREs well with the exception of 2 and Y45, where sPREs are
underestimated. The discrepancy for 2 could potentially be explained by
the previously reported large amplitude motions of the strand involving
rotations around its long axis, which render the amide nitrogens more
solvent accessible.55 We note that ultimately conformational dynamics
should be taken into account when calculating sPREs from structures.
The 15N R1-based sPREs measured in GB1 crystals (GB1cryst) present a
quite different picture (Figure 2.1b): in contrast to GB1free, the outer 2
and 3 strands are much more protected in the crystal compared to the
most solvent accessible residues in loop 1. This is consistent with the fact
that in crystals, GB1 forms extended -sheets stabilized by
intermolecular hydrogen bonds between 2 and 3.56,57 Moreover, the
scaled theoretical 15N sPREs calculated for GB1 in a lattice agree
reasonably well with the experimental sPREs except for T11 and T49
which are located in the loops, and L6. In contrast to the previous study
on crystalline SH315 we do not observe the unexpectedly high relaxation
rates for sites in close proximity to hydroxyl groups (unless these sites
are solvent accessible, in which case we do observe high PREs). That this
effect is not observed in our experiments suggests that the assumption
of the absence of spin diffusion in a perdeuterated sample with 10%
back-exchanged protons at moderate spinning frequency (24 kHz)17
might not have been entirely justified. Residual spin diffusion due to
locally higher density of exchangeable protons and moderate spinning
frequency can easily explain the anomalously high sPREs observed by
Linser et al15. Under conditions suggested in the present work, proton
driven spin diffusion between nitrogens is extremely well suppressed,
which abolishes any effect of the exchangeable hydroxyl protons on the
relaxation rates of amide sites in the vicinity.
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Figure 2.1. Experimental 15N R1 solvent PREs for GB1 (a) in solution and (b) in a crystal. (c)
Experimental 15N R1 ΔsPREs for GB1 crystal (i.e. difference between, normalized to averages, 15N R1
sPREs in solution and in crystal) as a function of residue, and (d-e) projected onto structure of GB1 in
a lattice. Dashed lines in (a-b) indicate 15N sPREs calculated from structures: solution NMR structure
of isolated GB1 (PDB ID 3gb158) in (a) and GB1 in a lattice (PDB ID: 2qmt57) in (b). Each set of
predicted sPREs were scaled by a global factor equal to the ratio of the averages of the predicted
sPREs and experimental sPREs. Yellow lines in (d-e) represent intermolecular hydrogen bonds.
Residues for which data is not available either due to severe overlap, missing peak or insufficient
signal to noise are indicated in grey.
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Theoretical sPREs can be used to validate models by comparing the
experimental sPREs to the ones predicted from the model. However, even
in the absence of a model, intermolecular interactions can be detected by
identifying sites with increased protection from the solvent due to these
interactions. We propose to simply use the difference between
experimental sPREs in the absence and presence of intermolecular
interactions, i.e. for GB1 free in solution (GB1free) and GB1 in the
assembly (GB1cryst or GB1IgG in the latter part of the manuscript)
respectively. Remarkably, the difference PREs (ΔsPREs) provide a 
powerful way to detect intermolecular interactions. In general, one will
need to take into account any conformational changes upon binding,
whose effect cannot be distinguished from reduced solvent accessibility
due to binding without additional data. GB1 does not undergo any large
backbone conformational changes either in crystal or GB1:IgG
complex7,8,59 so no further correction is required. In cases where
secondary chemical shifts indicate conformational change upon binding,
solving structure of the considered protein in a complex will be
prerequisite for quantification of protein interface using sPREs (though
qualitative information about the interactions still can be obtained in the
absence of such structure). Because of the “built-in” compensation for
solvent accessibility pattern due to conformation of the molecule, the
effect of intermolecular interactions is effectively “amplified” in ΔsPREs. 
The potential of ΔsPREs is illustrated by the experimental 15N R1 ΔsPREs 
for GB1cryst shown in Fig. 2.1c-e, which highlight the increased protection
of 2 and 3 due to the presence of intermolecular hydrogen bonds in the
crystal. At the same time, other subtler features become apparent such
as better protection of the N-terminus compared to the C-terminus or
slightly higher protection of the C-terminal end of the helix compared to
the N-terminal end. Note that to minimize the bias and to account for the
different dynamic ranges of the data sets that are subtracted to yield
ΔsPREs they were scaled by a global factor equal to the ratio of the rate 
averages of the two data sets (see the experimental section). For
visualization purposes a constant (equal to absolute value of the
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minimum ΔsPREs) is added so that all experimental ΔsPREs have the 
same sign.
2.3.3 sPREs in GB1:IgG complex
Currently only structures of protein G domains with immunoglobulin
fragments are available. Interactions between the Fab fragment of IgG
and protein G domains have been investigated by X-ray crystallography60
and solution NMR61. The crystal structure showed that the main
interactions between the Fab fragment and GB3 correspond to residues
10-18 of GB1, and a minor contact between the Fab fragment and
residues 33 and 37 of GB1 (for clarity we use GB1 residue numbering
throughout this paragraph). The solution NMR analysis identified
chemical shift perturbations (CSPs) in residues 9-17 (also 7, 19, 36, 37,
38, 40, 43 and 53).61 In solution NMR studies of GB2 and the Fc
fragment of IgG, residues in regions 23-36 and 40-46 which are located
in 3 and the -helix of GB1 were found to be involved in the
interaction.62 This is in agreement with a crystal structure of GB2 in
complex with the Fc fragment of IgG where the residues involved in
binding correspond to residues 27, 28, 31, 32, 35, 40, 42 and 43 of
GB1.63 It is worth noting that residues involved in binding to the Fab
fragment (residues 9-18) were not affected by the interaction with the Fc
fragment.63 In our previous solid-state NMR study of the complex of GB1
bound to full length human IgG, we established that GB1 binds to both
Fab and Fc fragments of IgG simultaneously.7 Here we use the sPRE
methodology validated above on the GB1 crystal to obtain further
insights into the GB1-IgG interactions. In the range explored by us, 15N
R1 or R1ρ relaxation rates vs. Gd(DTPA-BMA) concentration in a
precipitated GB1:IgG complex show a good linear relationship (see Fig.
2.2a-b and Fig. SI 2.3). The sPREs obtained from slopes of such trends
are shown in Fig. 2.2c (15N R1 sPREs) and 2.2d (15N R1ρ sPREs). A direct
comparison of predicted and experimental sPREs (Fig. SI 2.1) shows that
interactions with both Fc and Fab fragments must be present.
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Figure 2.2. Examples of linear fits for sPREs for GB1 in a complex with IgG (GB1IgG) based on (a) 15N
R1 and (b) 15N R1 relaxation rates. (c) 15N R1 sPREs and (d) 15N R1 sPREs for GB1 in a precipitated
complex with IgG.
To further analyze the increased protection due to protein – protein
interactions we focus the discussion on ΔsPREs. As we mentioned above, 
this is preferred to direct analysis of sPREs because ΔsPREs mostly 
suppress pattern of protection from solvent due to conformation of the
studied protein, leaving one with a pattern mostly based on
intermolecular interactions (unless the protein undergoes significant
conformational change upon binding where the analysis becomes much
more involved). Figure 2.3a-b shows experimental 15N R1 and R1ρ ΔsPREs 
for GB1IgG. Both data sets reveal a rather similar pattern, which differs
somewhat from ΔsPREs for GB1cryst. Overall, as expected due to the
shorter T1ρ times compared to T1 times, the dynamic range of R1ρ ΔsPREs 
is smaller but still sufficient to identify changes in the solvent accessibility
caused by complex formation. The fact that 15N R1ρ ΔsPREs appear to be 
sufficiently sensitive to characterize intermolecular contacts in the
GB1:IgG complex is fortunate because the acquisition of high quality R1ρ 
sPREs requires much shorter experimental times compared to 15N R1
sPREs. (from several days to sometimes less than 24 h; see Table SI
2.11).
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Figure 2.3. 15N ΔsPREs for GB1IgG based on (a) R1 and (b) R1 relaxation rates (grey bars). Lines
indicate scaled ΔsPREs calculated from back-predicted sPREs: GB1:IgG complex model (red 
continuous), GB1:Fab complex model (dashed blue) and GB1:Fc complex model (dotted grey). For the
comparison, all back-predicted data sets are scaled so that the average of the set is equal to the
average of the experimental data. The expected binding sites are highlighted: Fab interface (residues
9-18) and Fc interface (residues 23-46). Experimental 15N R1 (c) and R1 (d) ΔsPREs projected onto 
the structural model of GB1 in a complex with IgG. Red indicates residues with the largest changes in
solvent accessibility upon binding and blue the residues with the smallest changes upon binding.
Residues for which data is not available either due to severe overlap, missing peak or insufficient
signal to noise are indicated in grey.
The most prominent feature arising from a comparison of 15N R1 and R1ρ 
ΔsPREs in GB1IgG and 15N R1 ΔsPREs in GB1cryst is that 2 is most
protected in both assemblies. This is consistent with the intermolecular
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hydrogen bonds between GB1 molecules in the crystal and intermolecular
hydrogen bonds to the Fab fragment in the GB1:IgG complex. On the
other hand, 3 which interacts but does not form hydrogen bonds with
the Fc fragment in GB1IgG is somewhat less protected than in the crystals
where it forms intermolecular hydrogen bonds.
Figure 2.4. 1H R1 relaxation rates (a), 1H R1 sPREs (b) and 1H R1 ΔsPREs (c) for GB1IgG. Lines
indicate scaled ΔsPREs calculated from back-predicted sPREs: GB1:IgG complex model (red 
continuous), GB1:Fab complex model (dashed blue) and GB1:Fc complex model (dotted grey). The
scaling procedure is the same as in Fig. 2.. 3. The expected binding sites are highlighted as in Fig. 2..
3. (d) 1H R1 ΔsPREs plotted onto the structure of GB1 in complex with full length IgG. Residues for 
which data is not available either due to severe overlap, missing peak or insufficient signal to noise are
indicated in grey.
Even more interestingly the N-terminal residues in the helix seem
similarly or better protected than 2 as a result of complex formation.
The above observations seem to be consistent with creation of the
interface between the helix and 3 of GB1 with the Fc part of IgG.
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To further investigate the protein-protein interfaces we also measured
amide 1H solvent PREs. 1H sPREs of the GB1:IgG complex were obtained
from 1H R1 measurements (for historical reasons using CuEDTA37 rather
than Gd(DTPA-BMA), and are presented in Figure 2.4b (data in Tables SI
2.6-2.7, comparison between predicted and experimental sPREs in Fig. SI
2.2). Reference experimental 1H sPREs for isolated GB1 in solution were
taken from ref. 64.
The overall trend in 1H ΔsPREs for the GB1:IgG complex is similar to 15N
ΔsPREs: again, as a result of the complex formation 2 is the most
strongly protected, 3 is also protected but to a lesser extent with Y45
exhibiting the strongest level of protection. However, relative to the level
of protection in 2, the residues in the helix seem to be very slightly less
protected than in 15N ΔsPREs. 
The ΔsPREs back-calculated from models of GB1:IgG, GB1:Fab and 
GB1:Fc complexes are plotted as lines in Fig. 2.3a-b and 2.4c. A simple
visual inspection suffices to see that all three experimental ΔsPRE sets 
are more compatible with the ΔsPREs back-calculated from a model of 
the GB1:IgG complex where both of the binding interfaces are occupied
at the same time. In all the cases, ΔsPREs calculated for GB1:Fab grossly 
underestimate the level of protection for 3 and helix while ΔsPREs 
calculated for GB1:Fc grossly underestimate the level of protection for 2
and overestimate the level of protection for 3 acquired upon complex
formation.
In order to obtain a more quantitative handle on how well the different
structural models reproduce experimental data we have also performed a
series of fits of the experimental ΔsPREs to ΔsPREs back-calculated from 
the different models (note that scaling of individual back-calculated
sPREs is not required before calculation of theoretical ΔsPREs), with a 
global scaling factor as the only fit parameter. Again, in such data the
trends are “cleaned up” from the effects of GB1 conformation simplifying
quantification of the contribution from intermolecular interactions. In all
the cases, data back-predicted from the GB1:IgG complex where both
Fab and Fc interfaces are occupied gives the lowest 2 thus identifying it
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as the best from the considered models of the interaction (see Table SI
2.12).
Upon closer inspection of the best fitting theoretical sPRE trends against
the experimental ones we identify one particularly interesting feature
where the two types of data differ. According to the experimental data
the protection due to interactions between GB1 and IgG are similar for
some residues in β4 as for β3 suggesting that either the first residues in 
β3 are less protected than expected or β4 is more protected than 
expected. Different levels of protection can be explained by either a
change of backbone conformation between GB1free and GB1IgG, internal
molecular motion, or an additional interaction with IgG.
The C secondary chemical shifts for GB1 in complex with IgG are very
similar to the ones calculated for GB1 in solution (see Fig. SI 2.5, based
on data from ref. 7), with exception of L6, T11, L12 and K50 (Fig. 2.5a).
Consequently, subtle changes in the backbone conformation are unlikely
to explain the changes in the solvent accessibility of β4. Internal 
molecular motions could explain the differences in the sPREs for
residues which exhibit large amplitude backbone motions, but can be
safely neglected for the rest of the residues including those in 4.8,59 This
means that the observed deviations, if real and not just experimental
errors, must arise from changes in the intermolecular interactions:
additional interactions for the increased protection and abolished
interactions for the decreased protection. Some changes in the solvent
accessibility might be expected if GB1 undergoes a small amplitude
anisotropic overall motion in the complex, as we have suggested based
on the analysis of relaxation rates measured in the complex.8 To
investigate what effect such motion would have on the pattern of solvent
accessibility we generated a series of conformers where the molecule of
GB1 was rotated around the axes of the motion by 7, which corresponds
to the approximate amplitude of motion determined in our rather simple
analysis8 (the actual amplitude of motion may differ because in the
absence of dipolar order parameter relaxation analysis is not very
reliable51,59) followed by translating the molecules assuming that 2
hydrogen bonded to Fab is the anchoring the point.
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Figure 2.5. (a) Models of GB1:IgG complex with: A - only Fab and Fc interface (cornflower blue) and B
- Fab, Fc and additional contact with 4 (green). Residues with higher than average chemical shift
perturbations (CSPs) are indicated in orange.7 Previously unexplained above average CSPs for res 7,
53, 54 are shown in red.7 Sites with deviations of C secondary chemical shift compared to solution are
indicated in blue.7  (b-c) Experimental ΔsPREs vs. ΔsPREs predicted from GB1:IgG models in (a): 
model A (red line) and model B (black dashed line). (d-e) Back-predicted sPREs for GB1 in complex
with IgG assuming small amplitude overall anisotropic motion of GB1 as suggested in ref. 8. The lines
in (d-e) represent a range of ΔsPREs based on 5 generated conformers. 
The distribution of sPREs calculated for 5 generated conformers is
illustrated in Fig. 2.5d-e. In the case of a proposed overall motion the
residues most immune to changes in solvent accessibility as a result of
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this motion would be 1, 4 and the C-terminal half of the helix. Such a
motion could, however, contribute to the discrepancies observed for 3,
V21 and loop 4 (D47 is the most influenced of all residues).
Interestingly, we previously observed large chemical shift perturbations
(CSPs) for T53, V54 and L7 upon GB1:IgG complex formation but were
unable to completely explain their origin (Fig. 2.5a; L7 could potentially
be explained by a small backbone conformation change indicated by
change in C secondary chemical shift of L6C compared to solution). The
presence of these CSPs and the elevated sPREs suggest that there
might be an additional interaction between GB1 and IgG, which involves
4 and that is not observed in the complexes of protein G domains with
IgG fragments. Obviously, with the available data it is not possible for us
to identify the region of IgG responsible for this potential additional
interaction. However, we can simulate the effects of proximity of
molecular fragments to 4 on the ΔsPRE pattern in GB1IgG. We have
generated a model by translating one of the extended IgG loops to make
an intermolecular contact with 4 (Fig. 2.5a). This additional contact
indeed reduces the anomalous sPRE trend for 4. In spite of complete
arbitrariness of this model (the exact structure of the fragment and its
position is likely different), it is clear that the presence of a similar
additional interaction is consistent with the observed elevated ΔsPREs for 
4 and the large CSPs for residues 53 and 54. Interestingly, the existence
of such a contact would also help to explain why the complex of GB1 with
IgG gives such high-quality NMR spectra that are atypical for a
precipitate. With three interfaces the local environment of GB1 in the
complex would be defined almost entirely by the specific interactions with
IgG leaving GB1 largely unaffected by any heterogeneity of the sample.
2.3 Conclusions
We introduced 1H and 15N solvent PREs as a general and powerful tool
for characterizing intermolecular interfaces in large biomolecular
complexes in the solid state. The proposed methods can be applied over
the majority of range of spinning frequencies employed in biomolecular
solid-state NMR: moderate spinning frequencies (15N R1), intermediate
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spinning frequencies (15N R1, 15N R1) and fast spinning frequencies (15N
R1, 15N R1, 1H R1), which allows to fine tune this methodology to the
specific requirements of different systems and available instrumentation.
We demonstrate for 100% back-exchanged protein in the presence of a
fully protonated binding partner that 1H-1H spin diffusion is sufficiently
slowed down at 100 kHz to allow the use of 1H R1 as a site-specific probe
of solvent accessibility. 1H R1 and 15N R1 are the most sensitive probes
enabling accurate measurement of even small PREs. At the same time
15N R1, even though less sensitive than 1H R1 and 15N R1 as sPRE probes,
yields essentially the same picture with the added benefit of overall
shorter experiments where satisfactory signal to noise ratio can be
achieved in a reasonable amount of time, even for large biomolecular
complexes characterized by low sensitivity. We establish the benefits of
comparing sPREs of isolated protein in solution to sPREs of the protein in
a complex in the solid state to identify reduced solvent accessibility of
regions involved in protein-protein interactions.
Moreover, we demonstrate the utility of solid-state sPREs for
determining intermolecular interactions by applying it to characterize
intermolecular contacts in GB1 crystal and protein-protein interfaces in
GB1 in a complex with full length IgG. The experimental sPREs are in a
very good agreement with predicted sPREs based on crystal structures.
All three sPRE probes: 15N R1, 15N R1, 1H R1 yield a highly consistent view
of the GB1 interactions with IgG. Based on the local deviations of ΔsPRE 
trends and CSPs we suggest that the extraordinary GB1:IgG binding
interface might involve three different regions, painting a more complex
picture than what can be deduced from the structures of protein G with
IgG fragments, emphasizing the importance of using full length proteins
in interaction studies if at all possible.
We envision the proposed approach to be widely applicable for
characterization of intermolecular interfaces in large protein complexes
and especially the ones that are not accessible to other high resolution
techniques as is the case for the precipitated complex of GB1:IgG.
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2.4 Experimental Section.
Sample preparation. Isotope labelled GB1 2Q6I was expressed using
pGEV2 in BL21(DE3)65. [U-13C,15N]GB1 was purified from cultures grown
in M9 supplemented with [U-13C]glucose and 15NH4Cl. [U-2H,13C,15N]GB1
was expressed in M9 prepared in D2O with deuterated [U-13C]glucose and
15NH4Cl. Cells were grown to an OD600 >1.0 in two liters LB for each liter
of M9 and washed once with PBS before resuspension in M9. Expression
was induced with 0.5 mM IPTG after 1 h incubation at 37 C. After
expression for 4 h at 37 C, the cells were pelleted (4000  G for 20 min
at 16 C), and lysed by sonication in buffer (50 mM potassium
phosphate; 200 mM NaCl; 1 mg/ml lysozyme; pH 7.0). The lysate was
then incubated at 75 C for 10 min and cleared by centrifugation (12000
 G for 50 min). After precipitation over night with 80% ammonium
sulfate, GB1 was pelleted (15000  G for 50 min), resuspended in buffer
(50 mM potassium phosphate; 200 mM NaCl; pH 7.0), and purified on a
16/600 Sephadex pg75 (GE Healthcare) gel filtration column. Fractions
containing GB1 were collected, desalted, freeze-dried and stored at -20
C.
Freeze-dried [U-2H,13C,15N]GB1 was dissolved in buffer (50 mM sodium
phosphate buffer pH 5.5) to obtain a protein concentration of 10 mg/ml
and crystallized with the aid of 2:1 2-methyl-2,4-pentanediol
(MPD):Isopropanol66. Lyophilized IgG from human serum was purchased
from Sigma-Aldrich. GB1:IgG complex was formed by mixing GB1 and
IgG solutions in 2:1 molar ratio7. Crystalline GB1 and precipitated
GB1:IgG complex were packed into NMR rotors using the following
procedure: The crystals/precipitate were spun down by centrifugation (1
min at 20 000  G using a bench top centrifuge), and resuspended in a
small volume of the supernatant containing 2% DSS and Gd(DTPA–BMA)
at the desired concentration. The 1.3 mm rotors were packed by
centrifugation (20 000  G) and the rotor caps sealed with a silicone-
based glue to prevent leakage. The smaller 0.81 mm rotors were filled
manually using microspatulas.
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The solution NMR sample was prepared in a 3 mm tube containing 200
µl of 1 mM [U-13C,15N]GB1 in 50 mM sodium phosphate, pH 5.5, 10%
D2O, and 30 µM DSS.
Solution NMR. All solution NMR data was recorded at 298 K on a 700
MHz Bruker Avance spectrometer equipped with a cryogenically cooled
probehead. 15N longitudinal relaxation rates (R1) were measured with a
15N-HSQC based standard Bruker pseudo 3D (hsqct1etf3gpsi3d.2) with 8-
10 points using delays between 0.05 and 2.0 s (details are listed in SI
Table 11). Spectral widths were 8400 Hz for 1H and 2700 Hz for 15N, and
FIDs had 2048 and 256 points, respectively. The recycle delay was 3.5 s.
To obtain the sPREs, the sample was titrated with Gd(DTPA–BMA)
(Omniscan; stock 20 mM) up to 2.5 mM (details in SI Table 11).
All spectra were processed in TopSpin 3.2 and CCPNMR67 and MatLab
R2014a was used to analyze the relaxation data.
Solid state NMR. Solid state NMR spectra were recorded at 600 MHz
Bruker Avance II+, 700 MHz Bruker Avance III HD and 850 MHz Bruker
Avance III spectrometers, using Bruker 1.3 mm triple resonance probes
(at MAS frequencies of 50-60 kHz) or a volume optimized 0.81 mm
double resonance probe from Samoson laboratory (for experiments at
~100 kHz MAS). A Bruker BCU-X cooling unit was used to regulate the
internal sample temperature to 27 ± 1 °C (measured from the chemical
shift of water with respect to DSS. For experiments recorded at 700 MHz
1H Larmor frequency 10 % D2O was added to the sample buffer before
packing the rotors and deuterium locking was used in the same way as in
solution NMR. 15N-1H 2D correlation spectra were recorded using a
proton-detected heteronuclear correlation sequence. Double quantum
cross-polarization (CP) contact times were between 0.5 – 1.5 ms and
individually optimized for each sample. Recycle delays between 0.2 – 2.5
s were used depending on the amount of paramagnetic agent and
magnetic field.
The maximum employed concentrations were chosen so that the
paramagnetic effect does not lead to significant line broadening and are
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thus are different for different samples, e.g. larger concentrations could
be used in GB1:IgG complex than in GB1 crystal to obtain similar line
widths.
In all solid-state experiments, hard pulses were applied at nutation
frequencies of 100 kHz (1.3 mm probe) or 125 kHz (0.81 mm probe) for
1H and 83.3 kHz for 15N. 10 kHz WALTZ-16 decoupling was applied on
protons during 15N evolution, and on 15N channel during direct 1H
acquisition, while quadrature detection was achieved using the States-
TPPI method. Suppression of the water signal was achieved by saturation
with 50 - 200 ms of slpTPPM 1H decoupling applied at an amplitude of ¼
of the MAS frequency38 or 100-140 ms MISSISSIPPI68 at an amplitude of
½ the MAS frequency on resonance with the water signal.
R1 and R1ρ relaxation curves were sampled using 8-11 points for all
experiments except the diamagnetic 15N R1 in the complex where only 2
points were used (SI Tables 10-11). Error estimates for the integrals
were achieved by duplicating one of the relaxation delays (R1) or spin-
lock lengths (R1ρ). 10 kHz nutation frequency, measured by a nutation
experiment, was used for the spin-lock field in the R1ρ experiments.
All spectra were processed using TopSpin 3.2. GB1 resonances in the
complex with IgG were previously assigned on the basis of 3D H(H)NH,
CONH, CO(CA)NH and CANH experiments.7 Peak integrals were
calculated in TopSpin 3.2. OriginPro 2016 and MatLab R2014a was used
to analyze the relaxation data.
Error estimates. Peak integrals from TopSpin or peak volumes from
CCPNMR were exported to MatLab where an exponential function was
used with the fminsearchbnd function to fit the relaxation data. Errors
were calculated by a Monte Carlo error estimations for R1 and R1ρ
exponential fits. A random number between 0 and 1 was multiplied with
the integral error and added to the recalculated integrals or volumes. The
fitting was then repeated 2000 times with a new random number
between 0 and 1 generated each time. Two times the standard deviations
of the R1 or R1ρ values received from the fits for each residue were used
as errors. Errors for sPREs were obtained in the same way but with linear
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fits instead of exponential. Error propagations for ΔsPREs were calculated 
using standard formulas for error propagation.
PRE predictions. Predicted sPRE data was computed using a previously
published grid-based approach30,33,54 To this end, the structural model
was placed in a grid with equally-spaced grid points. The grid point-to-
grid point distance was set to 0.2 Å and the distance between the outer
atoms of the protein and the edges of the grid box was set to 20 Å. Next,
all grid points that are positioned within a radius   clash around an atom of
the protein were removed. The radius   clash was set to   clash =   vdW, i +   Gd
where   vdW, i is the van-der-Waals radius of atom   and   Gd is the radius
of the paramagnetic compound and was set to 3.5 Å. Next, the sPRE
value (sPRE   ) of atom   of the protein was computed by summing up the
contributions of all remaining grid points according to
sPRE   = ∑                     Å (2.1)
where   is the index of the protein atom, the index   iterates over all
remaining grid points and       is the distance between the atom   and grid
point   .
Whenever two sPREs data sets of different origin (e.g. theoretical and
experimental sPREs or experimental sPREs derived from different
relaxation measurements) are compared directly, one of the data sets is
scaled by the ratio of the averages of the sPREs in each data set. Only
data points for residues present in both data sets were used to calculate
the average.
C++ code for calculating sPREs is available from the authors upon
request. For published structures that contained several models (like
solution NMR structure of GB1), the error of the sPRE prediction was
estimated using the standard deviation of the sPRE values of the different
models. For calculation of sPREs for GB1free solution structure (PDB ID:
3gb158; our construct is a T2Q mutant but comparison of sPREs
calculated from isolated GB1 from several different solution and x-ray
structures suggested that in the case of amide sPREs differences are very
small) was used with the sPRE reported as an average of the sPREs
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calculated for each conformer in the bundle. For calculation of sPREs for
GB1cryst X-ray structure (PDB ID: 2qmt57) was used with a molecule in the
middle of a 3x3 unit cell crystal lattice generated in Chimera69 using
Multiscale Models tool. For sPREs for GB1:Fab complex model obtained by
structural alignment of X-ray structure of GB1 (PDB ID: 2qmt57) with GB3
in X-ray structure of GB3:Fab (PDB ID 1igc70) was used. For sPREs for
GB1:Fc complex model obtained by structural alignment of X-ray
structure of GB1 (PDB ID: 2qmt57) with GB3 in X-ray structure of GB2:Fc
(PDB ID 1fcc63) was used. For sPREs for GB1:IgG complex, model
obtained by the alignment of the above two complexes on GB1 (PDB ID
1igc70 and 1fcc63). Before sPRE calculation protons were added to the
models using the default tool in Chimera.69
sPREs were calculated as a difference between sPREs for isolated
molecule in solution and sPREs in the assembly. Both experimental and
theoretical sPREs were calculated. sPREs were scaled by ratio of
averages before calculating sPREs to minimize bias from any particular
data set. Here we typically scaled up the sPREs from the assembly to
solution sPREs. Note that comparison of the two different theoretical
sPRE data sets does not require scaling.
Fitting of the experimental sPREs to sPREs back-predicted from
various models was performed in Matlab. The best fit was determined by
minimizing the 2 target function:
    = ∑ (∆               ,       ∆                 ,  )  
  ∆        ,      ,    (2.2)
where ∆               ,   is experimental sPRE for residue i, ∆                 ,   is sPRE
for residue i calculated from a given model,   ∆         ,       ,    is error for
experimental sPRE for residue i and A is a constant and the only fit
parameter.
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2.7 Supporting Information
2.7.1 Results and Discussion
Direct comparisons between experimental and predicted sPREs of GB1IgG
are presented in SI figure 2.1 for 15N data, SI figure 2.2 for 1H data
including a comparison of predicted 1H sPREs for GB1free with published
experimental sPRE data1.
Examples of linear fits used to calculate sPREs from relaxation rates
measured at different concentrations of Gd(DTPA-BMA) in GB1IgG samples
are compared to linear fits obtained for GB1free in SI figure 2.3. The
model of GB1 in complex with full length IgG that was used for the
calculation of theoretical sPREs is presented in SI figure 2.4. Cα 
secondary chemical shifts for GB1free and GB1IgG, based on data from ref 2
are shown in SI figure 2.5. All data used in SI figures 2.1-2.3 are detailed
in SI tables 2.1-2.9. SI tables 2.10 and 2.11 contain relaxation delays
and spin-lock lengths used for all relaxation measurements. SI table 2.12
contains results from a χ2 – based best fitting comparison between
experimental and predicted ΔsPRE data sets.   
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SI figure 2.1. Comparison between experimental and predicted 15N sPREs for GB1 in complex with
IgG. For visualization purposes the predicted sPREs were scaled so that the average values are the
same in the data sets that are compared. (a) GB1IgG based on 15N R1, (b) GB1IgG based on 15N R1ρ.
The lines represent predicted sPREs; red line for GB1 in complex with both fragments of IgG, dashed
blue line for GB1 in complex with the Fab fragment of IgG and dotted grey line for GB1 in complex with
the Fc fragment of IgG.
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SI figure 2.2. Comparison between experimental and predicted 1H sPREs for GB1 free in solution (a)
(experimental data from ref1) and GB1 in complex with IgG (b). For visualization purposes the
predicted sPREs were scaled so that the average values are the same in the data sets that are
compared. The lines represent predicted sPREs; black line for GB1 free in solution, red line for GB1 in
complex with both fragments of IgG, dashed blue line for GB1 in complex with the Fab fragment of IgG
and dotted grey line for GB1 in complex with the Fc fragment of IgG.
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SI figure 2.3. Examples of linear fits used to extract 15N sPREs for (a) GB1free, (b) GB1IgG based on R1
and (c) GB1IgG based on R1ρ.
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SI figure 2.4. Model of GB1 in complex with IgG used for calculations of theoretical sPREs. The model
is based on crystal structures, solution NMR and solid state NMR: Crystal structures of the Fab
fragment of IgG in complex with GB33 and the Fc fragment of IgG in complex with GB24; Solution NMR
of GB2 in complex the Fab fragment5, GB2 in complex with the Fc fragment6 and GB1 in complex with
the Fc fragment7; and solid state NMR of GB1 in complex with full length IgG2.
SI figure 2.5. Cα secondary chemical shifts for GB1 free in solution (black squares) and GB1 in
complex with IgG (red circles), based on published data2.
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SI table 2.1. 15N R1 rates (s-1) for GB1free with varying concentration of Gd(DTPA-BMA)
0 mM 0.1 mM 0.3 mM 0.7 mM
Residue R1 Error R1 Error R1 Error R1 Error
2 2.2326 0.0109 2.2001 0.0110 2.2237 0.0113 2.3445 0.0104
3 2.2463 0.0111 2.2032 0.0110 2.2397 0.0111 2.3218 0.0103
4 2.2599 0.0115 2.3086 0.0117 2.3171 0.0119 2.3321 0.0103
5 2.3500 0.0118 2.3674 0.0124 2.3522 0.0121 2.3909 0.0103
6 2.2624 0.0110 2.2501 0.0116 2.2608 0.0116 2.3240 0.0099
7 2.2469 0.0111 2.2131 0.0112 2.2011 0.0110 2.2641 0.0098
8 2.1480 0.0108 2.1297 0.0110 2.1450 0.0108 2.1735 0.0095
9 2.2315 0.0111 2.2020 0.0109 2.2193 0.0111 2.2531 0.0097
10 2.1400 0.0106 2.1291 0.0107 2.1306 0.0110 2.1557 0.0091
11 2.0404 0.0096 2.0031 0.0101 2.0173 0.0102 2.0595 0.0088
12 1.8230 0.0087 1.8143 0.0089 1.8224 0.0090 1.9066 0.0083
13 2.0546 0.0103 2.0336 0.0101 2.0411 0.0103 2.1427 0.0093
14 2.0068 0.0098 2.0026 0.0099 2.0255 0.0099 2.0932 0.0090
15 2.0886 0.0103 2.0634 0.0104 2.1244 0.0107 2.1948 0.0096
16 2.2233 0.0111 2.2152 0.0113 2.2348 0.0113 2.2870 0.0101
17 2.1667 0.0104 2.1296 0.0103 2.1982 0.0109 2.3272 0.0100
18 2.2355 0.0112 2.2350 0.0112 2.2646 0.0113 2.3528 0.0101
19 2.0743 0.0101 2.0720 0.0102 2.1024 0.0107 2.1472 0.0088
20 2.2268 0.0109 2.2541 0.0114 2.2486 0.0113 2.2709 0.0099
21 2.2359 0.0112 2.2269 0.0112 2.2485 0.0115 2.3144 0.0100
23 2.2456 0.0112 2.2371 0.0113 2.2659 0.0113 2.3357 0.0103
24 2.1352 0.0105 2.1307 0.0108 2.1566 0.0108 2.2235 0.0096
25 2.2187 0.0107 2.1634 0.0105 2.1800 0.0109 2.2584 0.0098
26 2.3589 0.0117 2.3282 0.0117 2.3465 0.0122 2.4935 0.0107
27 2.2470 0.0110 2.2287 0.0111 2.2247 0.0112 2.2986 0.0101
28 2.2584 0.0112 2.2122 0.0111 2.2250 0.0113 2.3432 0.0101
29 2.2448 0.0112 2.2419 0.0116 2.2698 0.0112 2.3653 0.0102
30 2.2877 0.0114 2.2647 0.0116 2.2797 0.0116 2.3507 0.0103
31 2.2924 0.0114 2.3002 0.0117 2.2807 0.0115 2.3041 0.0098
32 2.2207 0.0112 2.2073 0.0114 2.2151 0.0116 2.2687 0.0098
33 2.2454 0.0114 2.2710 0.0115 2.2798 0.0115 2.2853 0.0099
34 2.3471 0.0118 2.3515 0.0117 2.3744 0.0126 2.4396 0.0104
35 2.1855 0.0111 2.1431 0.0105 2.1576 0.0109 2.2884 0.0100
36 2.2268 0.0116 2.2242 0.0113 2.2342 0.0116 2.2964 0.0102
39 2.1725 0.0109 2.1820 0.0114 2.1982 0.0110 2.2718 0.0096
40 1.9386 0.0097 1.9496 0.0099 1.9333 0.0098 1.9150 0.0084
42 2.1449 0.0106 2.1689 0.0112 2.1897 0.0110 2.2368 0.0098
43 2.1709 0.0109 2.1990 0.0113 2.2064 0.0108 2.2368 0.0098
44 2.2814 0.0110 2.2893 0.0117 2.3434 0.0120 2.4124 0.0105
45 2.1529 0.0108 2.1477 0.0103 2.1984 0.0109 2.2936 0.0101
46 2.2105 0.0107 2.2404 0.0113 2.2648 0.0110 2.2829 0.0096
47 2.1837 0.0105 2.1346 0.0102 2.1733 0.0109 2.2536 0.0097
48 2.0891 0.0103 2.0544 0.0104 2.0930 0.0105 2.1823 0.0095
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49 2.1031 0.0101 2.0504 0.0099 2.0625 0.0103 2.1770 0.0095
50 2.3415 0.0115 2.2964 0.0113 2.3074 0.0119 2.3909 0.0105
51 2.2567 0.0109 2.2252 0.0108 2.2506 0.0113 2.3320 0.0100
52 2.2550 0.0110 2.2045 0.0110 2.2195 0.0110 2.2853 0.0103
53 2.2307 0.0106 2.1749 0.0105 2.1867 0.0106 2.2419 0.0097
54 2.4056 0.0122 2.3584 0.0117 2.3854 0.0120 2.4970 0.0111
55 2.2265 0.0108 2.2040 0.0112 2.2162 0.0112 2.2248 0.0095
56 2.2278 0.0112 2.2380 0.0112 2.2400 0.0113 2.2976 0.0098
SI table 2.2. 15N R1 rates (s-1) for GB1free with varying concentration of Gd(DTPA-BMA)
1.2 mM 2 mM 2.5 mM
Residue R1 Error R1 Error R1 Error
2 2.3745 0.0110 2.3765 0.0102 2.4624 0.0114
3 2.3449 0.0110 2.2817 0.0097 2.2944 0.0102
4 2.3566 0.0109 2.3138 0.0098 2.3593 0.0104
5 2.4162 0.0112 2.3725 0.0099 2.3969 0.0114
6 2.3466 0.0104 2.2964 0.0099 2.3474 0.0106
7 2.3069 0.0107 2.2922 0.0100 2.3115 0.0104
8 2.1914 0.0101 2.1964 0.0095 2.1935 0.0099
9 2.2947 0.0104 2.2868 0.0099 2.2989 0.0106
10 2.2125 0.0101 2.2257 0.0096 2.2647 0.0101
11 2.1274 0.0095 2.1581 0.0093 2.2132 0.0099
12 1.9534 0.0087 1.9788 0.0085 1.9910 0.0092
13 2.2675 0.0105 2.3586 0.0100 2.3710 0.0106
14 2.1876 0.0099 2.2328 0.0097 2.3300 0.0104
15 2.3092 0.0105 2.4385 0.0104 2.4739 0.0111
16 2.4347 0.0111 2.5293 0.0109 2.5890 0.0118
17 2.4779 0.0117 2.5131 0.0106 2.5884 0.0117
18 2.4764 0.0113 2.5235 0.0109 2.5959 0.0117
19 2.2528 0.0100 2.2856 0.0100 2.3276 0.0107
20 2.3137 0.0103 2.3113 0.0101 2.3941 0.0110
21 2.3260 0.0106 2.3189 0.0097 2.3325 0.0107
23 2.4389 0.0112 2.3803 0.0104 2.4513 0.0109
24 2.2774 0.0104 2.2337 0.0095 2.2892 0.0102
25 2.2907 0.0105 2.2897 0.0101 2.3690 0.0106
26 2.4992 0.0112 2.3722 0.0105 2.3540 0.0108
27 2.3379 0.0104 2.3243 0.0101 2.3736 0.0107
28 2.3463 0.0108 2.2651 0.0095 2.2421 0.0097
29 2.3480 0.0108 2.3023 0.0099 2.3096 0.0105
30 2.3671 0.0110 2.3621 0.0097 2.4090 0.0109
31 2.3353 0.0108 2.3103 0.0101 2.3137 0.0105
32 2.3000 0.0104 2.2500 0.0096 2.2757 0.0103
33 2.3335 0.0110 2.3394 0.0099 2.3386 0.0105
34 2.4259 0.0112 2.3442 0.0101 2.4010 0.0110
35 2.3018 0.0108 2.2492 0.0097 2.2746 0.0104
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36 2.3313 0.0108 2.2946 0.0096 2.3394 0.0107
39 2.2842 0.0106 2.2449 0.0096 2.2691 0.0101
40 1.9780 0.0089 2.0013 0.0087 2.0483 0.0095
42 2.2913 0.0103 2.3274 0.0102 2.3359 0.0105
43 2.3219 0.0105 2.3774 0.0101 2.4369 0.0107
44 2.4561 0.0111 2.4673 0.0110 2.5077 0.0112
45 2.4224 0.0111 2.4768 0.0105 2.5738 0.0113
46 2.3895 0.0110 2.4126 0.0102 2.4464 0.0110
47 2.3385 0.0107 2.3676 0.0100 2.3951 0.0107
48 2.2256 0.0099 2.2382 0.0094 2.3414 0.0107
49 2.2145 0.0100 2.2701 0.0096 2.2642 0.0100
50 2.4307 0.0111 2.4533 0.0105 2.4683 0.0112
51 2.3415 0.0110 2.2728 0.0097 2.3099 0.0104
52 2.3211 0.0105 2.3414 0.0099 2.3961 0.0107
53 2.2821 0.0104 2.2498 0.0099 2.2661 0.0102
54 2.4939 0.0115 2.4206 0.0104 2.4426 0.0112
55 2.3001 0.0103 2.3009 0.0098 2.3139 0.0105
56 2.3409 0.0107 2.3299 0.0100 2.3663 0.0106
SI table 2.3. 15N R1 rates (s-1) for GB1cryst with 0 and 2 mM Gd(DTPA-BMA)
0 mM 2 mM
Residue R1 Error R1 Error
2 0.0616 0.0060 0.0783 0.0080
3 0.0343 0.0041 0.0474 0.0065
6 0.0157 0.0025 0.0392 0.0056
8 0.0343 0.0043 0.0461 0.0065
9 0.0466 0.0052 0.0594 0.0070
10 0.0814 0.0090 0.0954 0.0098
11 0.0993 0.0104 0.1605 0.0171
12 0.0986 0.0102 0.1193 0.0115
14 0.0542 0.0062 0.0573 0.0067
15 0.0330 0.0047 0.0377 0.0060
16 0.0416 0.0046 0.0358 0.0056
17 0.1044 0.0118 0.1063 0.0110
18 0.0650 0.0069 0.0826 0.0088
19 0.1047 0.0106 0.1255 0.0133
24 0.0358 0.0047 0.0627 0.0075
26 0.0223 0.0033 0.0238 0.0045
28 0.0252 0.0041 0.0362 0.0058
29 0.0271 0.0041 0.0422 0.0058
32 0.0259 0.0042 0.0419 0.0064
33 0.0279 0.0043 0.0327 0.0058
35 0.0316 0.0044 0.0457 0.0066
36 0.0264 0.0043 0.0393 0.0059
39 0.0514 0.0056 0.0610 0.0069
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40 0.1590 0.0185 0.1644 0.0175
44 0.0217 0.0034 0.0211 0.0047
45 0.0163 0.0034 0.0258 0.0050
46 0.0246 0.0037 0.0333 0.0056
49 0.0614 0.0068 0.0902 0.0096
51 0.0205 0.0035 0.0239 0.0054
52 0.0112 0.0030 0.0174 0.0047
53 0.0110 0.0029 0.0173 0.0047
54 0.0149 0.0034 0.0192 0.0051
55 0.0225 0.0040 0.0370 0.0058
56 0.0531 0.0056 0.0722 0.0078
SI table 2.4. 15N R1 rates (s-1) for GB1IgG with varying concentrations of Gd(DTPA-BMA)
0 mM 3.5 mM 5 mM 7.5 mM
Residue R1 Error R1 Error R1 Error R1 Error
1 0.0334 - 0.0526 0.0269 0.0610 0.0248 - -
9 0.0373 - 0.0819 0.0272 0.0877 0.0260 0.1194 0.0282
10 0.0547 - 0.1512 0.0445 0.1100 0.0367 0.1943 0.0502
11 - - 0.1066 0.0296 0.0828 0.0300 0.2619 0.0594
14 0.0126 - 0.0858 0.0243 0.1057 0.0308 0.1039 0.0255
15 0.0620 - 0.0841 0.0324 0.0672 0.0257 0.1401 0.0377
17 0.0449 - 0.0595 0.0290 0.0623 0.0231 0.1436 0.0462
18 0.0556 - 0.0563 0.0214 0.0763 0.0284 0.0917 0.0266
19 0.0487 - 0.1452 0.0362 0.1540 0.0396 0.1971 0.0542
20 0.1158 - 0.1068 0.0352 0.1686 0.0436 0.2058 0.0614
21 0.0781 - 0.2517 0.0553 0.2270 0.0584 0.2838 0.0758
26 0.0309 - 0.0909 0.0237 0.0614 0.0224 0.0927 0.0267
27 0.0044 - 0.0270 0.0236 0.0555 0.0213 0.0225 0.0185
28 0.0296 - 0.0746 0.0236 0.0299 0.0244 0.0795 0.0278
29 0.0110 - 0.0432 0.0276 0.0540 0.0258 0.0370 0.0174
31 0.0305 - 0.0374 0.0249 0.0330 0.0212 0.0212 0.0201
38 0.0264 - 0.0557 0.0278 0.1207 0.0364 0.1716 0.0417
40 0.0644 - 0.0763 0.0311 0.0540 0.0245 0.2138 0.0484
42 0.0322 - 0.0854 0.0297 0.1276 0.0290 0.2133 0.0483
44 0.0005 - 0.0073 0.0174 0.0706 0.0260 0.2697 0.0644
45 0.0204 - 0.0573 0.0285 0.1210 0.0333 0.1722 0.0445
47 0.0422 - 0.1429 0.0384 0.2719 0.0697 0.4298 0.1216
48 0.0530 - 0.1578 0.0416 0.1331 0.0344 0.1951 0.0518
49 0.0277 - 0.3069 0.0774 0.1149 0.0329 0.4797 0.1182
50 0.0344 - 0.2602 0.0512 0.2072 0.0486 0.2279 0.0735
51 0.0227 - 0.0481 0.0227 0.0798 0.0277 0.1389 0.0374
52 0.0150 - 0.0668 0.0250 0.0999 0.0300 0.0630 0.0272
54 0.0256 - 0.0495 0.0266 0.0819 0.0278 0.0748 0.0249
56 0.0372 - 0.1102 0.0318 0.1166 0.0353 0.1765 0.0437
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SI table 2.5. 15N R1ρ rates (s-1) at 10 kHz nutation frequency for GB1IgG with varying concentrations of
Gd(DTPA-BMA)
0 mM 1 mM 2 mM 3.5 mM
Residue R1ρ Error R1ρ Error R1ρ Error R1ρ Error
3 6.04 0.57 5.39 0.49 7.72 0.92 8.04 1.04
9 5.78 0.61 6.57 0.68 10.03 1.13 9.32 1.15
10 6.74 0.58 5.94 0.65 10.63 1.03 9.20 1.21
11 6.85 0.73 7.18 0.60 9.38 0.88 9.58 1.34
14 5.78 0.50 6.75 0.68 11.10 1.04 7.23 0.99
15 6.09 0.60 7.80 0.67 7.70 0.86 6.11 0.90
17 3.27 0.36 7.18 0.61 6.17 0.85 6.78 1.18
18 3.66 0.39 6.41 0.59 6.41 0.80 6.76 1.00
19 4.89 0.54 7.62 0.75 6.49 0.86 7.45 1.09
20 6.44 0.57 6.39 0.57 8.36 0.74 7.29 0.90
21 5.76 0.57 7.59 0.68 8.74 1.05 9.86 1.04
26 4.89 0.63 5.80 0.60 7.17 0.89 9.26 1.20
27 8.47 0.71 6.27 0.65 7.55 0.72 8.23 0.93
28 9.14 0.81 7.21 0.69 5.93 0.73 7.25 1.06
29 6.73 0.70 7.48 0.70 6.25 0.66 7.09 0.85
38 5.76 0.57 9.97 0.92 8.75 1.00 12.23 1.59
40 7.84 0.67 5.48 0.56 7.55 0.60 6.37 0.79
42 6.97 0.66 6.19 0.61 9.99 1.02 10.50 1.28
44 6.58 0.74 5.28 0.55 6.24 0.64 7.34 0.85
45 5.08 0.54 5.37 0.61 7.09 0.82 7.46 1.01
47 5.05 0.52 5.80 0.59 8.68 0.90 9.57 1.14
48 6.19 0.57 6.69 0.68 8.03 0.91 8.12 1.13
49 7.27 0.69 8.56 0.79 9.99 1.10 11.23 1.42
50 4.85 0.49 6.14 0.68 8.02 0.93 8.12 1.13
51 6.62 0.64 7.12 0.73 7.96 0.86 7.19 0.82
52 6.94 0.64 4.88 0.56 7.16 0.81 6.46 0.97
54 6.21 0.72 7.65 0.73 7.47 0.84 7.76 1.10
56 5.50 0.56 5.25 0.58 6.53 0.79 5.70 1.06
SI table 2.6. 1H R1 rates (s-1) for GB1IgG with 0 and 100 mM Cu(EDTA)
0 mM 100 mM
Residue R1 Error R1 Error
1 1.925 0.166 4.102 0.171
3 1.151 0.109 4.188 0.179
9 1.913 0.210 3.794 0.155
10 1.952 0.229 4.492 0.183
11 1.223 0.145 5.680 0.255
14 1.046 0.098 3.387 0.165
15 0.948 0.099 3.531 0.144
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17 1.124 0.118 4.336 0.174
18 1.172 0.119 3.487 0.161
19 0.958 0.104 6.577 0.289
20 1.945 0.219 7.762 0.350
21 1.556 0.166 7.580 0.338
26 1.645 0.189 4.868 0.206
27 1.457 0.146 5.439 0.208
28 1.683 0.200 4.964 0.176
29 0.977 0.116 3.841 0.155
31 1.845 0.270 3.847 0.151
38 1.071 0.166 4.008 0.173
40 0.636 0.073 4.024 0.129
42 1.433 0.159 3.603 0.136
44 0.975 0.108 3.686 0.149
45 2.227 0.256 5.043 0.225
47 1.344 0.143 5.731 0.251
48 1.000 0.102 5.482 0.218
49 1.470 0.176 9.712 0.427
50 1.275 0.151 6.866 0.328
51 1.279 0.135 5.802 0.228
52 1.250 0.116 3.394 0.142
54 1.098 0.113 3.412 0.151
56 1.194 0.114 3.911 0.185
SI table 2.7. Experimental 15N sPRE values (mM-1 s-1) for GB1free, GB1cryst and GB1IgG and 1H sPREs
for GB1IgG
15N R1 GB1free
15N R1 GB1cryst
15N R1 GB1IgG
15N R1ρ GB1IgG
1H R1 GB1IgG
Residu
e
PRE Error PRE Error PRE Error PRE Error PRE Error
1 - - - - 0 0.0025 - - 0.0218 0.0028
2 0.0944 0.0053 0.0084 0.0056 - - - - - -
3 0.0271 0.005 0.0065 0.0045 - - 0.7156 0.3773 0.0304 0.0025
4 0.0228 0.0052 - - - - - - - -
5 0.0145 0.0055 - - - - - - - -
6 0.0317 0.0051 0.0117 0.0035 - - - - - -
7 0.0378 0.0052 - - - - - - - -
8 0.0248 0.005 0.0059 0.0046 - - - - - -
9 0.0357 0.0051 0.0064 0.0051 0.0107 0.0059 1.1588 0.4248 0.0188 0.003
10 0.0541 0.0048 0.0070 0.0073 0.0168 0.0101 0.9828 0.4281 0.0254 0.0034
11 0.0789 0.0047 0.0306 0.0115 0.0294 0.0132 0.8748 0.483 0.0446 0.0034
12 0.0762 0.0043 0.0103 0.0090 - - - - - -
13 0.1495 0.005 - - - - - - - -
14 0.1296 0.0048 0.0016 0.0035 0.0128 0.0054 0.6142 0.3647 0.0234 0.0022
15 0.1706 0.0053 0.0024 0.0034 0.0091 0.0074 0 0.2029 0.0258 0.002
16 0.1593 0.0055 0.0010 0.0024 - - - - - -
17 0.1832 0.0054 0.0010 0.0053 0.0121 0.008 0.7815 0.3969 0.0321 0.0024
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18 0.15 0.0054 0.0088 0.0066 0.005 0.005 0.7663 0.3577 0.0231 0.0023
19 0.1072 0.0049 0.0104 0.0096 0.0195 0.0099 0.5544 0.4032 0.0562 0.0036
20 0.055 0.0053 - - 0.0126 0.0101 0.3511 0.3448 0.0582 0.0048
21 0.0408 0.0052 - - 0.0265 0.0135 1.1452 0.3779 0.0602 0.0043
22 - - - - - - - - - -
23 0.0822 0.0053 - - - - - - - -
24 0.059 0.0049 0.0134 0.0051 - - - - - -
25 0.0675 0.0052 - - - - - - - -
26 0.0065 0.0053 0.0010 0.0019 0.0074 0.0052 1.2675 0.4171 0.0322 0.0032
27 0.0548 0.0052 - - 0.0035 0.0042 0.0857 0.2732 0.0398 0.003
28 0.0074 0.005 0.0055 0.0041 0.0052 0.0054 0 0.2381 0.0328 0.0031
29 0.0238 0.0052 0.0076 0.0041 0.004 0.0051 0.0054 0.2093 0.0286 0.0022
30 0.0508 0.0054 - - - - - - - -
31 0.0103 0.0053 - - 0 0.0028 - - 0.02 0.0036
32 0.0238 0.0053 0.0080 0.0043 - - - - - -
33 0.0358 0.0052 0.0024 0.0033 - - - - - -
34 0.0089 0.0055 - - - - - - - -
35 0.0451 0.0051 0.0070 0.0045 - - - - - -
36 0.043 0.0053 0.0065 0.0042 - - - - - -
37 - - - - - - - - - -
38 - - - - 0.0199 0.0067 1.5898 0.5496 0.0294 0.0027
39 0.0344 0.0049 0.0048 0.0048 - - - - - -
40 0.0426 0.0046 0.0027 0.0097 0.0172 0.0084 0 0.1836 0.0339 0.0017
41 - - - - - - - - - -
42 0.077 0.0051 - - 0.0238 0.0078 1.2338 0.465 0.0217 0.0023
43 0.1036 0.0052 - - - - - - - -
44 0.0869 0.0054 0.0010 0.0019 0.0257 0.0074 0.3167 0.3382 0.0271 0.0021
45 0.1717 0.0053 0.0047 0.0034 0.0208 0.0068 0.7502 0.3728 0.0282 0.0039
46 0.0929 0.0053 0.0043 0.0038 - - - - - -
47 0.102 0.0051 0.0053 0.0044 0.0521 0.0158 1.4001 0.4093 0.0439 0.0034
48 0.1009 0.005 - - 0.0178 0.0099 0.5972 0.4123 0.0448 0.0028
49 0.0875 0.0048 0.0144 0.0068 0.0519 0.0177 1.1401 0.5106 0.0824 0.0053
50 0.0667 0.0054 - - 0.025 0.013 0.974 0.4039 0.0559 0.0042
51 0.0226 0.0051 0.0017 0.0026 0.0153 0.0058 0.1878 0.3055 0.0452 0.0031
52 0.0668 0.0052 0.0031 0.0031 0.0077 0.0056 0.0688 0.2669 0.0214 0.0021
53 0.0283 0.0049 0.0031 0.0030 - - - - - -
54 0.0215 0.0055 0.0022 0.0028 0.0073 0.0055 0.3692 0.4143 0.0231 0.0022
55 0.0447 0.0051 0.0073 0.0040 - - - - - -
56 0.054 0.0051 0.0096 0.0056 0.018 0.0079 0.1379 0.3161 0.0272 0.0025
SI table 2.8. Predicted 15N sPRE values (mM-1 s-1) for GB1free, GB1cryst, GB1IgG and GB1 in complex
with IgG fragments
GB1free GB1cryst GB1IgG GB1IgG(Fab) GB1IgG(Fc)
Resid
ue
PRE Error PRE Error PRE Error PRE Error PRE Error
1 - - - - - - - - - -
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2 4.234 0.275 0.241 - 3.564 - 3.652 - 4.128 -
3 1.944 0.134 0.179 - 1.219 - 1.328 - 1.685 -
4 1.593 0.07 0.159 - 0.929 - 1.021 - 1.288 -
5 1.245 0.028 0.092 - 0.594 - 0.677 - 1.054 -
6 1.344 0.023 0.081 - 0.892 - 0.974 - 1.251 -
7 1.554 0.093 0.097 - 0.964 - 1.021 - 1.561 -
8 1.826 0.11 0.203 - 1.267 - 1.343 - 1.782 -
9 2.030 0.111 0.262 - 1.060 - 1.134 - 1.795 -
10 3.447 0.098 0.603 - 1.570 - 1.640 - 3.046 -
11 4.965 0.062 0.516 - 1.106 - 1.139 - 4.556 -
12 4.079 0.078 0.175 - 0.541 - 0.569 - 3.666 -
13 4.337 0.188 0.132 - 0.715 - 0.733 - 4.072 -
14 4.217 0.161 0.100 - 1.601 - 1.617 - 4.906 -
15 4.557 0.192 0.074 - 1.134 - 1.146 - 4.838 -
16 3.029 0.043 0.116 - 0.607 - 0.636 - 2.854 -
17 3.990 0.112 0.290 - 0.588 - 0.639 - 3.616 -
18 3.016 0.103 0.454 - 0.547 - 0.676 - 2.440 -
19 4.470 0.084 0.853 - 0.986 - 1.285 - 3.871 -
20 3.142 0.06 0.234 - 1.613 - 2.158 - 2.717 -
21 4.445 0.108 0.109 - 2.565 - 3.866 - 3.072 -
22 3.773 0.037 0.133 - 2.664 - 3.563 - 2.818 -
23 3.106 0.058 0.374 - 2.047 - 3.105 - 2.103 -
24 3.899 0.032 0.444 - 1.396 - 3.705 - 1.442 -
25 3.046 0.026 0.187 - 0.844 - 2.764 - 0.946 -
26 1.666 0.032 0.118 - 0.488 - 1.452 - 0.705 -
27 1.557 0.015 0.087 - 0.304 - 1.229 - 0.443 -
28 2.441 0.035 0.097 - 0.210 - 1.881 - 0.372 -
29 2.297 0.067 0.236 - 0.230 - 1.789 - 0.714 -
30 1.357 0.023 0.191 - 0.172 - 0.845 - 0.699 -
31 1.373 0.029 0.095 - 0.133 - 1.083 - 0.435 -
32 2.322 0.094 0.153 - 0.158 - 1.837 - 0.678 -
33 2.259 0.062 0.321 - 0.240 - 1.127 - 1.523 -
34 1.483 0.023 0.129 - 0.147 - 0.626 - 0.994 -
35 2.225 0.079 0.170 - 0.195 - 1.177 - 1.094 -
36 4.091 0.162 0.214 - 0.247 - 1.198 - 2.686 -
37 4.257 0.07 0.138 - 0.207 - 0.582 - 3.836 -
38 5.536 0.136 0.138 - 0.349 - 0.721 - 4.667 -
39 2.980 0.068 0.124 - 0.472 - 0.868 - 2.211 -
40 2.808 0.09 0.221 - 0.971 - 1.740 - 1.795 -
41 3.629 0.128 0.295 - 1.166 - 2.405 - 1.429 -
42 3.854 0.071 0.219 - 1.637 - 3.084 - 1.725 -
43 4.062 0.104 0.087 - 1.023 - 3.530 - 1.059 -
44 3.141 0.046 0.063 - 1.289 - 3.267 - 1.313 -
45 4.404 0.086 0.066 - 1.544 - 4.141 - 1.557 -
46 3.362 0.049 0.081 - 2.121 - 3.265 - 2.140 -
47 4.889 0.225 0.180 - 3.273 - 4.713 - 3.294 -
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48 6.265 0.154 0.147 - 5.107 - 5.714 - 5.122 -
49 5.042 0.049 0.171 - 4.663 - 4.889 - 4.695 -
50 2.830 0.041 0.183 - 2.568 - 2.764 - 2.623 -
51 1.813 0.031 0.121 - 1.475 - 1.685 - 1.554 -
52 1.176 0.017 0.064 - 0.839 - 1.100 - 0.937 -
53 1.455 0.016 0.069 - 0.971 - 1.333 - 1.057 -
54 1.340 0.017 0.089 - 0.815 - 1.106 - 0.960 -
55 1.999 0.047 0.164 - 1.323 - 1.695 - 1.474 -
56 2.695 0.075 0.386 - 2.208 - 2.473 - 2.501 -
SI table 2.9. Predicted 1H PRE values (mM-1 s-1) for GB1free, GB1IgG and GB1 in complex with IgG
fragments
1H GB1free
1H GB1IgG
1H GB1IgG(Fab)
1H GB1IgG(Fc)
Residue PRE Error PRE Error PRE Error PRE Error
1 - - - - - - - -
2 6.05579 0.86467 5.713 - 5.771 - 6.225 -
3 1.92983 0.07241 1.043 - 1.166 - 1.674 -
4 1.58913 0.06759 1.020 - 1.125 - 1.278 -
5 1.44369 0.04194 0.592 - 0.658 - 1.247 -
6 1.26859 0.02899 0.907 - 1.015 - 1.165 -
7 1.8265 0.07138 1.075 - 1.117 - 1.890 -
8 1.59691 0.04574 1.038 - 1.142 - 1.442 -
9 2.00112 0.07334 0.889 - 0.951 - 1.727 -
10 3.23847 0.13902 1.424 - 1.518 - 2.725 -
11 4.24353 0.18799 0.946 - 0.992 - 3.780 -
12 3.45689 0.13274 0.577 - 0.617 - 2.996 -
13 6.39924 0.26087 0.641 - 0.653 - 6.128 -
14 3.20512 0.19916 1.964 - 1.986 - 4.184 -
15 7.10608 0.63004 1.078 - 1.087 - 7.666 -
16 2.24653 0.10432 0.608 - 0.645 - 2.049 -
17 6.05796 0.23198 0.576 - 0.622 - 5.773 -
18 2.42318 0.11199 0.614 - 0.731 - 1.866 -
19 6.66838 0.63787 0.908 - 1.262 - 5.941 -
20 2.88295 0.18841 1.753 - 2.123 - 2.589 -
21 5.294 0.25301 2.133 - 4.159 - 2.745 -
22 3.29529 0.11104 1.884 - 2.901 - 2.086 -
23 4.47693 0.33442 3.417 - 4.690 - 3.447 -
24 5.16172 0.15534 2.304 - 4.973 - 2.349 -
25 3.13895 0.14487 1.172 - 3.001 - 1.265 -
26 1.72057 0.05982 0.634 - 1.556 - 0.812 -
27 1.74493 0.07566 0.388 - 1.427 - 0.500 -
28 2.55056 0.27893 0.264 - 1.976 - 0.408 -
29 2.17533 0.13373 0.245 - 1.737 - 0.660 -
30 1.29119 0.04752 0.181 - 0.863 - 0.594 -
31 1.43688 0.09264 0.138 - 1.179 - 0.399 -
32 2.26622 0.18417 0.163 - 1.806 - 0.642 -
95
33 2.08873 0.10234 0.229 - 1.120 - 1.346 -
34 1.35966 0.0466 0.142 - 0.676 - 0.825 -
35 2.07551 0.14472 0.172 - 1.297 - 0.889 -
36 3.36134 0.17582 0.231 - 1.191 - 2.085 -
37 3.14332 0.10107 0.195 - 0.611 - 2.650 -
38 5.39785 0.25964 0.324 - 0.823 - 4.271 -
39 2.72259 0.1352 0.349 - 0.751 - 1.971 -
40 3.05651 0.28448 1.174 - 1.745 - 2.147 -
41 3.9637 0.91033 0.841 - 2.320 - 1.087 -
42 3.69336 0.14428 2.023 - 3.097 - 2.124 -
43 6.38352 0.62965 1.038 - 5.179 - 1.065 -
44 2.28854 0.06131 1.198 - 2.417 - 1.234 -
45 7.23329 0.11884 2.227 - 6.785 - 2.234 -
46 2.4899 0.04131 1.713 - 2.467 - 1.738 -
47 7.35167 0.0862 4.824 - 7.204 - 4.875 -
48 7.15681 0.10108 5.291 - 6.043 - 5.305 -
49 4.5353 0.0803 3.932 - 4.236 - 3.955 -
50 3.03221 0.09807 2.602 - 2.868 - 2.641 -
51 2.05768 0.0396 1.671 - 1.933 - 1.726 -
52 1.09254 0.01821 0.759 - 0.958 - 0.893 -
53 1.61171 0.0239 0.967 - 1.498 - 1.029 -
54 1.28433 0.02151 0.839 - 1.047 - 1.026 -
55 2.13988 0.08549 1.295 - 1.824 - 1.415 -
56 2.53396 0.17187 1.992 - 2.183 - 2.354 -
SI table 2.10. Relaxation delays (s) used and total experimental time for R1 measurements of GB1free
and GB1cryst
15N R1, GB1 free in solution, Gd(DTPA-BMA) 15N R1, GB1
crystals, Gd(DTPA-
BMA)
0 mM 0.1
mM
0.3
mM
0.7
mM
1.2
mM
2 mM 2.5
mM
0 mM 2 mM
0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.001 0.001
0.1 0.1 0.1 0.075 0.075 0.075 0.075 0.2 0.1
0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.5 0.4
0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.8 0.8
0.5 0.5 0.5 0.3 0.3 0.3 0.3 1.2 1.5
0.75 0.75 0.75 0.4 0.4 0.4 0.4 2.2 3
1 1 1 0.5 0.5 0.5 0.5 4 5.5
1.5 1.5 1.5 0.75 0.75 0.6 0.75 8 9
2 1 1.1 0.75 1 15 15
1.2 1 22
Total 46 h 35 h 35 h 42.5 h 42 h 46.5 h 42.5 h 12 h 12 h
SI table 2.11. Relaxation delays (s) and spin-lock lengths (s) and total experimental time used for R1
and R1ρ measurements of GB1IgG
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15N R1, Gd(DTPA-BMA)
15N R1ρ, Gd(DTPA-BMA)
1H R1, CuEDTA
0 mM 3.5 mM 5 mM 7.5
mM
0 mM 1 mM 2
mM
3.5
mM
0 mM 100 mM
0.01 0.001 0.001 0.001 0.002 0.002 0.002 0.002 0.25 0
15 0.01 0.01 0.01 0.005 0.005 0.005 0.005 0.5 0.02
0.05 0.04 0.04 0.01 0.01 0.01 0.01 0.75 0.04
0.2 0.1 0.1 0.02 0.02 0.02 0.02 1 0.07
0.5 0.5 0.5 0.04 0.04 0.04 0.04 1.25 0.1
1.5 1.5 1.5 0.07 0.06 0.06 0.06 1.5 0.14
3.2 3 3 0.1 0.09 0.09 0.09 1.75 0.2
6 7.5 7.5 0.15 0.13 0.13 0.13 2.2 0.3
Total 87 h 89 h 65.5 h 65.5
h
120 h 24 h 18h 23.5
h
30 h 37 h
SI table 2.12. Result of fitting of experimental sPREs against sPREs back-calculated for several
different models with global scaling as the only fit parameters and weighted by experimental errors.
Experimental data set Predicted data set Scaling factor χ2
15N R1 GB1:IgG (model B Fig. 5) 16.34 4.10
15N R1 GB1:IgG 13.33 4.34
15N R1 GB1:Fab 11.86 9.63
15N R1 GB1:Fc 11.26 14.09
15N R1ρ GB1:IgG (model B Fig. 5) 16.27 3.29
15N R1ρ GB1:IgG 13.60 4.30
15N R1ρ GB1:Fab 12.40 8.64
15N R1ρ GB1:Fc 11.10 12.58
1H R1 GB1:IgG (model B Fig. 5) 59.07 5.27
1H R1 GB1:IgG 51.27 6.77
1H R1 GB1:Fab 50.91 14.44
1H R1 GB1:Fc 36.18 19.23
SI table 2.13. Predicted 1H sPREs for GB1IgG based on modified models with an additional interaction
site (model B) or anisotropic motion (1-5).
Residue Model B Motion 1 Motion 2 Motion 3 Motion 4 Motion 5
2 5.593 5.753 5.612 5.685 5.614 5.748
3 0.956 1.087 1.030 1.052 1.013 1.095
4 0.690 1.039 1.026 1.029 1.018 1.041
5 0.308 0.593 0.612 0.598 0.594 0.600
6 0.185 0.917 0.911 0.912 0.923 0.899
7 0.187 1.049 1.137 1.087 1.125 1.033
8 0.239 1.054 1.051 1.053 1.095 0.997
9 0.275 0.885 0.931 0.902 0.978 0.814
10 0.971 1.459 1.447 1.432 1.613 1.286
11 0.616 0.974 0.994 0.955 1.166 0.799
12 0.308 0.583 0.618 0.586 0.704 0.492
13 0.178 0.583 0.763 0.653 0.778 0.532
14 0.311 1.831 2.197 1.991 2.141 1.764
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15 0.420 0.965 1.276 1.089 1.166 0.999
16 0.285 0.589 0.656 0.613 0.619 0.606
17 0.458 0.563 0.632 0.577 0.544 0.621
18 0.537 0.650 0.614 0.622 0.594 0.658
19 0.894 1.114 0.781 0.912 0.797 1.082
20 1.736 1.885 1.638 1.760 1.593 1.918
21 2.134 2.358 1.979 2.139 1.710 2.650
22 1.880 1.990 1.804 1.892 1.666 2.103
23 3.343 3.323 3.447 3.390 3.141 3.536
24 2.251 2.205 2.334 2.278 1.883 2.595
25 1.157 1.232 1.097 1.168 0.946 1.417
26 0.618 0.671 0.608 0.637 0.555 0.729
27 0.357 0.407 0.375 0.388 0.343 0.440
28 0.250 0.280 0.248 0.259 0.219 0.317
29 0.238 0.255 0.241 0.243 0.222 0.275
30 0.157 0.197 0.168 0.179 0.174 0.190
31 0.110 0.144 0.125 0.131 0.132 0.136
32 0.150 0.153 0.168 0.154 0.161 0.157
33 0.217 0.265 0.195 0.223 0.247 0.214
34 0.114 0.159 0.125 0.137 0.157 0.125
35 0.155 0.192 0.153 0.166 0.209 0.142
36 0.224 0.250 0.215 0.226 0.256 0.225
37 0.183 0.236 0.161 0.191 0.233 0.179
38 0.311 0.436 0.252 0.319 0.479 0.247
39 0.315 0.439 0.293 0.348 0.483 0.268
40 1.087 1.367 1.030 1.173 1.449 0.958
41 0.736 0.964 0.742 0.842 0.977 0.725
42 1.518 2.260 1.773 2.028 2.139 1.929
43 0.567 1.447 0.769 1.039 1.147 0.956
44 0.260 1.413 1.007 1.198 1.247 1.153
45 0.578 3.006 1.677 2.218 2.283 2.144
46 0.515 1.868 1.572 1.710 1.702 1.710
47 2.902 5.642 3.927 4.840 4.597 5.052
48 2.794 5.524 5.015 5.300 5.231 5.345
49 1.890 4.024 3.861 3.946 3.932 3.951
50 1.743 2.658 2.568 2.611 2.594 2.622
51 0.762 1.722 1.638 1.677 1.670 1.682
52 0.288 0.786 0.747 0.765 0.764 0.764
53 0.183 1.050 0.892 0.967 0.985 0.949
54 0.176 0.876 0.813 0.847 0.870 0.822
55 0.615 1.417 1.153 1.300 1.359 1.245
56 1.083 2.035 1.957 2.003 2.090 1.913
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SI table 2.14. Predicted 1H sPREs for GB1IgG based on modified models with an additional interaction
site (model B) or anisotropic motion (1-5).
Residue Model B Motion 1 Motion 2 Motion 3 Motion 4 Motion 5
2 3.477 3.630 3.491 3.559 3.487 3.625
3 1.099 1.254 1.213 1.227 1.195 1.263
4 0.649 0.945 0.940 0.939 0.924 0.951
5 0.281 0.600 0.609 0.602 0.600 0.601
6 0.192 0.894 0.910 0.900 0.912 0.884
7 0.165 0.954 1.004 0.976 1.008 0.932
8 0.239 1.268 1.300 1.284 1.339 1.204
9 0.367 1.059 1.097 1.072 1.159 0.976
10 0.938 1.566 1.639 1.581 1.775 1.422
11 0.657 1.095 1.200 1.114 1.357 0.928
12 0.255 0.532 0.596 0.551 0.665 0.456
13 0.186 0.664 0.829 0.730 0.848 0.607
14 0.318 1.455 1.859 1.626 1.783 1.408
15 0.376 1.036 1.305 1.146 1.212 1.064
16 0.318 0.579 0.667 0.611 0.615 0.605
17 0.453 0.581 0.635 0.593 0.564 0.627
18 0.487 0.591 0.541 0.552 0.522 0.594
19 0.968 1.152 0.880 0.992 0.879 1.137
20 1.602 1.783 1.466 1.618 1.403 1.843
21 2.565 2.759 2.414 2.572 2.174 2.959
22 2.660 2.769 2.579 2.673 2.424 2.882
23 1.999 2.028 2.049 2.040 1.869 2.165
24 1.356 1.364 1.399 1.384 1.154 1.595
25 0.832 0.900 0.783 0.841 0.672 1.050
26 0.473 0.523 0.466 0.489 0.424 0.568
27 0.273 0.322 0.291 0.303 0.272 0.341
28 0.195 0.222 0.199 0.205 0.179 0.246
29 0.223 0.231 0.233 0.227 0.215 0.248
30 0.149 0.189 0.155 0.169 0.169 0.175
31 0.103 0.141 0.119 0.125 0.132 0.126
32 0.145 0.151 0.162 0.149 0.162 0.147
33 0.229 0.281 0.205 0.234 0.262 0.222
34 0.121 0.168 0.130 0.143 0.167 0.129
35 0.178 0.224 0.170 0.189 0.247 0.158
36 0.241 0.275 0.226 0.243 0.285 0.244
37 0.197 0.256 0.167 0.203 0.246 0.199
38 0.332 0.480 0.271 0.345 0.528 0.259
39 0.430 0.603 0.393 0.471 0.667 0.356
40 0.901 1.140 0.844 0.971 1.215 0.782
41 1.039 1.307 1.049 1.168 1.320 1.027
42 1.249 1.883 1.408 1.640 1.754 1.539
43 0.509 1.342 0.786 1.025 1.115 0.953
44 0.292 1.613 1.031 1.289 1.355 1.229
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45 0.393 1.949 1.246 1.538 1.567 1.506
46 0.664 2.387 1.876 2.120 2.103 2.122
47 1.929 3.679 2.882 3.278 3.169 3.373
48 3.274 5.277 4.937 5.121 5.064 5.157
49 2.664 4.735 4.624 4.681 4.668 4.680
50 1.735 2.611 2.549 2.578 2.565 2.586
51 0.723 1.514 1.458 1.483 1.476 1.488
52 0.275 0.875 0.818 0.844 0.844 0.842
53 0.173 1.029 0.918 0.972 0.988 0.957
54 0.195 0.867 0.771 0.822 0.846 0.796
55 0.554 1.414 1.218 1.331 1.382 1.280
56 1.389 2.276 2.136 2.217 2.301 2.131
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3. Intermolecular interactions and protein
dynamics by SSNMR
This chapter was published as:
Intermolecular interactions and protein dynamics by SSNMR, Lamley,
J.M., Öster, C., Stevens, R.A., Lewandowski, J.R. Angewandte
Chemie 2015 54(51), 15374–15378.
3.1 Abstract
Understanding the dynamics of interacting proteins is a crucial step
toward describing many biophysical processes. Here we investigate the
backbone dynamics for protein GB1 in two different assemblies:
crystalline GB1 and precipitated >300 kDa GB1-antibody complex. We
perform these measurements on samples containing as little as 8
nanomoles of protein. From measurements of site-specific 15N relaxation
rates including relaxation dispersion we obtain snapshots of dynamics
spanning nine orders of magnitude in terms of time scale. Comparison of
measurements for GB1 in either environment reveals that while many of
the dynamic features of the protein are conserved between them (in
particular for the fast (ps-ns) motions), much greater differences occur
for slow motions with >500 ns range motions being more prevalent in
the complex. The data suggest that GB1 can potentially undergo a small-
amplitude overall anisotropic motion sampling the interaction interface in
the complex.
3.2 Introduction and Discussion
Protein dynamics are fundamental to a wide range of biophysical
processes, from enzymatic catalysis and ligand binding to molecular
recognition and signaling.[1] Often, the mechanisms that underlie these
processes rely on the interactions of proteins with other molecules. Thus,
characterization of the dynamics of interacting proteins and the manner
in which intermolecular interactions influence those dynamics is required
to fully understand them. In general, the local molecular environment of
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a protein potentially has significant effects upon motions relevant to its
function.[2]
NMR offers access to atomic-resolution details about dynamics over a
wide range of time scales.[3] Unfortunately, proteins and protein
complexes above a few tens of kDa represent a severe challenge for
solution NMR methods, where slow molecular tumbling leads to enhanced
T2 relaxation and hence broad NMR lines. In solid-state NMR (SSNMR)
experiments, however, this size-dependent broadening does not occur
and so biomolecules of several hundred kDa and beyond may be studied,
provided intrinsic challenges of sensitivity and resolution can be
successfully addressed.[4]
We recently demonstrated that high quality spectra could be obtained
for a protein in a precipitated large protein complex, by using an
approach based on combination of high field, fast (60-100 kHz) magic
angle spinning (MAS) and optional sample deuteration.[4d] Notably, this
methodology is applicable to a general case of systems with little or no
overall symmetry, and samples containing only a few nanomoles of
protein can yield spectra with the sensitivity and resolution suitable for
performing quantitative measurements of structure and dynamics.[4d, 4g]
We take advantage of the described approach to, for the first time, use
SSNMR to conduct widespread site-specific relaxation measurements that
shed light on motions for a protein GB1 in a large (> 300 kDa) protein-
antibody complex. We compare these data to analogous data for GB1 in a
crystal, where the pattern of intermolecular interactions is different than
in the complex. Since the backbone conformation of GB1 is very similar
in either form[4d, 5] we expect these to be ideal systems with which to
investigate the influence of different intermolecular interactions and
packing on molecular dynamics. In our comparison we take advantage of
the fact that relaxation rates in the solid state are sensitive to motions
spanning nine orders of magnitude in terms of time scale (this enhanced
range of sensitivity compared to the solution case is related to the lack of
overall tumbling) Relaxation rates relate directly to the time scales and
amplitudes of motions, and thus observed changes in relaxation rates
measured under identical experimental conditions will necessarily reflect
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changes in the underlying protein dynamics (time scales, amplitudes or
both). To ensure a direct comparison, relaxation rates were measured at
the same magnetic field (850 MHz 1H Larmor frequency), spinning
frequency (60 kHz) and sample temperature (27  1 °C) in the two
different assemblies: a GB1 (~6 kDa) crystal and precipitated complex of
GB1 and immunoglobulin G (IgG; ~150 kDa) where GB1 binds to both
the Fab and Fc fragments of the IgG antibody in a >300 kDa complex.[4d,
7] Note that GB1:IgG complex precipitates instantaneously upon mixing
of the GB1 and IgG solutions and without application of any centrifugal
force (i.e. is not sedimented). 100% back-exchanged [U-2H,13C,15N]GB1
was used for preparation of both samples with proteins dissolved in pH
5.5 phosphate buffer. All samples were fully hydrated with bulk solvent
being present in the rotors. The amount of GB1 was estimated to be ~8
nanomoles and ~310 nanomoles in the samples of the complex and
crystal respectively.
Figure 3.1. 15N R1 (a) and R1ρ (b) relaxation rates measurements in 100% proton back-exchanged [U-
2H,13C,15N]GB1 in a complex with IgG (black) and in a GB1 crystal (red). For the severely overlapping
peaks values were removed (see Fig. S3.2-3). Experiments were performed at 850 MHz spectrometer,
60 kHz spinning frequency and with a 17 kHz spin-lock field for measurements in (b). Sample
temperature was 27  1 °C as calculated from the chemical shift of water protons.
In contrast to solution, in the solid state the absence of overall
tumbling enables access to motions in the full range from ps to ms
through NMR relaxation measurements.[3c] To obtain snapshots of
dynamics at different time scales we performed three types of site-
specific measurements dominated by motions on different time scales:
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15N R1, R1ρ and R1ρ relaxation dispersion. At 20 T, 15N R1 is dominated by
ns-range motions.[6] 15N R1ρ is sensitive to ps-ms motions but is
dominated by the motions with longer correlation times.[6, 8] When the
time scales of motions approach that associated with spinning (i.e. μs-ms 
motions), the incoherent (molecular motion) and coherent (spinning)
processes interfere with one another, introducing an R1ρ spinning
frequency dependence.[9] Finally, exchange contributions to 15N R1ρ can be
evaluated from relaxation dispersion, which  reports on μs-range 
motions.[10]
Figure 3.1a shows 15N R1 rates measured for GB1 in both environments
as a function of the residue number (GB1:IgG complex in black and GB1
crystal in red). The R1 rates are similar between crystal and complex with
a few notable localized differences, e.g. residues K10-K13 and D40-G41,
which are elevated in the crystal compared to in the complex. These
differences could be explained by different intermolecular contacts[11]:
these loop residues are involved in specific interactions with IgG in the
complex[4d] but have a large solvent accessible surface and some of the
largest amplitude motions in the crystal.[6] Consequently, overall the fast
ps-ns motions seem largely similar in GB1 in the two different molecular
assemblies, which is consistent with the general observation that a
crystalline environment does not induce large changes in fast ps-ns
dynamics compared to a free molecule in solution (unless a strong direct
contact is present)[11-12] or the interpretation that ps-ns dynamics are
primarily defined by the fold of a protein.
Figure 3.1b shows 15N R1ρ rates measured for GB1 in both environments
as a function of the residue number (complex rates in black, crystal rates
in red). Remarkably, the rates for GB1 in the complex are, on average (at
the same temperature), ~6 times higher than those in the crystal (mean
R1ρ values of 8.1 s-1 and 1.4 s-1 respectively). The similarity of 15N R1’s in
the complex and crystal suggests that these differences in R1ρ rates must
originate primarily from differences in motions occurring on a high-ns to
ms time scale, which have a minimal effect on R1.
Besides the general offset in the 15N R1ρ rates for GB1 in the crystals
and complex, we observe changes in their relative magnitudes as a
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function of the residue number. 15N R1ρ rates are generally elevated in the
loops and at the ends of β-strands both in crystal and complex. However, 
in the crystal, the rates for the helix residues are generally similar or
smaller compared to the rates in β-sheet but they are elevated in the 
complex.
Assuming that the basic interaction interfaces between GB1 and IgG
are well represented by the interfaces observed in crystal structures of
GB1 analogues in complexes with IgG fragments,[4d] one can compare the
local density of packing for GB1 in the crystal and complex. For the
portions of GB1 involved in interactions with IgG, the buried surface area
for the solvent accessible surface is larger in the complex compared to in
the crystal (see Fig. S3.7). The increased 15N R1ρ rates observed in the
complex are therefore more likely to be due to generally longer
correlation times rather than larger amplitudes of motions (i.e. due to
denser packing in the complex, the amplitudes of motions are unlikely to
be greater than in the crystal). Since in GB1 crystals the average
correlation time for the slow motions at this temperature is ~450 ns,[6]
the average correlation time for the dominant slow motions in the
complex must be >500 ns.
Since the 15N R1ρ rates are elevated for all the residues in the complex
compared to crystal, this means that either local slow motions are
induced in most residues upon binding with IgG (these also might be
motions that are present in the crystal but become slower in complex)
and/or GB1 undergoes a small amplitude overall slow motion in the
complex. In the first scenario, local conformational changes occurring on
a slow time scale are likely to modulate isotropic chemical shift and thus
be observable by chemical exchange based methods such as 15N R1ρ
relaxation dispersion.[10, 13] In the second scenario, motion may not
modulate isotropic chemical shift if it is not associated with a local
conformational change, and thus may not be picked up by the relaxation
dispersion measurements. However, such motions in the μs-ms range 
should induce a spinning frequency dependence of R1ρ.[9]
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Figure 3.2. Residues clearly exhibiting chemical exchange on the μs time scale in (a) crystalline GB1 
and (b) GB1 in complex with IgG. The colors of the residues indicate: red - clear μs-exchange 
contribution, blue - no clear μs-exchange contribution and grey - data is unavailable (see SI Figs. S5 & 
S6 for the selection criteria). Example decay curves from measurements on the complex are shown in
the inset of panel (b).
In order to distinguish motion-induced effects from motionally
independent dipolar dephasing, currently, 15N R1ρ relaxation dispersion
and spinning dependent measurements need to be conducted in heavily
deuterated samples preferably at spinning frequencies of >40 kHz.[8b, 10]
First, we measured relaxation dispersion for 100% back-exchanged
deuterated crystalline GB1 (at 50-60 kHz MAS apparently no further
dilution of proton network is required, with coherent contributions being
smaller than 1 s-1 at lower spin-lock fields). Clear dispersion is observed
for only a handful of residues in crystalline GB1 (see Fig. S3.5), which
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must undergo local μs-range motions (more precisely motions on a time 
scale of tens to hundreds of μs). In general, residues with μs-range 
motions cluster in two regions: the C-terminal end of b3, loop 4 and the
N-terminal end of b4 (residues 44, 46, 48-53) and the C-terminal end of
b2 and loop 2 (residues 17, 19-20) (see Fig. 3.2). In the complex, the
presence of μs-range motions (though not the precise rate of exchange) 
can be evaluated by comparing 15N R1ρ measurements at two different
spin-lock values. In the presence of μs-range motions, the contribution 
from chemical exchange should render the measured rate of decay larger
at the lower spin-lock frequencies. For many of the GB1 residues, rates
measured using a 2.5 kHz spin-lock field are considerably elevated
compared to those measured using a 17 kHz spin-lock field, which
indicates that local μs-range motions are much more common in the 
complex compared to in the crystal. Generally, the regions displaying
conformational exchange on the μs-time scale in the crystal show similar 
behavior in the complex (though with a few differences). Other residues,
e.g. the C-terminal end of the helix and b1 strand (see Fig. 3.2) exhibit
the presence of μs-range motions only in the complex.  However, many 
residues that have elevated 15N R1ρ rates in the complex compared to
crystal do not contain significant contributions from chemical exchange in
the μs range (at least not above the current experimental errors). Such 
residues either undergo motions that are outside of the sensitivity range
for the 15N R1ρ relaxation dispersion (e.g. in ms or < 10 μs range) or 
undergo motions that do not modulate isotropic chemical shift and thus
do not contribute to the rates through chemical exchange. In either case,
such motions with correlation times > 1 μs should display spinning 
frequency-dependent 15N R1ρ rates.[9]
Fig. 3.3a shows a comparison of 15N R1ρ rates measured at 60 kHz, 52
kHz and 45 kHz spinning frequencies. Overall, the rates at 45 kHz
spinning are on average about 8 s-1 larger than at 60 kHz spinning,
indicating the presence of slow (μs-ms) motions for essentially all the 
residues (in contrast, in the crystal most rates are either the same within
the experimental error or different by less than 0.5 s-1 under similar
conditions, see Fig. S3.8). A pertinent question is whether the
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omnipresence of slow motions may be a manifestation of an overall small
amplitude motion.[14] Cases in which a protein samples different
orientations in a transient complex were reported previously.[15]
Depending on the nature of the overall motion it would contribute
differently to the observed rates: isotropic motion would result in an
equal contribution to all the rates; anisotropic motion would induce
contributions to the rates that depend on the orientation of the NH bond
vector with respect to the axis of motion.[3c, 14, 16] Figure S3.4 in the
supporting information illustrates this idea by showing the simulated
effect on the 15N R1ρ rates in GB1 in different cases of overall 3D
Gaussian Axial Fluctuations (GAF)[3c, 14, 16] of the molecule. We use the
same model (see S.I.) to fit the experimental 15N R1ρ’s obtained at three
spinning frequencies to get an idea of the type of overall motion that
would be compatible with them. In such a procedure one can safely
neglect any contribution from fast ps-ns motions because they contribute
only to a small fraction of the observed rates and are spinning frequency
independent.[6] Because of the limitations of the available data we also
have been forced to neglect at this stage contributions of slow local
motions (e.g. some of the motions picked up by the relaxation
dispersion). The model involves 6 fit parameters: three amplitudes of
fluctuations against three orthogonal axes, a single time scale for the
overall motion and the two parameters describing the orientation of the
motional reference frame in which the coordinates for all NH vectors are
expressed. The overall motion that leads to the best reproduction of data
(see Fig 3.3c) is essentially axially symmetric, with the largest fluctuation
of ~7° against the blue and green axes in Fig. 3.3b and ~4° against the
red axis and a correlation time of ~80 μs. Note that for such slow 
motions, contributions to the rates from non-directly bonded to nitrogen
protons (including IgG protons) may be non-negligible. In the SI we
consider how including such contributions would affect the above
analysis.
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Figure 3.3. (a) 15N R1ρ rates for GB1 in complex with IgG measured at 60 kHz (blue bars; ω1N/2π = 17 
kHz), 52 kHz (red bars; ω1N/2π = 13.1 kHz) and 45 kHz (black bars; ω1N/2π = 13 kHz) spinning 
frequency at 850 MHz 1H Larmor frequency and a sample temperature of 27  1 °C. (b) Visualization
of the overall 3D GAF motion of GB1 in the complex with IgG consistent with the data in (a). The
amplitudes of fluctuations are listed next to the axes of motion. The approximate correlation time for
the motion is 80 μs. (c) Comparison of 
15N R1ρ rates back-calculated from the best-fit to the 3D GAF
model in (b) to experimental rates.
Proper quantification of the amplitudes and time scales of motions for
GB1 in the complex will require further extensive measurements and a
far more involved analysis (our results suggest that motions occurring at
even four distinct timescales may need to be considered to model
adequately the dynamics for some residues). However, even without this
information it is clear that changes to protein dynamics associated with
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differences in intermolecular interactions are potentially very complex,
that studies of protein dynamics in actual assemblies provide additional
insights not available from studies on isolated systems and that
information about the dynamics of proteins in large complexes may be
now accessed directly through approaches similar to the one proposed
here.
In summary, we have presented a comparison of site-specific backbone
dynamics spanning over nine orders of magnitude in time scale for the
protein GB1 in two different environments: a crystalline form and the >
300 kDa precipitated GB1:IgG complex. Comparison of site-specific 15N
R1 measurements under the same experimental conditions highlighted
general similarities of fast ps-ns dynamics in both environments only
minimally perturbed by strong intermolecular contacts. Comparison of
site-specific 15N R1ρ measurements including relaxation dispersion and
spinning frequency-dependent measurements suggested that different
intermolecular interactions modify the pattern of slow motions, with slow
μs-ms motions being more prevalent in the complex. The generally 
elevated 15N R1ρ rates throughout GB1 in the complex compared to crystal
are consistent with an overall small amplitude anisotropic orientation
sampling of the interaction interface of the protein. This study paves the
way for direct characterization of dynamics in biologically important but
sensitivity-limited samples of proteins within large complexes that will
supplement the picture from studies of isolated proteins.
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3.5 Supplementary Information
3.5.1 Experimental Section
Deuterated [13C,15N]-labeled GB1 (T2Q) was expressed in E.coli
BL21(DE3) after one cycle of adaptation to D2O in a 50 mL pre-culture.
The production was carried out in a 3.6 L fermenter using 1 L D2O M9
minimal media with 6 g 13C-glucose and 1.5 g 15NH4Cl. The final yield
after cell rupture by heating to 75 °C and HPLC purification (RP HPLC
column, Jupiter 10 mm C4 300 Å) was 152 mg. The level of deuteration
was approximately 87%, estimated from solution-state 1D NMR spectra.
After lyophilization, the final buffer (10 mL) was adjusted by dialysis
against 4 x 1 L 50 mM sodium phosphate, pH 5.5. Lyophilized IgG from
human serum was purchased from Sigma-Aldrich. The complex sample
was prepared for solid-state NMR by mixing 0.3 mM GB1 and 0.15 mM
IgG solutions (2:1 molar ratio; note that in later experiments we used
1:1 molar ratio to the same effect), which resulted in instantaneous
precipitation of the complex. The resulting precipitate was centrifuged
into a Bruker 1.3 mm NMR rotor. Note that in contrast to several studies
that rely on sedimentation by ultracentrifugation for preparing sample of
a complex in the case of GB1:IgG complex precipitation occurs
spontaneously without any application of centrifugal force. Thus as
studied here the complex is not a sediment but a precipitate, which is a
direct consequence of bivalent nature of interaction of GB1 with IgG.
Here centrifugation is a means for mechanical transfer of already formed
solid-state sample and not as a way of preparing the sample. The
amount of GB1 in the final sample was estimated to be on the order of 8
nanomoles (or ~50 μg of protein). 
GB1 was also crystallized from a 10 mg/mL solution with the aid of a
precipitant of 2:1 2-methylpentane-2,4-diol:propan-2-ol.[1] The resulting
nanocrystals were then centrifuged into a Bruker 1.3 mm rotor. The
amount of GB1 in the final sample was estimated to be on the order of
310 nanomoles (or ~2 mg of protein).
All solid-state NMR spectra shown, except for 15N R1ρ relaxation
dispersion on crystalline GB1, were recorded at 850 MHz 1H Larmor
frequency with a Bruker Avance III spectrometer, with a Bruker 1.3 mm
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triple resonance probe operating at a magic-angle spinning (MAS)
frequency of 60 kHz. 15N R1ρ relaxation dispersion experiments on
crystalline GB1 were recorded at 600 MHz 1H Larmor frequency with a
Bruker Avance II+ spectrometer, with a Bruker 1.3 mm triple resonance
probe operating at an MAS frequency of 50 kHz. The rotor caps were
sealed with a silicone-based glue to eliminate water leakage, while a
Bruker BCU-X cooling unit was used to regulate the internal sample
temperature to 27 ± 1 °C (measured from the chemical shift of water
with respect to DSS; Bruker macro for calibrating the sample
temperature can be downloaded from the authors’ website). 15N R1ρ rates
in the complex were measured by recording a series of 15N -1H
correlation spectra using the proton-detected pulse sequence shown in SI
Fig.1, where the spin-lock duration, , is incremented between full
experiments.
The nutation frequencies for all the spin lock fields used for 15N R1ρ
measurements were determined using nutation experiments.
For 15N R1ρ measurements on the complex at 60 kHz spinning, double
quantum cross-polarization (CP) contact times were 1 ms (1H-15N) and
0.4 ms (15N-1H), with nutation frequencies of 10 kHz and ~50 kHz for 15N
and 1H (with 5% tangential sweep) respectively. Relaxation series were
collected with spin-lock nutation frequencies of both 17 kHz and 2.5 kHz.
For each experiment within the 17 kHz series, 224 scans of 74 t1
increments were taken (experimental time ~85 h), while for the 2.5 kHz
series 96 scans of 64 t1 increments were taken per experiment
(experimental time ~10 h). Recycle delays were 2 s.
For 15N R1ρ measurements on the complex at 52 kHz spinning, double
quantum cross-polarization (CP) contact times were 1.3 ms (1H-15N) and
0.75 ms (15N-1H), with nutation frequencies of 10 kHz and ~42 kHz for
15N and 1H (with 5% tangential sweep) respectively. Relaxation series
were collected with spin-lock nutation frequencies of 13.1 kHz. 168
scans of 46 t1 increments were taken (experimental time ~45 h). Recycle
delays were 2 s. Data was acquired in an interleaved fashion.
For 15N R1ρ measurements on the complex at 45 kHz spinning, double
quantum cross-polarization (CP) contact times were 1.2 ms (1H-15N) and
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0.5 ms (15N-1H), with nutation frequencies of 8 kHz and ~37 and ~53
kHz for 15N and 1H (with 5% tangential sweep) respectively. Relaxation
series were collected with spin-lock nutation frequencies of 13 kHz. 160
scans of 68 t1 increments were taken (experimental time ~63 h). Recycle
delays were 2 s. Data was acquired in an interleaved fashion.
For 15N R1 measurements on the complex at 60 kHz spinning, double
quantum cross-polarization (CP) contact times were 1.2 ms (1H-15N) and
0.85 ms (15N-1H), with nutation frequencies of 10 kHz and ~50 kHz for
15N and 1H respectively. The relaxation curve was sampled with five
points with relaxation delays between 2 ms and 24 s. 128 scans of 56 t1
increments were taken (experimental time 118.5 h). Recycle delays were
2 s.
For 15N R1ρ relaxation dispersion on crystalline GB1, a series of
interleaved 15N R1ρ measurements were performed at spin-lock
frequencies 1.95, 2.44, 3, 4, 5, 6 and 8 kHz. Each R1ρ curve was sampled
using 10-12 points with spin-locks up to 0.5 s. 4 scans of 70 t1
increments were collected, with a recycle delay of 2 s (total experimental
time X). 1H-15N and 15N-1H CP contact times were 1.5 and 1.0 ms,
respectively, with nutation frequencies of 10 kHz (15N) and ~40 kHz (1H).
For 15N R1 measurements on crystalline GB1 at 60 kHz spinning, double
quantum cross-polarization (CP) contact times were 0.6 ms (1H-15N) and
0.7 ms (15N-1H), with nutation frequencies of 10 kHz and ~50 kHz for 15N
and 1H respectively. The relaxation curve was sampled with ten points
with relaxation delays between 2 ms and 27 s. 16 scans of 98 t1
increments were taken (experimental time 42 h). Recycle delays were 2
s.
For all experiments, 10 kHz WALTZ-16 heteronuclear decoupling was
applied to 1H during 15N evolution, and to 15N during direct 1H acquisition,
while suppression of the 1H signal of water was achieved by saturation
with 200 ms (for the complex) or 50 ms (for the crystals) of slpTPPM 1H
decoupling[2] applied at an amplitude of ¼ of the MAS frequency. In all
experiments, hard pulses were applied at nutation frequencies of 100
kHz (1H and 13C) and 50 or 83.3 kHz (15N). Quadrature detection was
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achieved using the States-TPPI method. Each of the spin-lock frequencies
were determined using nutation experiments.
TopSpin 3.2 and CcpNmr Analysis 2.2.2 were used to process spectra
and analyze the relaxation data, which was subsequently fitted using
Origin 9.1. Fig.3.2-3.3 were produced using the UCSF Chimera
package[3].
Figure S3.1. Pulse sequence used for measuring 15N R1ρ rates in the GB1:IgG complex, where direct 
proton detection offers a crucial enhancement in sensitivity compared to nitrogen or carbon detection.
Hard π/2 pulses are shown as black rectangles. The spin-lock pulse, colored in gray, is incremented 
(length τ) between experiments to follow the R1ρ relaxation of the 15N nuclei. Phase cycling: φ1=(+y), 
φ2=(+y +y +y +y -y -y -y -y), φ3=(+x), φ4=-φ5=(+x +x -x -x), φ6=(+y +y -y -y), φ7=(+y -y +y -y), 
φrec=(+y -y -y +y -y +y +y -y) 
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Figure S3.2. Assigned 2D 15N-1H spectrum of deuterated (full-protonated at exchangeable sites) [U-
13C,15N]GB1 in complex with natural abundance full-length human IgG, recorded at a 1H Larmor
frequency of 850 MHz and at an MAS frequency of 60 kHz.
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Figure S3.3. Assigned 2D 15N-1H spectrum of deuterated (full-protonated at exchangeable sites)
crystalline [U-13C,15N]GB1, recorded at a 1H Larmor frequency of 850 MHz and at an MAS frequency of
60 kHz.
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Figure S3.4. Simulated 15N R1ρ rates for overall anisotropic motion of GB1 about three different
motional axes (inertia axes for GB1 structure PDB ID: 2qmt[4]). The rates were simulated using 3D
GAF[5] for a 10 degree fluctuation against the indicated axes, with a correlation time of 80 ns at 850 1H
Larmor frequency. Both 15N-1H dipolar and 15N CSA contributions were considered. For 15N CSA the
following parameters were assumed: σ11=231.4 ppm, σ22 = 80.6 ppm and σ33=54.0 ppm.
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Figure S3.5. 15N R1ρ relaxation dispersion curves measured on crystalline 100% back-exchanged [U-
2H,13C,15N]GB1 at a 1H Larmor frequency of 600 MHz, 50 kHz MAS and at a sample temperature of
27 °C. Spin-lock frequencies were determined by recording nutation experiments. While the majority of
residues display little in the way of dispersion (i.e. most are flat), residues 17, 19, 20, 44, 46, 49, 50,
51, 52 and 53 show clear dispersion (displayed in Fig. 3b in the main manuscript). For those that are
“flat”, the R1ρ rate at a spin-lock field of 1.95 kHz is actually on average 1.7 s-1 higher than the plateau
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value at 8 kHz spin-lock, an increase we attribute to the presence of coherent contributions to the
measured rates at the lower spin-lock field.
Figure S3.6. Differences between the 15N R1ρ relaxation rates measured at 2.5 kHz and 17 kHz spin-
lock fields (i.e. R1ρ[2.5 kHz] - R1ρ[17 kHz]) in 100% back-exchanged deuterated GB1 in complex with
IgG, at a sample temperature of 271 °C. Exchange contributions are decoupled at 17 kHz, but at 2.5
kHz have observable effects on the decay rates. The horizontal blue line at 1.7 s-1 represents the
average coherent contribution to measured rates as found in crystalline deuterated GB1 at 50 kHz
MAS and a spin-lock field amplitude of 1.95 kHz. While the latter conditions differ slightly from those
used here (60 kHz MAS and 2.5 kHz spin-lock), this fact only ensures that 1.7 s-1 is a safe
overestimate of the coherent contribution in this case. All residues for which R1[2.5 kHz] - R1[17 kHz]
is greater than this threshold by about one error bar or more (calculated from fit errors) were taken to
be undergoing exchange processes on the μs-time scale (displayed in Fig. 3a in the main manuscript). 
These are residues 3-5,7,9,10,16,19,20,24,27,30-31,34,36,42,46,49,51 and 52.
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Figure S3.7. Comparison of helix packing in GB1 crystal (modeled using structure with PDB ID 2qmt[4])
and complex with IgG (modeled using structure of GB1 in complex with Fc fragment of IgG with PDB
ID 1fcc;[6] our previous studies show that the interaction interface identified for a complex with a
fragment is consistent with the interface in the complex with full length IgG). The buried surface area
for the solvent accessible surface, calculated for the interface between the loop2-helix-loop3 fragment
of GB1 and other molecules, is ~440 Å2 for the GB1 in the crystal and ~571 Å2 for GB1 in the complex.
This indicates denser packing of the helix in the complex compared to in the crystal. Similarly, the
buried surface area for the solvent accessible surface, calculated for the interface between the loop1-
strand2-loop2 fragment of GB1 and other molecules, ~334 Å2 for the GB1 in the crystal and ~457 Å2
for GB1 in the complex (PDB ID 1igc[7] used as reference). The buried surface area was calculated in
Chimera[3, 8] using models with added protons and deleted solvent molecules, ligands and ions.
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3.5.2 3D GAF model including spinning frequency dependent expressions
for R1ρ
Single rigid-body motion is assumed and parameterized using a 3D GAF
(Gaussian axial fluctuations) model where the coordinates of all NH
vectors are expressed in a common molecular frame. As a starting point
we expressed the NH vectors using polar coordinates in the inertia frame
of GB1 (computed for the x-ray structure (PDB ID: 2qmt[4])) and then
used two angles to define the orientation of the reference frame as fit
parameters. Thus the fit parameters included amplitudes of fluctuations
against three orthogonal axes (σα, σβ, σγ), a correlation time for the
overall motion, τ, and two angles Δθ and Δφ defining the orientation of 
the reference frame for the motion (see below).
Fitting of the relaxation data (see Fig. 3a) to the model was performed
in Matlab. The minimization was performed using code based on the
fminsearch function with several random starting points to ensure a
global minimum was found. The best-fit amplitude and time scale
parameters for all the models were determined by minimizing the χ2
target function:
where Xi are relaxation rates, σi appropriate experimental errors.
Both dipolar NH (rNH = 1.02 Å) and 15N CSA (assuming axially
symmetric CSA tensor collinear with NH vector; Δσ = - 170 ppm, η = 0) 
contributions to the relaxation were considered. The following
expressions for relaxation rates were used:
R1r ,N = R1r ,NH + R1r ,NCSA
c 2 =
Xi,calc - Xi ,exp( )2
s i ,exp
2
i
å
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The above expressions for R1ρ are based on the expressions from ref.
[9] considering an on-resonance R1ρ measurement .
The spectral density was defined as:
with the 3D GAF order parameter being defined as:
where are the second spherical harmonics and defines the
principal axis for the interaction μ in the 3D GAF reference frame for the
motions.[10] are the reduced Wigner matrix elements with the
rotation angle in the parenthesis. σα, σβ, σγ are the fluctuations (in rad)
against three orthogonal axes α, β, γ. 
For very slow motions the contributions to 15N R1ρ from fluctuations of
dipolar couplings between nitrogens and protons that are not directly
bonded to them (including protons on IgG) may be non-negligible. By
considering x-ray structures of GB1 analogues with IgG fragments we
estimated that typically the cumulative effect of such couplings should
not exceed the effective coupling corresponding to a distance of ~2.5 Å.
In order to evaluate how such contributions would influence the above
3D GAF analysis we refitted the data including an additional term for all
the residues corresponding to relaxation induced by 2.5 Å NH dipolar
relaxation. The isotropic S2 for this contribution was treated as an
additional fit parameter. In order to avoid solutions that may violate
assumptions of Redfield theory we have also imposed an additional
penalty for correlation times that approach the largest relaxation rates.
The best fit yielded fluctuations of 3.1º, 5.3º, 5.6º with Δθ= 11.8°, Δφ= 
14.7° (i.e. axes similar to the ones presented in Fig. 3.3), with a
correlation time of τ= ~54 μs and S2= 0.999.
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Figure S3.8. Comparison of 15N R1ρ rates measured at 56 and 39 kHz spinning frequencies measured
for crystalline 100% H2O [U-2H,13C,15N]GB1 at 1N/2 = 10 kHz, 600 MHz 1H Larmor frequency with a
sample temperature of 27  1 C.
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4. Accelerated Experiments for Probing
Microsecond Exchange in Large Protein Complexes
in the Solid State
4.1 Abstract
Solid state NMR is a powerful method to obtain information on structure
and dynamics of protein complexes, that due to solubility and size
limitations cannot be achieved by other methods. Here we present an
approach that uses a paramagnetic agent to accelerate 15N R1ρ relaxation
dispersion measurements thus enabling quantification of microsecond
conformational exchange in large protein complexes in reasonable
amounts of time. The method is validated on crystalline GB1 and then
applied to a > 300 kDa precipitated complex of GB1 with full length
human immunoglobulin G (IgG). We discover an exchange process
spanning the  sheet that is similar for GB1 in crystals and in complex
with IgG. Our results suggest that the intermolecular hydrogen bonds to
the 2 strand in GB1 involved in the molecular recognition might be the
main factor responsible for inducing this exchange process that does not
occur for the isolated GB1 in solution.
4.2 Introduction and Discussion
Protein dynamics play an important role in many biological processes
such as enzymatic catalysis, ligand binding, or molecular recognition.
Many motions implicated in these processes occur on a microsecond or
slower time scale and can be probed using chemical exchange based
methods, e.g. relaxation dispersion (RD).[1,2] Application of such or any
other methods in solution becomes increasingly difficult for slowly
tumbling proteins and protein complexes above a few tens of kDa due to
the enhanced T2 relaxation resulting in size dependent broadening of
NMR lines. In solid-state NMR, however, line broadening is independent
of size of the system so biomolecules in assemblies of several hundred
kDa and beyond may be studied, provided its intrinsic challenges of
sensitivity and resolution can be successfully addressed.[3–11] Previously,
we have shown that we can access information on protein backbone
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dynamics of a protein G domain (GB1) in a > 300 kDa asymmetric
complex with full length immunoglobulin G (IgG) by measuring 15N R1
and R1ρ relaxation rates.[3] The sensitivity enhancement from the proton
detection at > 50 kHz magic angle spinning (MAS) frequencies enabled
obtaining measurements in a reasonable amount of time for samples
where the observed protein (GB1) is present in very small quantities
(~50 µg in a 1.3 mm rotor).[4] However, since methods such as R1ρ
relaxation dispersion[12] rely on recording of numerous 2D spectra to
measure R1ρ relaxation rates at several different spin lock fields, they
require unpractically long experimental time for such a large complex
forcing us to resort in a previous study to more approximate methods to
detect presence of microsecond exchange.[3] By extrapolating from a
single 15N R1ρ measurement on GB1:IgG complex, recording of a full
relaxation dispersion curve with sensitivity sufficient for quantification
would require experimental times on the order of one-two months. In
order to circumvent this problem, here we propose to use paramagnetic
agents such as (Gd(DTPA-BMA)) as additives to the samples to
accelerate 15N R1ρ relaxation dispersion and thus enable us to perform
this type of experiment on large protein complexes in more realistic time
frames. The shortening of 1H T1’s due to addition of a paramagnetic
agent into the sample enables fast recycling of the experiments, and is
frequently used in solid state NMR to speed up acquisition for chemical
shift assignments and structure calculation.[4,13–27] Since the
paramagnetic agent also affects 1H and 15N R2’s (R2=1/T2), its
concentration needs to be adjusted so that it does not induce excessive
line broadening. However, the exchange contribution to R2 or R1
originating from modulation of isotropic chemical shift (or anisotropic
interactions near rotary resonance conditions),[2,12] which is the source of
relaxation dispersion, is not affected by the paramagnetic relaxation
enhancement (provided it does not induce paramagnetic shifts). Thus
quantitative relaxation dispersion can still be measured in the presence
of paramagnetic agents. The main difference in such
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Figure 4.1. 15N R1 relaxation dispersion for crystalline GB1. (a) Example fits based on the data from
crystalline GB1 in a presence of paramagnetic agent (GB1pre). From left to right; β and α regions 
showing dispersion and the region with no dispersion. Solid lines represent the results of Bloch-
McConnell fits of a two-state exchange model using data obtained at 14.1 and 16.4 T and a sample
temperature of 300  2 K. (b) Example fits based on data from crystalline GB1 without paramagnetic
dopant (GB1dia). From left to right; β region, α region and the region with no dispersion. Dotted black 
lines represent the results of Bloch-McConnell fits of a two-state exchange model using data obtained
at 14.1 and 16.4 T, solid lines represent the curves back-calculated from the best fit parameters for
GB1pre with R1ρ,0 from GB1dia.
an ACCELErated RElaxation Dispersion (ACCELERED) experiment
compared to one obtained in the absence of paramagnetic dopants
should be only a different base/plateau relaxation rate (R1ρ,0). To validate
the ACCELERED method we compared 15N R1ρ relaxation dispersion
experiments on crystalline GB1 where such measurements are practical
with (GB1pre) and without (GB1dia) the presence of a paramagnetic agent.
Subsequently, we applied this validated technique to obtain site specific
information on microsecond conformational exchange of GB1 in the >
300 kDa complex with IgG.
In the solid state in order to obtain quantitative relaxation dispersion
measurements the experiments need to be performed under conditions
where coherent effects, which originate from dipolar couplings that are
not completely averaged by magic angle spinning, are suppressed.[28,29]
For 15N measurements this is typically achieved by deuteration and
partial re-protonation at exchangeable sites of the studied protein and
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application of fast, >40 kHz, spinning.[12] The larger the concentration of
the remaining protons in the sample the faster spinning frequencies need
to be employed. Here we employ 60 kHz spinning in a 100 % back-
exchanged perdeuterated [U-13C,15N]GB1 sample. As can be seen by the
flat dispersion curves for residues not undergoing conformational
exchange the dipolar dephasing is sufficiently suppressed under these
conditions (Fig. 4.1). Generally, the same residues are showing clear
dispersion in experiments with and without paramagnetic dopant (SI
figure 4.7). We observe dispersion in two regions: residues in the α helix 
(region , residues 24, 26, 28, 29, 32, 33, 35, 36 in GB1pre indicated in
blue in Figure 4.1a) and residues in β sheet (region ; strands 2-4 and
loops between strand; residues 12, 17-18, 44-46, 49-53 GB1pre,
indicated in orange red in Fig. 4.1a). To quantify the microsecond
exchange processes in crystalline GB1 in diamagnetic and paramagnetic
samples we fitted residues showing clear dispersion in measurements at
two magnetic fields (14.1 and 16.4 T; SI figures 4.1-4.4, 4.7) to the two-
site exchange Bloch-McConnell formalism (eq. 4.1, see SI).[30,31] All
residues were initially fitted individually. Because the values of exchange
rates for residues that are close in space are rather closely distributed we
also fitted such groups of residues simultaneously assuming that they
undergo a common motion, i.e. assuming common exchange rate, kex,
and populations for the exchanging states, pA & pB, but residue specific
chemical shift differences between the states, . The fit where residues
in the  region were fitted simultaneously to one motion and residues in
the  region simultaneously to another motion (see Table 1) yielded the
lowest Bayesian Information Criterion suggesting that, at least
statistically, this is the most justified model (see SI table 4.14).
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Table 4.1. Results from RD fits for GB1dia (left) and GB1pre (right).
Crystalline GB1dia Crystalline GB1pre
kex (s
-1) ± pB (%) ± kex (s
-1) ± pB (%) ±
All 14094 420 1.28 0.08 14988 814 1.95 0.22
α 8750 546 0.9 0.07 4176 804 1.66 0.16
β 14374 486 2.54 0.24 19945 1320 3.73 0.21
The results of all performed fits are shown in the SI (SI tables 4.1-4.8).
Examples of relaxation dispersion profile fits for GB1pre are shown in Fig.
4.1a and for GB1dia in Fig. 4.1b. Overall, the parameters of the exchange
processes obtained from GB1pre agree well with the data for GB1dia
confirming that although a paramagnetic agent affects R1ρ relaxation
rates it does not affect the exchange contribution. As another way of
validating that relaxation dispersion curves in GB1pre paint the same
picture of microsecond exchange as relaxation dispersion curves in
GB1dia, we have also plotted in Fig. 4.1b dispersion curves back-
calculated from best fit parameters for GB1pre but with the plateau value
for R1ρ, R1ρ,0, from GB1dia. The orange and blue lines in Fig. 4.1b, which
represent the R1ρ rates back-calculated from GB1pre parameters follow
closely the best fit curves for GB1dia indicated with the dotted black lines.
Encouraged by the good correspondence of the view of microsecond
exchange between crystalline GB1dia and GB1pre, we have applied the
ACCELERED approach to a more challenging system, GB1 in a > 300 kDa
complex with IgG, where performing 15N R1 RD on a diamagnetic sample
would require unpractically long experimental times. For a diamagnetic
sample of GB1:IgG complex each R1ρ measurement requires ~3-5 days
to obtain signal to noise sufficient for quantitative analysis, yielding
experimental times on the order of 1-2 months for a full relaxation
dispersion. Even if such long times could be dedicated for a single
experiment, it is very challenging to maintain sufficient experimental
stability over such long periods of time.
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Figure 4.2. 15N R1 relaxation dispersion profiles for GB1 in complex with IgG measured at 16.4 T
(left) and 20 T (right) and sample temperature 300  2 K for the diamagnetic sample (GB1dia) and
sample with added paramagnetic agent (GB1pre). Best fit curves to a two-site exchange model
assuming common motion are shown as black lines.
The addition of Gd(DTPA-BMA) allowed us to perform these experiments
in 5 days on an 850 MHz spectrometer (20 T) and 10 days on a 700 MHz
spectrometer (16.4 T), using 10 different spin-lock field strengths at each
B0 field (RD profiles in SI figs 4.5-4.6; experimental durations in SI table
4.11). For the β region in the GB1:IgG complex dispersion was identified 
generally in the same places as in crystalline GB1, except for residue 38,
which showed dispersion in the GB1:IgG complex but is in the loop
region that was consistently flat in crystalline GB1 (see Fig. 4.3 and SI
figures 4.5-4.6 and 4.8; note that data for some residues that show s
exchange in crystalline GB1 could not be obtained due to either severe
overlap or insufficient signal to noise in the GB1:IgG complex).
134
Figure 4.3. Microsecond exchange in crystalline GB1 (a) and GB1 in a complex with IgG (b). Residues
in the  region are shown in orange. Residues in the  region are shown in blue. Exchange rates for
group fits of the regions and populations for the minor conformer are given above the figures. Grey
represents missing data.
The dispersion at the C-terminal end of β4 is less clear, especially at 
lower magnetic field, which could be potentially explained by the
additional intermolecular interaction in that region restricting the
amplitude of the conformational change or slowing its time scale, and
which we have recently proposed to be present in the complex with full
length IgG based on chemical shift perturbations and solvent PREs. No
residues in the α region could be identified as showing clear dispersion at 
both B0 fields, which may indicate that this slow motion seen in the
crystalline sample is not present in the complex or is slower and thus not
picked up by our experiments where the lowest spin lock field employed
was 2 kHz. Overall, the RD is identified in similar regions as with an
approximate method we applied to GB1:IgG complex in a previous
study[3] but a number of false positives from the approximate method
highlights the need for measuring full relaxation dispersion curves. In the
GB1:IgG complex all residues showing dispersion were considered as
being involved in the same motion and fitted together to obtain single
values for kex (13236 ± 2812 s-1; see Fig. 4.2) and minor state
population, pB (4.73 ± 0.73 %). The best fit parameters for individual
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residues separately and for a single motion in GB1:IgG are listed in SI
Tables 4.9-4.10. To investigate if there were separate motions for the
individual binding sites to the Fab and Fc fragments of IgG we fitted
residues close to each binding site separately, the results from these fits
are very similar to the fit of all residues combined (SI tables 4.11-4.12).
Interestingly, the results of 15N R1 RD on crystalline GB1 and GB1 in
the complex with full length IgG indicate that the conformational
exchange process occurring on microsecond time scale in the  region is
very similar in the two different assemblies: overall the same residues
seem to participate in the process which is characterized by similar
exchange rate and populations for the two states. In contrast, for
isolated GB3 in solution (which has virtually the same structure as GB1)
no microsecond exchange was detected at room temperature.[32] Using
high powered 1H RD with GB3 under supercooled conditions exchange in
the low microsecond range was detected for residues in loop 1 (residues
9-13),[32] which extrapolated to 310 K occurs with time scales on the
order of 400 ns. This timescale of the motion is consistent with the time
scale of motions at room temperature determined from the relaxation
measurements in crystalline GB1[33] though the average activation
energies for this slow backbone motion is estimated to be slightly
lower[34] (in the 35-45 kJ/mol range) than the value from solution
measurements. Thus the microsecond exchange observed using
ACCELERED both in crystalline GB1 and GB1 in complex with IgG seems
to be not present for the isolated GB1 in solution under the same
experimental conditions. The influence of intermolecular interactions on
the slow motions was observed previously, e.g. the main slow
conformational exchange process for ubiquitin observed in solution and
crystal involves the same residues but appears much slower in the
latter.[12,35] However, here the microsecond conformational exchange
process seems to be induced by intermolecular interactions. Importantly,
the similarity of the  region motion parameters for crystalline GB1 and
GB1:IgG complex seems to suggest that formation of intermolecular
hydrogen bonds for the 2 strand (to another molecule of GB1 in the
crystal and to the Fab fragment in the GB1:IgG complex), which exhibits
largest amplitude slow motions in isolated molecule in solution,[36] is the
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main factor determining the pattern of microsecond motions detected in
the  region in the solid state.
Our ACCELERED results explain a number of previous observations
about dynamics in crystalline GB1 and GB1:IgG complex. For example,
presence of s motions should induce spinning frequency dependence of
R1ρ but very little of such effect was observed for crystalline GB1.
However, low population for the minor state means that even though the
amplitude of motion may be appreciable the effective order parameter is
very high[37] and thus contribution to relaxation not very large. A similar
argument confirms that the strong spinning frequency dependence of 15N
R1ρ observed in GB1:IgG does not originate from s exchange and is
consistent with a presence of overall small amplitude motion of GB1 in
the complex with IgG.[3]
In summary, we have shown that adding a paramagnetic agent to
hydrated solid state samples enables relaxation dispersion measurements
in large protein complexes, in which low sensitivity otherwise prevents
such measurements from being performed in a realistic time frame. This
method, ACCELERED, has revealed a s motion in β strands and 
connecting loop regions that occurs in both crystalline GB1 and in the
GB1:IgG complex but is not present in isolated protein in solution. This
suggests that this motion may be induced by intermolecular interactions
and, in particular, intermolecular hydrogen bonds to the 2 strand of GB1
that is a common feature between the two studied assemblies.
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4.5 Supplementary Information
4.5.1 Experimental Section
Sample preparation. Isotope labelled [U-2H,13C,15N]GB1 2Q6I was
expressed in M9 with D2O, deuterated [U-13C]glucose and 15NH4Cl using
pGEV2 in BL21(DE3)[1]. Cells were grown to an OD600 >1.0 in two liters
LB for each liter of M9 and washed once with PBS before resuspension in
M9. Expression was induced with 0.5 mM IPTG after 1 h incubation at 37
C. After expression for 4 h at 37 C, the cells were pelleted (4000  G for
20 min at 16 C), and lysed by sonication in buffer containing lysozyme
(50 mM potassium phosphate; 200 mM NaCl; 1 mg/ml lysozyme; pH
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7.0). The lysate was then incubated at 75 C for 10 min and cleared by
centrifugation (12000  G for 50 min). After precipitation over night with
80% ammonium sulfate, GB1 was pelleted (15000  G for 50 min),
resuspended in buffer (50 mM potassium phosphate; 200 mM NaCl; pH
7.0), and purified on a 16/600 Sephadex pg75 (GE Healthcare) gel
filtration column. Fractions containing GB1 were collected, desalted,
freeze-dried and stored at -20 C.
Freeze-dried [U-2H,13C,15N]GB1 was dissolved in buffer (50 mM sodium
phosphate buffer pH 5.5) to obtain a protein concentration of 10 mg/ml
and crystallized with the aid of 2:1 2-methyl-2,4-pentanediol
(MPD):Isopropanol[2]. GB1:IgG complex was formed by mixing GB1 and
IgG (Sigma – Aldrich, lyophilized, human serum) solutions in 2:1 molar
ratio[3]. Crystalline GB1 and precipitated GB1:IgG complex were packed
into NMR rotors using the following procedure: The crystals/precipitate
were spun down by centrifugation (1 min at 20 000  G using a bench
top centrifuge), and resuspended in a small volume of the supernatant
containing 2% DSS and Gd(DTPA–BMA) at the desired concentration. The
samples were transferred into 200 μl pipette tips, which were then 
attached to the rotors, put into 1.5 ml Eppendorf tubes and centrifuged
(20 000  G) in 1-4 minutes intervals until the rotors were full. The rotor
caps were sealed with a silicone-based glue to prevent leakage.
Solid state NMR. Solid state NMR spectra were recorded at 600 MHz
Bruker Avance II+, 700 MHz Bruker Avance III HD and 850 MHz Bruker
Avance III spectrometers, using Bruker 1.3 mm triple resonance probes
at 60 kHz magic angle spinning. A Bruker BCU-X cooling unit was used to
regulate the internal sample temperature to 27 ± 2 °C (measured from
the chemical shift of water with respect to DSS. For experiments
recorded at 700 MHz 1H Larmor frequency with the GB1:IgG complex
10 % D2O was added to the sample buffer before packing the rotors and
deuterium locking was used in the same way as in solution NMR. 15N-1H
2D correlation spectra were recorded using a proton-detected
heteronuclear correlation sequence. Double quantum cross-polarization
(CP) contact times were between 0.5 – 1.5 ms and individually optimized
for each sample. Recycle delays between 0.2 – 2 s were used depending
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on the amount of paramagnetic agent and magnetic field. R1ρ relaxation
dispersion experiments were recorded as pseudo 3Ds with the varying
spin-lock lengths as the 3rd dimension or a pseudo 4D (GB1:IgG complex
at 850 MHz 1H Larmor frequency) with the varying spin-lock power as the
4th dimension.
In all solid-state experiments, hard pulses were applied at nutation
frequencies of 100 kHz for 1H and 83.3 kHz for 15N. 10 kHz WALTZ-16
decoupling was applied on protons during 15N evolution, and on the 15N
channel during direct 1H acquisition, while quadrature detection was
achieved using the States-TPPI method. Suppression of the water signal
was achieved by saturation with 50 - 200 ms of slpTPPM 1H decoupling
applied at an amplitude of ¼ of the MAS frequency[4] or 100-140 ms
MISSISSIPPI[5] at an amplitude of ½ the MAS frequency on resonance
with the water signal. R1ρ relaxation curves were sampled using 7-10
points for all experiments. 1-25 kHz nutation frequencies, measured by
nutation experiments, were used for the spin-lock fields in the R1ρ
experiments (see SI table 12 for number of points used and total
duration of the experiments). All spectra were processed using TopSpin
3.2. GB1 resonances in the complex with IgG were previously assigned
on the basis of 3D H(H)NH, CONH, CO(CA)NH and CANH experiments[3].
Peak integrals were calculated in TopSpin 3.2. OriginPro 2016 and
MatLab R2014a were used to analyze the relaxation data.
Data fitting. Peak integrals from TopSpin were exported to MatLab where
a mono-exponential function was used with the fminsearchbnd function
to fit the relaxation data. Average values calculated from integral regions
containing only noise were used as input errors. Fit errors were
calculated by Monte Carlo error estimations. A random number between
0 and 1 was multiplied with the integral error and added to the
recalculated integrals. The fitting was then repeated 2000 times with a
new random number between 0 and 1 generated each time. Two times
the standard deviations of the R1ρ values received from the fits for each
residue were used as errors.
Exchange coefficients (kex), population of the minor state (pB), difference
in chemical shifts between the two states (Δδ) were obtained by fitting 
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the R1ρ values obtained at two different B0 fields simultaneously to a
Bloch-McConnell two-site exchange equation (1) derived as described
in[6,7]:
      =       ,   +         ×∆     ×                      (4.1)
where R1ρ,0 is the plateau value for R1ρ, pApB are the populations of the
major and minor sites, Δδ is the chemical shift difference between the 
minor and the major site (in rad s-1), ω1 is the 15N spin-lock field strength
(in rad s-1) and kex is the exchange coefficient (s-1). For the higher B0 field
used in the fits the ratio between the fields squared was multiplied with
the fraction in the equation to account for the differences in field
strengths. Errors were calculated using Monte Carlo error estimation in
the same way as for R1ρ exponential fits. In these fits on resonance R1ρ
rates were used, and were calculated from the measured rates (R1ρ,obs)
by equation 2:
      =       ,                  ×              (4.2)
where the R1 rates used are published elsewhere[8] and the angle θ is 
calculated from equation 3 with Ω as the offset for each peak.  
  = tan       
 
(4.3)
The fitting of the data was done by minimization of the χ2 target
function:
    = ∑       ,              ,         
    ,       (4.4)
Where Xi are the data sets and σi, the corresponding error.
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To compare how different models performed Bayesian Information
Criterion (BIC) where calculated as:
      =     +   × ln(  ) (4.5)
where k is number of fit parameters and n number of data points (see SI
table 13 for comparisons between single residue and combined residue
fits).
4.5.2 Results and Discussion
SI figures 4.1-4.6 contain relaxation dispersion profiles for crystalline
GB1 and GB1 in complex with IgG. Crystalline GB1 without any addition
of paramagnetic relaxation enhancement agent (GB1dia) in SI figures 4.1-
4.2, crystalline GB1 with 2 mM Gd(DTPA-BMA) as solvent paramagnetic
relaxation enhancement agent (GB1pre) in SI figures 4.3-4.4. GB1 in
complex with IgG in SI figures 4.5-4.6. In SI figures 4.1-4.6 the values
on the y-axes are the same as the first plot for all plots unless other
values are given and the values on the x-axes are the same as in the last
plot for all.
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SI figure 4.1. Relaxation dispersion profiles for GB1dia at 16.4 T.
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SI figure 4.2. Relaxation dispersion profiles for GB1dia at 14.1 T. Based on previously published data[8].
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SI figure 4.3. Relaxation dispersion profiles for GB1pre at 16.4 T.
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SI figure 4.4. Relaxation dispersion profiles for GB1pre at 14.1 T.
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SI figure 4.5. Relaxation dispersion profiles for GB1 in complex with IgG, with 5 mM Gd(DTPA-BMA)
as paramagnetic relaxation enhancement agent, measured at 20 T.
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SI figure 4.6. Relaxation dispersion profiles for GB1 in complex with IgG, with 2 mM Gd(DTPA-BMA)
as paramagnetic relaxation enhancement agent, measured at 16.4 T.
Residues were identified, based on SI figures 4.1-4.6, to either be flat
(blue in SI figures 4.7-4.8) or show dispersion (red in SI figures 4.7-4.8).
Residues that couldn’t be clearly identified as flat or showing dispersion
are colored pink in SI figures 4.7-4.8 and residues for which data are
missing due to severe overlap or missing peaks in the spectra are colored
grey.
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SI figure 4.7. GB1 structures with residues colored based on relaxation dispersion profiles. (a) GB1dia.
(b) GB1pre. Residues showing flat dispersion curves are blue, residues showing dispersion are red,
residues that couldn’t be clearly identified as being flat or showing dispersion are pink and residues for
which data are missing due to severe overlap or missing peaks in the spectra are grey.
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SI figure 4.8. GB1 structures with residues colored based on relaxation dispersion profiles of GB1 in
complex with IgG. Residues showing flat curves are blue, residues showing dispersion are red,
residues that couldn’t be clearly identified as being flat or showing dispersion are pink and residues for
which data are missing due to severe overlap or missing peaks in the spectra are grey.
SI tables 4.1-4.12 contain results from RD fits for the residues identified
as showing dispersion at both fields for each sample (colored red in
‘combined’ in SI figures 4.7-4.8). For the GB1 samples, GB1dia and
GB1pre, the different fits were; Individual residues, all residues combined
(12, 17-20, 24, 26, 28, 29, 32-36, 44-46, 49-53, 55 for GB1dia, 12, 17,
18, 24, 26, 28, 29, 32, 33, 35, 36, 44-46, 49-53, for GB1pre) β region 
combined (12, 17-20, 44-46, 49-53, 55, for GB1dia, 12, 17, 18, 44-46,
49-53, for GB1pre), α region combined (24, 26, 28, 29, 32-36 for GB1dia,
24, 26, 28, 29, 32, 33, 35, 36, for GB1pre,).  Since the residues in the α 
helix mostly show clear dispersion at spin-lock fields below 2 kHz and the
RD measurements for GB1dia at 14.1 T were only done down to 1.95 kHz
all residues showing clear dispersion in the α helix at 16.4 T were used in 
the fits. For GB1 in complex with IgG no clear dispersion was seen in the
α-helix. Fits were done for individual residues, residues close to the Fab 
binding site in IgG, residues close to the Fc binding site of IgG and all
residues showing dispersion combined (11, 17-20, 38, 44, 49-51).
SI table 4.1. Results from RD fits of individual residues for GB1dia at 14.1 and 16.4 T.
Res kex (s
-1) Error pB (%) Error δΔ 
(ppm)
Error R1ρ,0 (s
-1) Error
at 16.4 T
R1ρ,0 (s
-1) Error
at 14.1 T
12 28481 9775 0.88 2.43 7.94 5.88 1.57 0.31 6.89 0.40
17 26002 10419 2.04 0.79 4.50 3.32 2.76 0.40 3.87 0.39
18 13888 2966 9.18 1.85 1.97 0.71 1.51 0.16 3.26 0.20
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19 10097 1079 5.49 0.26 3.43 0.61 0.54 0.06 3.03 0.07
20 12583 3228 4.29 0.64 3.56 1.02 1.35 0.15 5.01 0.26
24 19660 4427 5.51 1.43 2.44 0.75 0.40 0.15 1.73 0.12
26 7902 2116 7.87 2.45 2.57 1.81 0.49 0.10 2.01 0.12
34 16859 1683 6.16 0.74 2.65 0.72 0.75 0.07 1.38 0.07
36 2003 1904 3.30 5.23 4.62 9.19 0.57 0.03 1.50 0.05
44 10685 1936 4.80 0.66 3.85 0.91 1.64 0.13 2.61 0.17
45 21380 2071 3.96 1.05 3.92 1.23 1.02 0.10 1.95 0.12
46 14669 1948 5.91 0.97 2.78 0.65 0.26 0.06 0.93 0.07
49 12998 3047 6.41 0.22 3.50 0.56 0.47 0.12 1.60 0.20
50 14373 2148 5.77 0.58 3.43 0.78 0.27 0.14 1.19 0.12
51 12316 909 9.92 2.04 3.12 2.01 0.00 0.05 0.63 0.08
52 20040 2117 5.38 1.42 3.74 1.61 0.00 0.05 0.66 0.09
53 15632 2719 5.88 0.64 3.30 0.84 1.34 0.16 1.79 0.16
55 15936 1716 9.24 2.02 2.09 1.05 0.08 0.07 0.77 0.08
SI table 4.2. Results from RD fits of all residues combined for GB1dia at 14.1 and 16.4 T.
kex (s
-1) Error pB (%) Error
14094 420 1.28 0.08
Res δΔ (ppm) Error R1ρ,0 (s
-1) at
16.4 T
Error R1ρ,0 (s
-1) at
14.1 T
Error
12 5.85 1.02 1.88 0.19 7.29 0.27
17 4.39 0.88 3.19 0.24 4.32 0.16
18 5.08 0.81 1.50 0.13 3.24 0.16
19 6.70 0.93 0.44 0.05 2.90 0.07
20 6.33 1.02 1.34 0.14 4.98 0.24
24 4.70 0.74 0.51 0.12 1.85 0.06
26 5.77 0.93 0.37 0.11 1.85 0.11
28 4.63 0.70 0.07 0.06 2.92 8.19
29 4.38 0.72 0.12 0.07 2.20 5.73
32 3.93 0.58 0.31 0.05 4.35 7.73
33 3.77 0.59 0.38 0.06 52.96 3.66
34 5.57 0.78 0.82 0.06 1.46 0.05
35 3.71 0.57 0.21 0.05 1.61 22.71
36 4.25 0.60 0.42 0.04 1.29 0.06
44 7.18 1.06 1.53 0.12 2.45 0.16
45 6.24 0.88 1.26 0.07 2.25 0.09
46 5.82 0.82 0.28 0.06 0.95 0.05
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49 7.54 1.13 0.45 0.11 1.56 0.18
50 7.12 1.06 0.27 0.13 1.20 0.09
51 8.14 1.14 0.00 0.04 0.57 0.07
52 7.61 1.07 0.02 0.05 0.84 0.06
53 6.86 1.04 1.40 0.13 1.84 0.13
55 5.27 0.78 0.14 0.07 0.84 0.06
SI table 4.3. Results from RD fits of the β region combined for GB1dia at 14.1 and 16.4
kex (s
-1) Error pB (%) Error
14374 486 2.54 0.24
Res δΔ (ppm) Error R1ρ,0 (s
-1)
at 16.4 T
Error R1ρ,0 (s
-1)
at 14.1 T
Error
12 4.18 0.90 1.88 0.19 7.29 0.27
17 3.17 0.74 3.16 0.25 4.30 0.16
18 3.64 0.75 1.50 0.13 3.24 0.17
19 4.77 0.93 0.43 0.05 2.90 0.07
20 4.57 0.93 1.30 0.13 4.95 0.24
44 5.12 1.02 1.53 0.12 2.46 0.16
45 4.47 0.89 1.26 0.07 2.24 0.09
46 4.17 0.82 0.26 0.06 0.94 0.05
49 5.38 1.08 0.44 0.10 1.56 0.16
50 5.08 1.01 0.28 0.11 1.19 0.09
51 5.81 1.15 0.00 0.04 0.56 0.07
52 5.44 1.07 0.00 0.05 0.82 0.06
53 4.90 1.00 1.39 0.13 1.84 0.13
55 3.79 0.74 0.11 0.07 0.82 0.07
SI table 4.4. Results from RD fits of the α region combined for GB1dia at 14.1 and 16.4 T.
kex (s
-1) Error pB (%) Error
8750 546 0.90 0.07
Res δΔ (ppm) Error R1ρ,0 (s
-1) at
16.4 T
Error R1ρ,0 (s
-1) at
14.1 T
Error
24 5.47 1.21 0.66 0.11 1.98 0.06
26 7.19 1.52 0.47 0.10 1.99 0.11
28 5.60 1.19 0.16 0.06 1.15 6.36
29 5.10 1.10 0.22 0.06 2.13 8.19
32 4.63 0.97 0.39 0.04 3.91 3.80
33 4.52 0.93 0.44 0.05 2.43 4.63
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34 6.66 1.36 0.96 0.05 1.61 0.05
35 4.47 0.92 0.28 0.04 5.37 1.97
36 5.26 1.10 0.49 0.04 1.39 0.05
SI table 4.5. Results from RD fits of individual residues for GB1pre at 14.1 and 16.4 T
Res kex (s
-1) Error pB (%) Error δΔ 
(ppm)
Error R1ρ,0 (s
-1) Error
at 16.4 T
R1ρ,0 (s
-1) Error
at 14.1 T
12 22356 5972 4.49 1.28 4.09 3.03 6.16 0.34 3.30 0.33
17 24887 7785 0.89 1.27 7.95 5.08 7.14 0.39 4.38 0.42
18 15894 4908 3.15 1.26 3.43 1.56 6.27 0.26 5.40 0.36
24[a] 1000 3069 3.24 5.22 6.74 4.75 6.85 0.26 4.89 0.28
26[a] 1000 1667 21.58 3.87 3.87 4.09 3.36 0.14 2.29 0.17
28 3231 2234 25.44 3.79 1.77 5.82 3.17 0.13 2.49 0.15
29 15815 5163 9.19 1.10 1.66 0.63 3.25 0.16 2.41 0.17
32 23625 5465 6.49 0.95 2.25 0.87 3.51 0.16 2.33 0.16
33 28872 5851 6.97 1.71 2.37 1.95 2.43 0.15 2.03 0.18
35 8478 3409 3.41 2.47 2.54 1.29 4.23 0.16 3.12 0.18
36 1793 2429 7.95 7.50 2.79 11.71 4.07 0.07 2.99 0.10
44 16662 4421 5.79 1.68 2.79 0.96 3.27 0.19 2.54 0.20
45 35501 5714 9.14 3.04 3.03 2.04 2.44 0.22 1.87 0.22
46 19330 2711 7.03 0.52 2.80 0.55 2.01 0.12 1.33 0.13
49 18089 6223 7.54 1.02 3.50 1.14 5.04 0.37 3.54 0.43
50 4466 3875 4.02 3.52 3.89 8.66 5.69 0.31 3.96 0.36
51 11756 2156 5.31 0.32 3.87 0.72 3.24 0.27 2.44 0.32
52 15510 5224 7.43 1.08 2.51 1.24 1.96 0.17 2.00 0.18
53 20981 4940 5.82 2.11 3.06 1.30 2.95 0.23 2.29 0.27
[a] Residues did not reach a minima in the χ
2 fitting.
SI table 4.6. Results from RD fits of all residues combined for GB1pre at 14.1 and 16.4 T.
kex (s
-1) Error pB (%) Error
14988 814 1.95 0.22
Res δΔ (ppm) Error R1ρ,0 (s
-1) at
16.4 T
Error R1ρ,0 (s
-1) at
14.1T
Error
12 5.78 1.49 6.41 0.24 3.52 0.27
17 4.54 1.20 7.53 0.26 4.74 0.31
18 4.28 1.14 6.29 0.22 5.42 0.34
24 3.74 1.13 6.69 0.31 4.71 0.32
26 4.86 1.23 3.05 0.16 2.01 0.17
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28 4.51 1.16 2.86 0.15 2.19 0.16
29 3.45 0.92 3.27 0.13 2.42 0.17
32 3.55 0.91 3.69 0.11 2.48 0.13
33 3.53 0.89 2.72 0.10 2.30 0.14
35 3.45 0.94 4.10 0.16 3.02 0.18
36 3.44 0.86 3.86 0.08 2.79 0.10
44 4.67 1.20 3.30 0.15 2.57 0.18
45 4.59 1.15 3.12 0.13 2.48 0.15
46 4.98 1.24 2.14 0.10 1.44 0.12
49 6.63 1.70 5.15 0.31 3.65 0.38
50 4.96 1.34 5.32 0.32 3.69 0.38
51 6.39 1.64 3.07 0.24 2.29 0.32
52 4.75 1.21 1.97 0.13 2.01 0.17
53 4.84 1.26 3.13 0.18 2.44 0.21
SI table 4.7. Results from RD fits of the β region combined for GB1pre at 14.1 and 16.4 T.
kex (s
-1) Error pB (%) Error
19945 1320 3.73 0.21
Res δΔ (ppm) Error R1ρ,0 (s
-1) at
16.4 T
Error R1ρ,0 (s
-1) at
14.1T
Error
12 4.37 0.89 6.25 0.26 3.37 0.30
17 3.66 0.80 7.31 0.28 4.54 0.33
18 3.32 0.74 6.16 0.23 5.31 0.36
44 3.52 0.70 3.19 0.15 2.48 0.18
45 3.69 0.68 2.92 0.14 2.31 0.16
46 3.80 0.68 1.99 0.11 1.31 0.12
49 4.91 1.03 4.98 0.32 3.48 0.38
50 3.72 0.86 5.22 0.33 3.57 0.38
51 4.78 0.92 2.90 0.25 2.09 0.33
52 3.51 0.70 1.89 0.14 1.94 0.16
53 3.73 0.75 2.98 0.19 2.31 0.23
SI table 4.8. Results from RD fits of the α region combined for GB1pre at 14.1 and 16.4 T.
kex (s
-1) Error pB (%) Error
4176 804 1.66 0.16
Res δΔ (ppm) Error R1ρ,0 (s
-1) at
16.4 T
Error R1ρ,0 (s
-1) at
14.1T
Error
24 5.08 1.20 6.80 0.26 4.84 0.28
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26 6.64 1.30 3.30 0.14 2.24 0.18
28 5.56 1.10 3.14 0.12 2.46 0.15
29 3.90 0.88 3.50 0.12 2.62 0.15
32 4.01 0.84 3.94 0.10 2.70 0.12
33 3.68 0.76 3.01 0.08 2.58 0.13
35 3.93 0.90 4.35 0.13 3.20 0.17
36 4.30 0.86 4.03 0.07 2.95 0.10
SI table 4.9. Results from RD fits of individual residues for GB1 in complex with IgG at 16.4 and 20 T
Res kex (s
-1) Error pB (%) Error δΔ 
(ppm)
Error R1ρ,0 (s
-1) Error
at 20 T
R1ρ,0 (s
-1) Error
at 16.4 T
11[a] 1000 16317 12.67 5.92 12.57 8.48 8.43 2.64 8.34 2.58
17 15817 8270 8.89 1.28 4.62 1.94 6.89 1.76 4.76 1.94
18 22850 21418 5.05 2.02 3.75 5.25 9.28 1.92 6.51 1.49
19[a] 1000 6240 3.64 4.55 14.33 5.65 9.66 0.85 5.72 0.55
20 32233 14668 14.88 2.44 3.52 3.38 11.63 2.36 6.18 1.91
38 16636 12793 6.17 1.91 3.93 3.08 11.32 1.60 9.27 1.45
44 16261 9414 4.83 1.22 4.29 1.44 8.56 1.15 5.85 1.16
49 19194 16830 7.20 2.36 4.31 4.79 11.49 2.29 7.15 1.99
50 24513 34153 4.20 3.73 3.89 7.63 9.47 2.71 7.58 2.19
51 8827 4969 7.64 1.90 4.66 4.22 10.64 0.88 5.36 0.82
[a] Residues did not reach a minima in the χ
2 fitting.
SI table 4.10. Results from RD fits of all residues combined for GB1 in complex with IgG at 16.4 and
20 T.
kex (s
-1) Error pB (%) Error
13236 2812 4.73 0.73
Res δΔ (ppm) Error R1ρ,0 (s
-1) at
20 T
Error R1ρ,0 (s
-1) at
14.1 T
Error
11 5.77 1.99 7.80 2.34 8.15 2.62
17 6.15 1.66 7.23 1.28 5.20 1.40
18 3.47 1.08 10.04 1.06 7.13 0.88
19 4.09 1.11 9.04 0.83 5.22 0.60
20 4.73 1.34 13.91 1.20 8.11 1.03
38 4.36 1.29 11.60 1.30 9.59 1.16
44 4.26 1.17 8.80 0.87 6.12 0.83
49 5.18 1.59 12.08 1.58 7.64 1.46
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50 3.21 1.14 10.21 1.32 8.20 1.10
51 5.53 1.42 10.22 0.88 4.89 0.72
SI table 4.11. Results from RD fits of residues expected to bind the Fc fragment of IgG combined for
GB1 in complex with IgG at 16.4 and 20 T.
kex (s
-1) Error pB (%) Error
12274 4062 9.50 1.37
Res δΔ (ppm) Error R1ρ,0 (s
-1) at
20 T
Error R1ρ,0 (s
-1) at
16.4 T
Error
44 3.10 1.27 8.87 0.91 6.21 0.85
49 3.80 1.61 12.17 1.62 7.72 1.43
50 2.33 1.10 10.27 1.30 8.26 1.15
51 4.05 1.55 10.31 0.89 4.99 0.81
SI table 4.12. Results from RD fits of residues expected to bind the Fab fragment of IgG combined for
GB1 in complex with IgG at 16.4 and 20 T.
kex (s
-1) Error pB (%) Error
14295 3832 3.63 0.63
Residue δΔ (ppm) Error R1ρ,0 (s
-1) at
16.4 T
Error R1ρ,0 (s
-1) at
14.1T
Error
11 6.51 2.15 7.73 2.49 8.13 2.65
17 7.04 1.80 7.09 1.34 5.01 1.45
18 4.00 1.22 9.95 1.02 7.05 0.94
19 4.67 1.20 8.97 0.88 5.16 0.67
20 5.43 1.45 13.79 1.22 8.00 1.04
38 5.00 1.39 11.51 1.35 9.49 1.12
SI table 4.13. Number of spin-lock lengths, nutation frequencies and total duration of each experiment.
Sample Spin-lock lengths Nutation frequencies Total duration
GB1dia at 16.4 T 10 13 69.5 h
GB1pre at 14.1 T 8 11 24 h
GB1pre at 16.4 T 10 17 43 h
GB1:IgG at 16.4 T 7 10 231.5 h
GB1:IgG at 20 T 8 10 141 h
SI table 4.14. Statistical analysis of RD fits for all samples.
Sample ∑ χ2 Data points Parameters BIC
GB1pre
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Single residue 1488.8 532 57 1846.6
All 1712.5 532 21 1844.3
α / β 1609.3 532 23 1753.6
GB1dia
Single residue 3066.1 460 69 3489.2
All 3202.7 460 25 3356.0
α / β 3190.0 460 27 3355.5
GB1:IgG
Single residue 239.8 200 30 398.7
All 250.9 200 12 314.5
Fab / Fc 250.7 200 14 324.9
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5 Investigation of teixobactin-lipid II interactions
using solution and solid state NMR
5.1 Abstract
Teixobactin is a new promising lipid II binding antibiotic discovered in
uncultured soil bacteria with no detectable resistance in any bacteria
where it targets cell wall biosynthesis by binding lipid II. However, its
solubility and bioavailability are poor and analogues need to be
constructed to address these issues. Structural studies of teixobactin
itself and with its bacterial targets may give key information on the mode
of action and could aid in structure-based design of teixobactin analogues
to develop a new commercially available antibiotic. Here we present the
solution NMR 3D structure of teixobacin in membrane mimetics and
report on amino acids critical for the binding to lipid II. Moreover, we
identified teixobactin regions that undergo conformational changes upon
binding to lipid II by solution NMR titration experiments and solid state
NMR of a sedimented teixobactin-lipid II complex.
5.2 Introduction and Discussion
The majority of antibiotics currently in clinical use have been discovered
by screening cultivable soil bacteria. However, around 99% of
microorganisms are uncultured, meaning that they do not grow under
laboratory conditions. Recently, several methods to access potential
antimicrobial compounds from uncultured microorganisms were
developed[1–4], of which the iChip technology[2] led to the discovery of
teixobactin from a new species of β-proteobacteria called Eleftheria
terrae. Teixobactin was shown to have very good activity against many
difficult-to-treat bacterial infections and no resistant mutants were
obtained by in vitro studies with various bacteria.[5] Teixobactin is
simultaneously inhibiting the biosynthesis of peptidoglycan and teichoic
acids triggering synergistic effects leading to increased cell wall damage
and delocalization of autolysins. Additionally, teixobactin, in contrast to
vancomycin, does not bind mature peptidoglycan, which enables it to
efficiently kill bacteria with increased cell wall density such as
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vancomycin-intermediate Staphylococcus aureus (VISA) against which
vancomycin is ineffective.[6]
Since the discovery of teixobactin and identification of its biosynthetic
pathway[5] a lot of research has been conducted to gain more
understanding on the mode of action of teixobactin with the goal of
developing analogues with better pharmacological properties to generate
new powerful antibiotics against resistant strains for which there is now
no efficient treatment. Several groups have synthesised teixobactin
analogues to investigate the roles of the different residues in teixobactin
and potentially find active compounds that are easier to synthesize and
better suited for clinical use. An NMR study of seven analogues showed
the importance of the D-amino acids for activity[7]. The residue in
position 10, L-allo-enduracididine, is a non-proteinogenic amino acid,
which has been difficult to synthesise and hence replacing it with a
naturally available amino acid is an attractive approach. Arg10-
teixobactin[7–9] and lys10-teixobactin[9] showed good activity and recently
several other teixobactin analogues with different alternatives in position
10 were synthesised and found to have good activity against methicillin-
resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis and
Bacillus subtilis[10]. In this study, we focus on interactions between
teixobactin and lipid II and structural changes to teixobactin upon
binding of lipid II. We have determined the 3D structure of teixobactin in
a membrane like environment using dodecylphosphocholine (DPC)
micelles as membrane mimetics. We further investigated structural
changes of teixobactin induced by binding of lipid II using titration
experiments in solution NMR followed by solid state NMR of the
aggregated complex formed between teixobactin and lipid II in DPC
micelles.
Figure 5.1a shows the 20 lowest energy structures determined by
structure calculations from NMR data of teixobactin in DPC micelles (see
SI table 5.1 for details) and a crystal structure of the teixobactin
analogue Ac-Δ1-5Arg10-teixobactin as a hydrochloride salt[11]. The
expected pyrophosphate binding cage is nearly identical in the NMR and
crystal structures. The most obvious difference between the structures is
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the side-chain of residue 10, where in the analogue the allo-enduracidine
has been replaced by arginine. Additionally, the N-termini are different in
the structures since residues 1-5 were replaced by an acetyl group in the
crystal structure[11].
Figure 5.1. (a) Comparison between a solution NMR structure of teixobactin in DPC micelles with a
crystal structure of teixobactin analogue Ac-Δ1-5Arg10-teixobactin[11]. Beige backbone represents the
solution structure and light blue represents the crystal structure. (b) Results from Kd fits of a 2:1
teixobactin:lipid II binding mode, based on titrations with lipid II to teioxobactin in DPC micelles,
measured by solution NMR.
The effect on teixobactin by binding to lipid II was investigated by NMR
titrations. When lipid II was added to the teixobactin sample no changes
in chemical shifts were observed but rather a decrease in intensities of
the peaks, which is a behaviour characteristic for slow exchange. To
determine binding affinities in the presence of slow exchange the peak
intensities of the bound form are normally followed[12]. In this case that
was not possible due to severe broadening (no peaks appearing for the
bound form), probably caused by aggregation, so the intensities of the
peaks from free teixobactin were fitted to extract dissociation constants
(Kd) (see equation 5.1 in SI). The fitting was performed with several
different ratios of teixobactin:lipid II and the best fits were obtained
using a 2:1 ratio (see SI tables 5.5-5.6), which was reported to be the
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binding ratio previously[5]. It should be noted that the Kd values obtained
by these fits may be lower than the actual Kd values due to the effect
aggregation has on the NMR spectra. Even if the calculated Kd values
may not be exact, they can give qualitative information on where the
interaction takes place. Figure 5.1b shows the fitted Kd values for all
isolated peaks in 1H – 15N and 1H – 13C spectra (for a carbon or nitrogen
that have more than one proton the average Kd is reported). Overall, the
peaks in the expected pyrophosphate binding cage, residues 7-11, are
showing low Kd values indicating that these residues are involved in
binding lipid II. Low apparent Kd values were also seen for Cα of residues 
1, 3 and 4 (Kd for Cα of residue 2 is missing due to spectral overlap) 
suggesting allosteric effects upon binding.
To further investigate the interactions we measured spectra of the
complex formed between teixobactin and lipid II. Due to aggregation this
was not possible in solution NMR but the soluble aggregate was
sedimented by ultracentrifugation and packed into a solid state NMR
rotor. The increased line broadening seen in solution NMR due to large
size of a molecule is not seen in solid state NMR and hence complexes of
several hundreds of kDa may be studied. The sedimented complex
between teixobactin and lipid II gave high quality spectra (See SI Fig.
5.1-5.2) and full chemical shift assignments were possible (SI table 5.4).
Chemical shift perturbations (CSPs), Fig 5.2a, and secondary chemical
shifts, Fig 5.2b-d, were calculated (described in the SI). The CSPs based
on H-N peaks inform on binding and conformational changes, and we see
large CSPs for residues 3-5 and 9-10 suggesting that not only the
pyrophosphate binding cage is affected by binding of teixobactin to lipid
II. The Hα-Cα CSPs suggest that conformational changes mostly affect 
residues 2-7. This is more obvious in secondary chemical shifts, which
report on secondary structure deviations from random coil. Taken
together the Cα, Hα and Cβ secondary chemical shifts suggest that 
residues 2-6 change from random coil towards a more β-sheet like 
conformation while the back-bone conformation for residues 7-11
remains unchanged.
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Figure 5.2. Comparison of chemical shifts between teixobactin in solution and teixobactin in complex
with lipid II in solid state. (a) Chemical shift perturbations for H-N (light grey) and Hα-Cα (dark grey). 
Secondary chemical shifts based on Cα (b), Hα (c) and Cβ (d).
All random coil chemical shifts used in these calculations are defined for
L-amino acids[13], and hence for the modified and unusual amino acids
the chemical shifts from standard amino acids might not be
representative. This needs to be considered for residue 1, with a methyl
group attached to the amide nitrogen which will affect the Ca chemical
shift, for residue 10 which is significantly different from arginine which
was used as comparison and residue 8 which forms a lactone bond with
residue 11.
However, residues 1, 8 and 11 remained unchanged between free and
bound teixobactin with chemical shifts that indicated the presence of
secondary structure. In contrast, residues 2-6 showed deviations from
random coil shifts only in complex with lipid II in the solid state. The
chemical shift changes illustrated by CSPs and secondary chemical shifts
agree generally with the Kd fits in Fig. 5.1 and together they complement
each other well, as the involvement of residue 11 in binding is suggested
by the Kd fits but is not clear from the comparison of chemical shifts.
Furthermore, the low Kd values obtained for some residues outside the
expected pyrophosphate binding cage can mostly be attributed to
conformational changes in residues 2-6.
The N-terminus of teixobactin has been suggested to function as an
anchoring point to the cell membrane, however our data suggest that it
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could have a more involved role in the killing mechanism of teixobactin
by promoting aggregation, which may explain the lower activity seen in
analogues where residues 1-5 were replaced by a hydrophobic group.[11]
The general chemical shift changes towards β-sheet formation for 
residues 2-6 and the large soluble aggregates formed by interactions
between teixobactin and lipid II suggest that these residues may have an
important role in the aggregation process, perhaps by fibril formation, as
was previously reported for the ramoplanin:lipid II complex[14]. In the
case of ramoplanin, addition of 20% DMSO prevented aggregation to
some extent and the interactions could be studied in solution. That is not
the case for the teixobactin:lipid II complex where attempts to measure
interactions in solutions containing DMSO resulted in very poor quality
spectra and addition of up to 80% DMSO was not sufficient to prevent
aggregation.
The binding mode of teixobactin has previously been compared to that of
nisin[15], with regards to the pyrophosphate binding cage[9]. Nisin has a
second killing mechanism, in addition to accumulation of peptidoglycan
precursors, it forms pores by insertion of its elongated part into the cell
membrane. It is possible that the large aggregates formed between
teixobactin and lipid II in a micellar environment are related to some
type of pore formation, however further investigations need to be done
to confirm this.
In summary, we have solved the 3D structure of teixobactin confirming
the presence of a pyrophosphate binding cage previously suggested in
truncated teixobactin analogues. The combination of titrations in solution
NMR and solid state NMR experiments reveals that teixobactin undergoes
conformational changes upon binding to lipid II. Importantly, residues 2-
6 are, from a structural point of view, relevant for the high activity of
native teixobactin compared to truncated analogues. We suggest that
residues 2-6 are important for the activity due to their involvement in
aggregation of teixobactin – lipid II complexes, which in the cell would
lead to accumulation of lipid II and inhibition of cell wall synthesis. Here
we have, for the first time, used proton detected solid state NMR to
obtain site-specific information on interactions between an antimicrobial
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peptide and a cell wall precursor. And although further studies are
required to fully determine the structure of the complex formed between
teixobactin and lipid II, the advantages of using solid state NMR to study
the interactions between an antibiotic and its target without the use of
non-physiological solvents to solubilize aggregates are clear.
5.3 References
[1] T. Kaeberlein, K. Lewis, S. S. Epstein, Science 2002, 296, 1127–9.
[2] D. Nichols, N. Cahoon, E. M. Trakhtenberg, L. Pham, A. Mehta, A.
Belanger, T. Kanigan, K. Lewis, S. S. Epstein, Appl. Environ.
Microbiol. 2010, 76, 2445–2450.
[3] A. D’Onofrio, J. M. Crawford, E. J. Stewart, K. Witt, E. Gavrish, S.
Epstein, J. Clardy, K. Lewis, Chem. Biol. 2010, 17, 254–264.
[4] E. Gavrish, C. S. Sit, S. Cao, O. Kandror, A. Spoering, A. Peoples,
L. Ling, A. Fetterman, D. Hughes, A. Bissell, et al., Chem. Biol.
2014, 21, 509–518.
[5] L. L. Ling, T. Schneider, A. J. Peoples, A. L. Spoering, I. Engels, B.
P. Conlon, A. Mueller, D. E. Hughes, S. Epstein, M. Jones, et al.,
Nature 2015, 517, 455–459.
[6] T. Homma, A. Nuxoll, A. B. Gandt, P. Ebner, I. 4 Engels, T.
Schneider, F. Götz, K. Lewis, B. P. Conlon, 2016, 60, 6510–6517.
[7] Parmar A., S. H. Prior, A. Iyer, C. S. Vincent, D. Van Lysebetten, E.
Breukink, A. Madder, E. J. Taylor, I. Singh, Chem. Commun. 2017,
DOI: 10.1039/c6cc09490b.
[8] Y. E. Jad, G. A. Acosta, T. Naicker, M. Ramtahal, A. El-Faham, T.
Govender, H. G. Kruger, B. G. de la Torre, F. Albericio, Org. Lett.
2015, 17, 6182–6185.
[9] H. Yang, K. H. Chen, J. S. Nowick, ACS Chem. Biol. 2016, 11,
1823–1826.
[10] A. Parmar, A. Iyer, D. G. Lloyd, C. S. Vincent, S. H. Prior, A.
167
Madder, E. J. Taylor, I. Singh, Chem. Commun. 2017, DOI
10.1039/C7CC04021K.
[11] H. Yang, D. R. Du Bois, J. W. Ziller, J. S. Nowick, Chem. Commun.
2017, 8–11.
[12] M. P. Williamson, Prog. Nucl. Magn. Reson. Spectrosc. 2013, 73,
1–16.
[13] D. S. Wishart, Prog. Nucl. Magn. Reson. Spectrosc. 2011, 58, 62–
87.
[14] P. Cudic, J. K. Kranz, D. C. Behenna, R. G. Kruger, H. Tadesse, A.
J. Wand, Y. I. Veklich, J. W. Weisel, D. G. McCafferty, Proc. Natl.
Acad. Sci. U. S. A. 2002, 99, 7384–7389.
[15] S.-T. D. Hsu, E. Breukink, E. Tischenko, M. A. G. Lutters, B. de
Kruijff, R. Kaptein, A. M. J. J. Bonvin, N. A. J. van Nuland, Nat.
Struct. Mol. Biol. 2004, 11, 963–7.
5.4 Supplementary Information
5.4.1 Experimental Section
Sample preparation. Lipid II was obtained from the Dowson and Roper
groups at the School of Life Sciences, University of Warwick. Natural
abundance and [U-13C,15N]teixobactin was obtained from Kim Lewis and
Dallas Hughes at Novobiotics.
Solution NMR. [U-13C,15N]teixobactin was dissolved to a concentration of
2 or 3 mM in 10 mM NaP buffer, pH 6.5, with 100 or 150 mM d38
dodecylphosphocholine (DPC) (Eurisotop). For titrations lipid II was
dissolved in 10 mM NaP buffer, pH 6.5, with 150 mM d38 DPC. Natural
abundance teixobactin was prepared in the same way as isotopically
labelled teixobactin. All solution NMR experiments were performed on a
Bruker Avance II 700 MHz spectrometer equipped with a cryo-probe,
using 3 mm NMR tubes. Experiments were performed at 25 °C, additional
1H-15N and 1H-13C correlation experiments were performed at 37 °C so
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that assignments could be compared with assignments obtained in solid
state NMR experiments. Initial assignments were obtained from a natural
abundance teixobactin using 2D experiments: 1H-13C HSQC
(hsqcetgpsp.2, 16 scans, 256 t1 increments), 1H-15N SOFAST HMQC
(sfhmqccf3gpph, 0.3 s recycle delay, 64 sans, 62 t1 increments), 1H-1H
TOCSY (mlevesgppg, 8 scans, 256 t1 increments, 70 ms mixing time),
1H-1H COSY (cosygpprqf, 8 scans, 512 t1 increments). Assignments were
confirmed and completed from 3D experiments using [U-13C,15N]
teixobactin: BEST HNCACB (b_hncacbgp3d, 0.3 s recycle delay, 24
scans, 44 increments in the 15N dimension, 80 increments in the 13C
dimension), 13C HSQC-TOCSY (hcchdigp3d2, 2 scans, 96 increments in
the HSQC dimension, 160 increments in the TOCSY dimension, 16.3 ms
DIPSI-3 mixing time), CBCA(CO)NH (cbcaconhgpwg3d, 24 scans, 48
increments in the 15N dimension, 96 increments in the 13C dimension,
25% non-uniform sampling (NUS) reconstructed in TopSpin using the
MDD algorithm[1]. 3D NOESYs were used for distance restraints in the
structure calculations: 13C HSQC-NOESY (noesyhsqcetgpsi3d, 8 scans, 48
increments in the HSQC dimension, 96 increments in the NOESY
dimension, 200 ms mixing time), 15N HSQC-NOESY (noesyhsqcf3gpsi3d,
8 scans, 64 increments in the HSQC dimension, 256 increments in the
NOESY dimension, 200 ms mixing time). Titrations with lipid II to [U-
13C,15N] Teixobactin were measured using 1H-15N SOFAST HMQC (2
scans, 128 t1 increments) and 1H-13C HSQC (4 scans, 128 t1
increments). Lipid II was titrated to the following concentration (mM):
0.33, 0.79, 1.5, 2, 2.7, 3, 3.4, 3.7, 4, 4.3, 4, leading to a dilution of
Teixobactin to a final concentration of 2 mM from an initial concentration
of 3 mM. The dilution factor was accounted for in Kd fitting.
Solid State NMR. After titrations of lipid II to [U-13C,15N]teixobactin the
sample was transferred from the NMR tube, 10 mM NaP buffer pH 6.5,
with 2% 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) was added up to
500 μl leading to a final concentration of approximately: 0.6 mM [U-
13C,15N] teixobactin, 1.4 mM lipid II, 45 mM d38 DPC. The sample was
sedimented by ultracentrifugation (Beckmann Coulter Optima MAX-XP
Ultracentrifuge) for 46 hours at 700 000  G, forming a solid paste. Most
169
of the liquid was removed and a small amount of 10 mM NaP buffer
containing 2 mM gadolinium diethylenetriaminepentaacetic acid
bismethylamide (Gd(DTPA-BMA)) and 2% DSS was added to the
sediment. The sediment was packed into a 0.81 mm Samoson rotor. To
keep the sample hydrated during packing small amounts of buffer with
Gd(DTPA-BMA) and DSS was added to the rotor. All experiments were
recorded at a 600 MHz Bruker Avance II spectrometer using a Samoson
HXY 0.81 mm probe at 90 kHz magic angle spinning and a sample
temperature of 39 ± 2 °C measured from the water peak referenced to
DSS. Proton detection with 30 ms acquisition time was used for all
experiments. The addition of Gd(DTPA-BMA) enabled a recycle delay of
0.5 s. Water suppression was achieved by 100-150 ms slTPPM[2] at 22.5
kHz nutation frequency (¼ of the spinning speed). The following spectra
were acquired: 2D 1H-13C inverse cross polarization (CP) (32 scans, 160
t1 increments, 0.4 ms CP between 1H-13C and 13C-1H,) 2D 1H-15N inverse
CP (32 scans, 112 t1 increments, 1 ms CP between 1H-15N and 0.9 ms
between 15N-1H), 3D hCANH (64 scans, 48 increments in 13C dimension,
40 increments in the 15N dimension, 0.4 ms CP between 1H-13C, 11 ms
between 13C-15N, 0.9 ms between 15N-1H), 3D hCONH 64 scans, 28
increments in the 13C dimension, 44 increments in the 15N dimension, 2.5
ms CP between 1H-13C, 11 ms between 13C-15N, 0.9 ms between 15N-1H).
3D hCCH TOCSY (16 scans, 108 increments in both 13C dimensions, 0.4
ms for 1H-13C and 13C-1H CP, 15 ms DIPSI-2 mixing time at 10 kHz
nutation frequency) 3D hCOCACBHAHB DREAM (64 scans, 28 increments
in the 13CO dimension, 52 increments in the 13CA/CB dimension, 2.5 ms
CP between 1H-13CO, 0.4 ms CP between 13CA/CB-1HA/HB, 7 ms
DREAM[3] between 13CO – 13CA/CB at 45 kHz nutation frequency, ½ of the
spinning speed).
Data Analysis. TopSpin 3.2 was used to process all spectra. The spectra
were assigned in Sparky. Structure calculation was performed using
UNIO 10 with Cyana 2.1[4] as molecular dynamics software. Raw spectra
(13C HSQC-NOESY and 15N HSQC-NOESY) were used as input into the
structure calculation. Automatic peak picking and NOE assignments were
achieved by UNIO ATNOS-CANDID[5,6]. The results from the structure
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calculation are shown in SI table 1. Cyana library entries for D-amino
acids were produced using CyLib[7]: D-Glutamine (converted from
DGN.cif), D-allo-Isoleucine (converted from 28J.cif), D-Threonine
(converted from DTH.cif). A Cyana library entry for N-Methylated-D-
Phenylalanine was initially converted by Cylib from ZAE.cif and slightly
modified by producing a .cor file in cyana containing the new ZAE residue
as first residue and a peptide bond to another amino acid. The amide
proton was added in Chimera and a pdb file was exported and read in
Molmol where coordinates were exported as a library file. The library file
was edited manual in a text editor to fit to the Cyana library format.
The .cif files were obtained from http://www.bpc.uni-
frankfurt.de/guentert/wiki/index.php/Cyana_Residue_Library_Entries,
except for D-allo-isoleucine (28J.cif), which was obtained from
http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/28J.
A cyana library entry for allo-Enduracidine was produced from a drawing
of the chemical structure in ChemSketch (ACDLabs Freeware 2012)
including peptide bonds to residues before and after. The chemical
structure was exported as a .mol file and converted to PDB in UCSF
Chimera. MOLMOL was used to write coordinate files and the cyana
library entry was finalized by manually rearranging the atoms and adding
torsion angles in a text editor (PSPAD editor).
To determine binding affinities the peak intensities of free teixobactin
were measured in the titration spectra and fitted to:
  =  
  ∙   ∙[    ] ∙ (−     − [    ] +   ∙ [    ] +   4 ∙     ∙   ∙ [    ] + (    + [    ] −   ∙ [    ])  (5.1)
where P is normalized peak intensity, n is molar ratio for binding (lipid II
/ texiobactin), [Lt] is ligand concentration (lipid II), [Pt] is protein
concentration (teixobactin). Kd values were calculated for several
different values of n (0.25, 0.5, and 1) representing a molar binding ratio
of teixobactin:lipid II of 4:1, 2:1, and 1:1 (see SI table 6). The fitting of
the data was done by minimization of the χ2 target function:
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    = ∑       ,              ,         
    ,       (5.2)
where Xi are the data sets and σi the corresponding error. Secondary
chemical shifts were calculated from random coil chemical shifts from L-
amino acids[8], and hence for the modified and unusual amino acids D-N-
Me-Phe (L-Phe was used as comparison) and L-allo-End (Arg was used as
comparison) the chemical shifts from standard amino acids might not be
representative. Chemical shift perturbations were calculated as Euclidian
distances[9]:
      =    
 
[      + (  ∙       )] (5.3)
where δ is the difference in chemical shift between teixobactin in solution 
and solid state, α = 0.14 if x = N and α = 0.3 if x = C.  
5.4.2 Results and Discussion
1H-15N and 1H-13C solid state NMR spectra of [U-13C,15N]teixobactin in
complex with natural abundance lipid II in d38 DPC micelles are shown in
SI figures 5.1 and 5.2. Folded 15N side chains are indicated in SI figure
5.1. SI Table 5.1 contains information from the structure calculation of
[U-13C,15N]teixobactin in d38 DPC micelles. Resonance assignments for
teixobactin are gathered in SI table 5.2 (25 °C, solution), SI table 5.3
(37 °C solution) and SI table 5.4 (solid state NMR). SI tables 5.5 and 5.6
contain results from Kd fits based on titrations of lipid II to teixobactin.
172
SI figure 5.1. 1H-15N solid state NMR spectrum of [U-13C,15N]teixobactin in complex with natural
abundance lipid II in d38 DPC micelles. Side chains are folded in the 15N dimension.
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SI figure 5.2. 1H-13C solid state NMR spectrum of [U-13C,15N]teixobactin in complex with natural
abundance lipid II in d38 DPC micelles.
SI table 5.1. Results from structure calculation of [U-13C,15N]teixobactin in d38 DPC micelles in solution.
Assigned cross-peaks 1H – 15N HSQC NOESY 1H – 13C HSQC NOESY
Total 100 159
Diagonal 0 1
Intraresidual (i = j) 40 111
Sequential (|i - j| = 1) 40 24
Medium range (1 < |i - j| <
5)
19 21
Long range (|i - j| ≥ 5) 1 2
Distance restraints[a]
Total 125
Intraresidual (i = j) 37
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Sequential (|i - j| = 1) 47
Medium range (1 < |i - j| <
5)
38
Long range (|i - j| ≥ 5) 3
No. of restraints per
residue
11.4
Backbone rmsd 0.09 ± 0.01 Å
Heavy-atom rmsd 0.31 ± 0.09 Å
[a] only meaningful, non-redundant distance restraints are reported
SI table 5.2. Chemical shifts (ppm) for [U13C15N]teixobactin in d38 DPC micelles, solution NMR at
25 °C. Non-standard amino acids: DNP = N-methylated-D-phenylalanine, DGN = D-glutamine, DAI =
D-allo-isoleucine, DTH = D-threonine, END = allo-enduracidine.
Res 1 DNP 2 ILE 3 SER 4 DGN 5 DAI 6 ILE 7 SER 8 DTH 9 ALA 10
END
11 ILE
H 8.57 8.31 8.73 7.93 8.26 7.97 9.04 8.43
N 130.4
7
119.1
2
123.5
8
120.0
0
121.5
4
125.4
7
113.2
5
116.8
0
CA 65.21 60.73 58.28 55.39 60.48 60.11 59.14 58.88 55.41 54.94 60.69
HA 4.25 4.07 4.40 4.36 4.31 4.47 4.66 4.96 4.03 4.50 4.10
CB 39.16 39.11 63.91 28.87 39.61 39.33 65.74 73.85 18.66 39.44 37.68
HB 1.45 1.87 1.92 5.51 1.90
HB2 3.04 3.78 1.91 3.89 1.41 1.93
HB3 3.38 3.81 2.12 4.09 2.24
CG 33.79 55.41
CG1 27.10 28.50 27.49 27.91
CG2 17.61 17.14 18.55 18.05 17.72
HG 4.01
HG12 0.61 1.13 1.22 1.18
HG13 0.91 1.44 1.57 1.53
HG2 2.27
HG22 0.59 0.90 0.97 1.19 0.85
HG3 2.31
CD 51.12
CD1 62.70[
a] 13.59 14.09 13.42 12.45
HD12 0.64 0.88 0.88 0.87
HD1 7.26 3.32
HD2 7.31 3.89
CE1 60.97[
a]
HE1 7.25
HE2 7.31
HE21 6.87
HE22 7.57
ND 89.99
NE2 112.3
8
NG 79.53
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NZ 68.41
HND 8.17
HNG 8.09
HZ 7.13 7.64
C-Met 34.44
CZ 59.22[
a]
H12 2.66
[a] Assignments of folded peaks
SI table 5.3. Chemical shifts (ppm) for [U13C15N]teixobactin in d38 DPC micelles, solution NMR at
37 °C. Non-standard amino acids: DNP = N-methylated-D-phenylalanine, DGN = D-glutamine, DAI =
D-allo-isoleucine, DTH = D-threonine, END = allo-enduracidine.
Res 1 DNP 2 ILE 3 SER 4 DGN 5 DAI 6 ILE 7 SER 8 DTH 9 ALA 10
END
11 ILE
H 8.59 8.36 8.78 7.99 8.29 8.06 9.12 8.52
N 130.2
1
119.2
1
123.6
7
119.9
1
121.4
8
125.4
4
113.2
9
116.7
8
CA 65.41 60.82 58.40 55.54 60.56 60.37 59.11 59.01 55.52 55.05 60.85
HA 4.34 4.20 4.53 4.49 4.44 4.58 4.78 5.06 4.16 4.63 4.23
CB 39.35 39.31 64.09 29.02 39.85 39.25 65.85 74.01 18.81 39.51 37.98
HB 1.58 1.99 2.03 5.63 2.01
HB2 3.15 3.91 2.03 4.00 1.53 2.06
HB3 3.49 3.93 2.24 4.21 2.36
CG 33.95 55.52
CG1 27.18 28.66 27.57 28.02
CG2 17.74 17.22 18.66 18.20 17.83
HG 4.14
HG12 0.74 1.25 1.34 1.31
HG13 1.05 1.56 1.69 1.64
HG2 2.39
HG22 0.72 1.02 1.09 1.32 0.97
HG3 2.44
CD 51.27
CD1 52.92[
a] 13.67 14.05 13.64 12.62
HD12 0.77 1.00 1.00 0.99
HD1 7.38 3.45
HD2 7.43 4.01
CE1 51.18[
a]
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HE1 7.42
HE2 7.43
HE21 6.93
HE22 7.63
ND 90.25
NE2 112.1
0
NG 79.53
NZ 68.44
HND 8.26
HNG
HZ 7.25 7.71
C-Met 34.66
CZ 49.48[
a]
H12 2.78
[a] Assignments of folded peaks
SI table 5.4. Chemical shifts (ppm) for [U13C15N]teixobactin in complex with lipid II in d38 DPC micelles,
solid state NMR at 600 MHz 1H Larmor frequency, 90 kHz MAS and a sample temperature of 39 ±
2 °C. DNP = N-methylated-D-phenylalanine, DGN = D-glutamine, DAI = D-allo-isoleucine, DTH = D-
threonine, END = allo-enduracidine.
Residue 1 DNP 2 ILE 3 SER 4
DGN
5 DAI 6 ILE 7 SER 8 DTH 9 ALA 10
END
11 ILE
H 6.84 8.71 9.30 8.86 8.30 8.42 11.02 8.39 8.81 9.29 8.53
N 110.7
6
129.7
0
120.3
7
121.5
6
113.2
9
121.1
5
126.8
5
110.7
6
128.1
5
111.0
9
118.0
5
CA 64.49 59.14 57.26 55.06 57.28 57.19 60.91 58.21 55.75 54.26 60.63
HA 4.47 5.24 5.43 5.44 5.28 5.57 4.52 5.16 4.13 4.67 4.08
CB 38.63 42.48 66.66 32.24 44.13 38.63 64.94 72.81 19.11 40.18 38.40
HB 1.12 1.62 1.94 5.44 1.75
HB2 3.13 3.74 2.05 3.82 1.47 1.79
HB3 3.82 3.74 2.04 4.07 2.45
CG 33.61 54.51
CG1 27.03 29.92 27.11 27.80
CG2 17.18 16.45 18.24 18.19 17.45
HG 3.98
HG12 0.44 0.90 1.39 1.47
HG13 1.19 1.32 1.01 1.02
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HG2 2.22
HG22 0.27 0.90 1.08 1.47 0.74
HG3 2.23
CD 51.26
CD1 62.85[
a] 14.70 14.88 12.45 12.90
HD12 0.58 0.67 0.77 0.71
HD1 6.99 3.33
HD2 7.31 4.10
CE1 60.37[
a]
HE1 6.99
HE2 7.34
HE21 8.49
HE22 11.37
ND 70.23
NE2 41.09
NG 90.22
NZ 76.39
HND 7.91
HNG 8.75
HZ 6.99 7.24
C-Met 33.70
CZ 59.20[
a]
H12 2.74
[a] Assignments of folded peaks
SI table 5.5. Results from Kd fits (equation (5.1)) with a 2:1 ratio of teixobactin:lipid 2. Only isolated
peaks included. Kd values for carbons and nitrogens with more than one proton are combined.
Atom Kd (μM) Error
1CA 6.13 5.23
1CB 139.06 16.26
1C-Met 63.36 1.06
1CD1 159.19 37.06
1CE1 199.26 20.89
1CZ 251.64 52.65
2N 172.49 13.57
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2CB 127.60 15.39
2CG1 166.34 15.57
2CG2 113.46 1.35
2CD1 102.40 1.79
3N 103.54 9.67
3CA 45.45 21.85
3CB 171.66 7.01
4N 56.79 7.99
4CA 3.58 3.53
4CB 125.99 14.12
4CG 198.85 8.58
4 NE 474.05 15.20
5N 56.69 17.15
5CA 146.34 21.06
5CB 189.50 14.75
5CG1 191.60 11.51
5CG2 142.99 1.86
6N 10.36 8.70
6CA 117.65 23.95
6CB 68.02 13.26
6CG1 483.53 17.81
6CG2 87.49 2.05
7CB 30.29 22.26
8CB 6.75 6.77
8CG2 27.97 3.50
9N 42.34 22.68
9CB 49.43 2.84
10N 3.71 19.02
10CA 58.82 22.51
10CB 19.68 15.99
10CD 68.14 15.45
10NG 388.01 75.98
10ND 141.43 25.73
10NZ 176.06 44.88
11N 45.78 40.07
11CB 58.95 46.84
11CG1 181.00 12.38
11CG2 55.28 1.66
179
11CD1 36.49 2.33
SI table 5.6. Comparison of Kd fits with different ratios of teixobactin:lipid II. All peaks included.
Txb:lipid II 2:1 1:1 4:1
Peak Kd (μM) χ
2 Kd (μM) χ
2 Kd (uM) χ
2
1CD1-HD1 159.19 0.34 67.36 0.49 209.37 0.84
1CE1-HE1 199.26 0.11 81.21 0.68 266.56 0.42
1CZ-HZ 251.64 0.22 116.20 0.30 328.82 0.52
1CA-HA 6.13 3.83 0.00 60.15 7.31 5.14
1CB-HB3 120.02 0.33 46.98 1.02 159.33 0.93
1CB-HB2 158.11 0.11 60.68 1.18 213.40 0.50
1C-Met-H-
Met
63.36 0.16 13.52 6.68 88.16 0.86
2CA-HA 144.65 0.26 56.52 0.58 192.62 0.75
2CB-HB 127.60 0.09 42.30 1.91 175.37 0.50
2CG1-HG13 158.75 0.27 64.64 0.64 211.06 0.73
2CG1-HG12 173.93 0.18 69.60 0.68 232.46 0.57
2CD1-HD12 102.40 0.56 41.02 0.80 134.82 1.25
2CG2-HG22 113.46 0.14 38.90 1.73 153.74 0.67
3CA-HA 45.45 3.92 13.32 4.64 61.28 4.99
3CB-HB3 149.61 0.25 59.79 0.63 198.84 0.74
3CB-HB2 193.71 0.21 82.45 0.40 255.94 0.60
4CA-HA 3.58 4.52 1.60 2.97 4.52 5.54
4CG-HG3 198.13 0.39 84.51 0.36 261.25 0.78
4CG-HG2 199.58 0.40 88.56 0.28 261.29 0.82
4CB-HB3 145.96 0.40 38.09 3.81 212.81 0.48
4CB-HB2 106.03 1.09 47.64 0.67 136.35 1.85
5CA-HA 146.34 0.58 42.90 2.69 209.87 0.76
5CB-HB 189.50 0.21 78.66 0.49 251.64 0.58
5CG1-HG13 202.14 0.17 85.19 0.57 268.44 0.51
5CG1-HG12 181.06 0.22 76.22 0.47 239.50 0.63
5CG2-HG22 142.99 0.23 56.07 0.94 191.42 0.70
5CD1-HD12 198.28 0.18 83.18 0.49 263.26 0.53
6CA-HA 117.65 1.83 32.87 5.82 180.47 1.94
6CB-HB 68.02 0.34 20.10 3.05 92.23 1.11
6CG1-HG13 483.53 0.14 240.07 0.60 627.98 0.12
6CG1-HG12 195.81 0.32 84.82 0.36 257.73 0.72
6CG2-HG22 87.49 0.38 31.38 1.62 116.60 1.10
180
6CD1-HD12 202.83 0.20 86.81 0.40 268.08 0.57
7CA-HA 3.36 29.91 0.04 91.59 17.77 5.57
7CB-HB3 50.87 0.79 15.60 2.17 66.70 1.74
7CB-HB2 9.71 3.03 2.18 8.47 13.12 4.19
8CB-HB 6.75 5.76 0.88 8.90 7.02 6.96
8CA-HA 6.60 5.70 0.00 186.08 32.25 5.75
8CG2-HG22 27.97 1.44 11.03 2.12 35.34 2.59
9CA-HA 104.30 1.28 48.56 0.34 133.01 2.04
9CB-HB2 49.43 1.18 20.04 1.09 63.18 2.19
10CA-HA 58.82 3.76 13.33 4.20 79.52 4.65
10CG-HG 62.49 1.28 27.14 0.99 79.53 2.25
10CD-HD2 52.47 1.15 20.85 1.43 67.06 2.16
10CD-HD1 83.81 0.58 31.20 1.92 110.63 1.36
10CB-HB3 19.68 3.24 8.08 3.21 25.01 4.38
10CB-HB2 134.13 0.31 46.61 1.16 182.55 0.76
11CA-HA 95.80 0.35 31.59 1.96 130.16 0.95
11CB-HB 58.95 1.68 23.57 1.76 76.60 2.61
11CG1-HG13 181.00 0.33 77.36 0.40 238.54 0.76
11CG1-HG12 146.48 0.25 58.06 0.84 195.48 0.72
11CG2-HG22 55.28 0.94 21.13 1.34 71.58 1.90
11CD1-HD12 36.49 2.06 12.80 1.41 48.11 2.95
2N-H 172.49 0.10 14.96 15.85 222.30 0.52
3N-H 103.54 0.37 11.04 10.16 155.00 0.56
4N-H 56.79 0.78 5.78 11.22 86.96 1.28
5N-H 56.69 0.29 1.06 54.34 83.26 0.77
6N-H 10.36 2.36 0.00 10492.62 9.42 4.06
9N-H 42.34 0.48 0.00 108.95 68.51 0.72
10N-H 3.71 3.79 1.23 1.19 4.96 4.80
11N-H 45.78 1.68 0.00 31.27 97.24 1.18
4NE-HE22 346.32 0.25 95.28 0.76 458.80 0.31
4NE-HE21 601.77 0.12 208.66 0.29 757.32 0.11
10ND-HND 141.43 0.15 12.15 16.32 191.97 0.50
10NG-HNG 388.01 0.60 41.47 7.27 434.51 1.16
10NZ-HZ 176.06 1.15 0.00 38.58 184.37 2.14
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